
<html lang="en"     class="pb-page"  data-request-id="f3113f4d-9de4-46c9-b470-099c4890f7bf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2013.56.issue-16;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm4008664;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors" /></meta><meta name="dc.Creator" content="Xiaozhang  Zheng" /></meta><meta name="dc.Creator" content="Paul  Bauer" /></meta><meta name="dc.Creator" content="Timm  Baumeister" /></meta><meta name="dc.Creator" content="Alexandre J.  Buckmelter" /></meta><meta name="dc.Creator" content="Maureen  Caligiuri" /></meta><meta name="dc.Creator" content="Karl H.  Clodfelter" /></meta><meta name="dc.Creator" content="Bingsong  Han" /></meta><meta name="dc.Creator" content="Yen-Ching  Ho" /></meta><meta name="dc.Creator" content="Nikolai  Kley" /></meta><meta name="dc.Creator" content="Jian  Lin" /></meta><meta name="dc.Creator" content="Dominic J.  Reynolds" /></meta><meta name="dc.Creator" content="Geeta  Sharma" /></meta><meta name="dc.Creator" content="Chase C.  Smith" /></meta><meta name="dc.Creator" content="Zhongguo  Wang" /></meta><meta name="dc.Creator" content="Peter S.  Dragovich" /></meta><meta name="dc.Creator" content="Janet  Gunzner-Toste" /></meta><meta name="dc.Creator" content="Bianca M.  Liederer" /></meta><meta name="dc.Creator" content="Justin  Ly" /></meta><meta name="dc.Creator" content="Thomas  O’Brien" /></meta><meta name="dc.Creator" content="Angela  Oh" /></meta><meta name="dc.Creator" content="Leslie  Wang" /></meta><meta name="dc.Creator" content="Weiru  Wang" /></meta><meta name="dc.Creator" content="Yang  Xiao" /></meta><meta name="dc.Creator" content="Mark  Zak" /></meta><meta name="dc.Creator" content="Guiling  Zhao" /></meta><meta name="dc.Creator" content="Po-wai  Yuen" /></meta><meta name="dc.Creator" content="Kenneth W.  Bair" /></meta><meta name="dc.Description" content="Crystal structures of several urea- and thiourea-derived compounds in complex with the nicotinamide phosphoribosyltransferase (Nampt) protein were utilized to design a potent amide-containing inhib..." /></meta><meta name="Description" content="Crystal structures of several urea- and thiourea-derived compounds in complex with the nicotinamide phosphoribosyltransferase (Nampt) protein were utilized to design a potent amide-containing inhib..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 31, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4008664" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4008664" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4008664" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4008664" /></link>
        
    
    

<title>Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4008664" /></meta><meta property="og:title" content="Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0023.jpeg" /></meta><meta property="og:description" content="Crystal structures of several urea- and thiourea-derived compounds in complex with the nicotinamide phosphoribosyltransferase (Nampt) protein were utilized to design a potent amide-containing inhibitor bearing an aza-indole moiety (7, Nampt BC IC50 = 9.0 nM, A2780 cell proliferation IC50 = 10 nM). The Nampt–7 cocrystal structure was subsequently obtained and enabled the design of additional amide-containing inhibitors which incorporated various other fused 6,5-heterocyclic moieties and biaryl sulfone or sulfonamide motifs. Additional modifications of these molecules afforded many potent biaryl sulfone-containing Nampt inhibitors which also exhibited favorable in vitro ADME properties (microsomal and hepatocyte stability, MDCK permeability, plasma protein binding). An optimized compound (58) was a potent inhibitor of multiple cancer cell lines (IC50 &lt;10 nM vs U251, HT1080, PC3, MiaPaCa2, and HCT116 lines), displayed acceptable mouse PK properties (F = 41%, CL = 52.4 mL/min/kg), and exhibited robust efficacy in a U251 mouse xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4008664"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4008664">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4008664&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4008664&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4008664&amp;href=/doi/10.1021/jm4008664" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6413-6433</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400867d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400652r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaozhang++Zheng">Xiaozhang Zheng</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bauer">Paul Bauer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timm++Baumeister">Timm Baumeister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre+J.++Buckmelter">Alexandre J. Buckmelter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maureen++Caligiuri">Maureen Caligiuri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl+H.++Clodfelter">Karl H. Clodfelter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bingsong++Han">Bingsong Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yen-Ching++Ho">Yen-Ching Ho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikolai++Kley">Nikolai Kley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Lin">Jian Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dominic+J.++Reynolds">Dominic J. Reynolds</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Geeta++Sharma">Geeta Sharma</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chase+C.++Smith">Chase C. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongguo++Wang">Zhongguo Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+S.++Dragovich">Peter S. Dragovich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Gunzner-Toste">Janet Gunzner-Toste</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bianca+M.++Liederer">Bianca M. Liederer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justin++Ly">Justin Ly</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++O%E2%80%99Brien">Thomas O’Brien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Oh">Angela Oh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leslie++Wang">Leslie Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiru++Wang">Weiru Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Xiao">Yang Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Zak">Mark Zak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guiling++Zhao">Guiling Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Po-wai++Yuen">Po-wai Yuen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+W.++Bair">Kenneth W. Bair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Forma Therapeutics, Inc., 500 Arsenal Street, Watertown, Massachusetts 02472, United States </span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States </span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Pharmaron Beijing, Co. Ltd., 6 Tai He Road, BDA Beijing, 100176, P. R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: 857-209-2382. E-mail: <a href="/cdn-cgi/l/email-protection#7f0705171a11183f19100d121e0b171a0d1e0f1a0a0b161c0c511c1012"><span class="__cf_email__" data-cfemail="156d6f7d707b7255737a677874617d706774657060617c76663b767a78">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4008664&amp;href=/doi/10.1021%2Fjm4008664" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6413–6433</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 16, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 April 2013</li><li><span class="item_label"><b>Published</b> online</span>31 July 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 August 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4008664" title="DOI URL">https://doi.org/10.1021/jm4008664</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6413%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaozhang%2BZheng%252C%2BPaul%2BBauer%252C%2BTimm%2BBaumeister%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D16%26contentID%3Djm4008664%26title%3DStructure-Based%2BDiscovery%2Bof%2BNovel%2BAmide-Containing%2BNicotinamide%2BPhosphoribosyltransferase%2B%2528Nampt%2529%2BInhibitors%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6433%26publicationDate%3DAugust%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4008664"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2707</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">48</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4008664" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaozhang&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bauer&quot;},{&quot;first_name&quot;:&quot;Timm&quot;,&quot;last_name&quot;:&quot;Baumeister&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;J. Buckmelter&quot;},{&quot;first_name&quot;:&quot;Maureen&quot;,&quot;last_name&quot;:&quot;Caligiuri&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;H. Clodfelter&quot;},{&quot;first_name&quot;:&quot;Bingsong&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Yen-Ching&quot;,&quot;last_name&quot;:&quot;Ho&quot;},{&quot;first_name&quot;:&quot;Nikolai&quot;,&quot;last_name&quot;:&quot;Kley&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Dominic&quot;,&quot;last_name&quot;:&quot;J. Reynolds&quot;},{&quot;first_name&quot;:&quot;Geeta&quot;,&quot;last_name&quot;:&quot;Sharma&quot;},{&quot;first_name&quot;:&quot;Chase&quot;,&quot;last_name&quot;:&quot;C. Smith&quot;},{&quot;first_name&quot;:&quot;Zhongguo&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;S. Dragovich&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Gunzner-Toste&quot;},{&quot;first_name&quot;:&quot;Bianca&quot;,&quot;last_name&quot;:&quot;M. Liederer&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;Ly&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;O’Brien&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Oh&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Weiru&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Zak&quot;},{&quot;first_name&quot;:&quot;Guiling&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Po-wai&quot;,&quot;last_name&quot;:&quot;Yuen&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;W. Bair&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;6413-6433&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4008664&quot;},&quot;abstract&quot;:&quot;Crystal structures of several urea- and thiourea-derived compounds in complex with the nicotinamide phosphoribosyltransferase (Nampt) protein were utilized to design a potent amide-containing inhibitor bearing an aza-indole moiety (7, Nampt BC IC50 = 9.0 nM, A2780 cell proliferation IC50 = 10 nM). The Nampt–7 cocrystal structure was subsequently obtained and enabled the design of additional amide-containing inhibitors which incorporated various other fused 6,5-heterocyclic moieties and biaryl sulfone or sulfonamide motifs. Additional modifications of these molecules afforded many potent biaryl sulfone-containing Nampt inhibitors which also exhibited favorable in vitro ADME properties (microsomal and hepatocyte stability, MDCK permeability, plasma protein binding). An optimized compound (58) was a potent inhibitor of multiple cancer cell lines (IC50 &lt;10 nM vs U251, HT1080, PC3, MiaPaCa2, and HCT116 lines), displayed acceptable mouse PK properties (F = 41%, CL = 52.4 mL/min/kg), and exhibited robust efficacy in&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008664&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008664" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008664&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008664" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4008664&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008664" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4008664&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4008664&amp;href=/doi/10.1021/jm4008664" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4008664" /></input><a href="/doi/pdf/10.1021/jm4008664" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4008664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4008664%26sid%3Dliteratum%253Aachs%26pmid%3D23859118%26genre%3Darticle%26aulast%3DZheng%26date%3D2013%26atitle%3DStructure-Based%2BDiscovery%2Bof%2BNovel%2BAmide-Containing%2BNicotinamide%2BPhosphoribosyltransferase%2B%2528Nampt%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D16%26spage%3D6413%26epage%3D6433%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291071" title="Nicotinamide">Nicotinamide</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jmcmar.2013.56.issue-16/production/jmcmar.2013.56.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Crystal structures of several urea- and thiourea-derived compounds in complex with the nicotinamide phosphoribosyltransferase (Nampt) protein were utilized to design a potent amide-containing inhibitor bearing an aza-indole moiety (<b>7</b>, Nampt BC IC<sub>50</sub> = 9.0 nM, A2780 cell proliferation IC<sub>50</sub> = 10 nM). The Nampt–<b>7</b> cocrystal structure was subsequently obtained and enabled the design of additional amide-containing inhibitors which incorporated various other fused 6,5-heterocyclic moieties and biaryl sulfone or sulfonamide motifs. Additional modifications of these molecules afforded many potent biaryl sulfone-containing Nampt inhibitors which also exhibited favorable in vitro ADME properties (microsomal and hepatocyte stability, MDCK permeability, plasma protein binding). An optimized compound (<b>58</b>) was a potent inhibitor of multiple cancer cell lines (IC<sub>50</sub> <10 nM vs U251, HT1080, PC3, MiaPaCa2, and HCT116 lines), displayed acceptable mouse PK properties (F = 41%, CL = 52.4 mL/min/kg), and exhibited robust efficacy in a U251 mouse xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nicotinamide adenine dinucleotide (NAD) is a critical cofactor for multiple enzymes involved in cell metabolism and homeostasis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Mammalian cells utilize multiple biological pathways to generate NAD which initiate with different precursors, such as tryptophan (Trp), nicotinamide (NAM), nicotinic acid (NA), and nicotinamide riboside (NR). In the NAM to NAD biosynthetic pathway, nicotinamide phosphoribosyltransferase (Nampt) is the rate-limiting enzyme. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, the homodimeric Nampt protein complex uses an ATP-activated reaction to generate nicotinamide mononucleotide (NMN, the immediate biosynthetic precursor of NAD) via the condensation of NAM with 5-phosphoribosyl-1-pyrophosphate (PRPP). The NAM employed in this process can be obtained from exogenous sources but can also be produced by NAD-consuming enzymes such as poly-ADP-ribose polymerases (PARPs) and sirtuins (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Many tumors consume NAD at a higher rate than normal tissues due to increased PARP activity.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Rapidly proliferating cancers have increased biosynthetic and homeostatic requirements that utilize NAD as a cofactor and/or substrate.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This combination of increased NAD consumption and dependence upon NAD-driven processes make the proliferation and/or survival of many cancers highly dependent upon Nampt activity. Therefore, Nampt is an attractive target for the development of new cancer therapies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of NAD biosynthetic pathways found in mammalian cells. Nampt catalyzes the conversion of NAM to NMN.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several classes of Nampt inhibitors have been reported in the scientific literature, and the two most advanced compounds, <b>1</b><a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (GMX-1778) and <b>2</b><a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (APO-866), have been progressed to human clinical trials (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> We recently reported the structure-based identification of urea-containing Nampt inhibitors, exemplified by compounds <b>3</b> and <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> In the current work, we describe the continuation of our Nampt-related research which led to the structure-enabled discovery of novel and highly potent amide-containing Nampt inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of Nampt inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Discovery of a Novel Amide-Containing Nampt Inhibitor</h3><div class="NLM_p">In our previously disclosed cocrystal structure of compound <b>5</b> with Nampt, we observed that the thiourea moiety formed water-mediated hydrogen-bonds with the side chains of the Nampt Asp219 and Ser241 residues (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Similar water-mediated interactions were also crystallographically noted between the urea present in compound <b>4</b> and the Nampt protein.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Given these observations, we were intrigued by the possibility of replacing the (thio)urea moieties contained in <b>4</b> and <b>5</b> with an azaindole-derived amide (e.g., compound <b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This modification would ideally enable direct formation of a hydrogen bond between the azaindole NH group and the Nampt Asp219 side chain. In addition, the amide NH moiety present in <b>6</b> was envisioned to mimic the corresponding (thio)urea NH group contained in <b>4</b> and <b>5</b> and thus favorably interact with the Asp219 and/or Ser241 side chains either directly or in a water-mediated manner. The particular azaindole isomer depicted in compound <b>6</b> was purposefully selected via modeling to best position the N-atom for condensation with the PRPP cofactor in the Nampt active site (a possible requirement for obtaining potent cell activity identified in our earlier studies).<a onclick="showRef(event, 'ref9 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref12">(9, 12)</a> Disappointingly, however, compound <b>6</b>, was completely inactive in our biological assays. We speculated that the rigidity of <b>6</b>, combined with the anticipated altered Nampt binding mode described above, prevented its proper fit into the Nampt binding site. Previous structure–activity relationships (SAR) from the urea series corresponding to <b>5</b> indicated that the addition of a methylene group between the urea and the phenyl linker moiety was tolerated.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> We thus introduced such functionality into compound <b>6</b>, and the resulting (more flexible) molecule (<b>7</b>) encouragingly exhibited potent Nampt biochemical inhibition activity as well as excellent potency in cell-based assays (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These properties compared favorably with those exhibited by the well-known Nampt inhibitors <b>1</b> and <b>2</b> in similar assessments (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Discovery of a novel amide-containing Nampt inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Linker SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0017.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability—% remaining at 30 min.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability—% remaining at 30 min.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Racemic compound. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> SAR Discussion</h3><div class="NLM_p">To enable further optimization of the described amide-containing series of Nampt inhibitors, a cocrystal structure of <b>7</b> in complex with Nampt was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The bicyclic azaindole portion of the ligand was observed in the NAM binding site of Nampt and was stacked between the Tyr18′ and Phe193 side chains of the protein. As envisioned in the design strategy depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, the azaindole did indeed displace the crystallographic water that was previously observed near Asp219 in cocrystal structures of related urea- and thiourea-containing Nampt inhibitors.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> As a result of this displacement, the Asp219 side chain carboxyl was located within hydrogen bonding distance of both the <b>7</b> amide NH and the azaindole NH moiety. The direct interaction between <b>7</b> and Asp219 shifted the ligand closer to this Nampt residue relative to the binding location observed previously for urea- and thiourea-containing inhibitors (e.g., <b>5</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> This movement created space in the vicinity of Ser275, which was occupied in the <b>7</b>-Nampt cocrystal structure by a water molecule (W1) that formed hydrogen bonds with the <b>7</b> amide carbonyl and the Ser275 and Arg311 side chains. The Ph-SO<sub>2</sub>-piperidine portion of <b>7</b> was bound to the Nampt “tunnel” region in a manner similar to that noted previously for related urea and thiourea inhibitiors<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> with water-mediated (W2, W3, and W4) hydrogen bonds being formed to both sulfonamide oxygen atoms. However, due to the shift in the position of <b>7</b> relative to <b>5</b> described above, the Ph-SO<sub>2</sub>-piperidine and azaindole-carboxamide moieties of <b>7</b> were spatially distant and could not be directly linked (as was attempted in the inactive compound <b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This observation clearly explained how the nonobvious inclusion of the methylene group present in <b>7</b> enabled optimal binding of the linked Ph-SO<sub>2</sub>-piperidine and azaindole-carboxamide moieties to Nampt, thereby affording the dramatic potency improvements relative to <b>6</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystal structure of <b>7</b> (green) in complex with Nampt (determined in this work; PBD code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFN">4KFN</a>; monomers in gray and cyan).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Water molecules are depicted as red spheres and possible hydrogen bonds are indicated with dashed yellow lines. The resolution of the structure is 1.87 Å. For comparison, the previously published crystal structure of a related thiourea-containing inhibitor (<b>5</b>) is shown in magenta.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the preceding crystallographic information in hand, we initiated activities to define various structure–activity relationships within the amide inhibitor series. We first confirmed that, consistent with our previous findings,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> an inhibitor bearing a terminal phenyl sulfone was equipotent and more metabolically stable than the corresponding piperidine-sulfonamide (compare <b>7</b> and <b>8</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). With respect to the moiety linking the amide and diaryl sulfone, we found that, consistent with the close proximity of the methylene group present in <b>7</b> to various Nampt residues, adding a methyl group to this portion of <b>7</b> caused a complete loss of activity (<b>9</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Similarly, replacing the methylene present in <b>8</b> with an ethylene linker (compound <b>10</b>) caused a 30-fold loss in biochemical activity and an even more dramatic loss of cellular potency. This unfavorable outcome was likely due to the inability to appropriately reposition the diaryl sulfone moiety of <b>10</b> in the Nampt tunnel region in order to accommodate the larger linker group. Collectively, these results identified an unsubstituted methylene moiety as the preferred linker for obtaining both potent biochemical and cellular anti-Nampt activity. Accordingly, this functional group was retained in subsequent inhibitor designs throughout the remainder of the SAR studies.</div><div class="NLM_p">Encouraged by this discovery, we next investigated the SAR surrounding the azaindole moiety present in compounds <b>7</b> and <b>8</b>. Our previous modifications to the corresponding region of related urea-containing inhibitors indicated that an appropriately positioned nucleophilic nitrogen atom was often necessary to provide potent, cell-active compounds and that subtle positional alterations of this atom could have severe negative effects.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> These results are believed to be due to the ability of certain inhibitors to function as NAM mimics and readily form PRPP-derived phosphoribosylated adducts in the Nampt active site.<a onclick="showRef(event, 'ref12 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref15">(12, 15)</a> Consistent with this hypothesis, the PRPP adduct corresponding to the potent cell-active inhibitor <b>8</b> was observed by mass spectrometry in biochemical Nampt inhibition experiments (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for more details). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, moving the pyrido nitrogen atom present in <b>7</b> to the adjacent position (compound <b>11</b>) caused a >100-fold loss of biological activities. The weak biological activities exhibited by <b>11</b> may result from its inability to form the corresponding PRPP adduct, although we did not confirm this possibility via mass spectrometry.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Introducing an additional nitrogen atom into the azaindole system drastically diminished biological activity (<b>12</b>), likely due to ionization of the new heterocycle under physiological conditions, thus causing an electrostatically unfavorable interaction with Asp219 (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>; JChem predicts an NH p<i>K</i><sub>a</sub> value of 7.7 for compound <b>12</b> and its tautomeric form as compared to 10.8 for compound <b>8</b>). Similarly, methylation of the pyrrole nitrogen of <b>8</b>, which was expected to disrupt a hydrogen bonding interaction with the side chain of Asp219 (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), led to significant loss of biological activities (compare to <b>13</b>). In contrast, the N-methylated compound <b>14</b> exhibited slightly improved biochemical activity as compared with the unmethylated analog <b>11</b>. This result was consistent with an altered Nampt binding mode for <b>11</b> relative to <b>8</b> which did not involve formation of a hydrogen bond between the azaindole NH of <b>11</b> and Asp219 (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Not unexpectedly, changing the amide attachment location to the 3-position of the azaindole, and thereby likely significantly altering the positioning of this moiety relative to that observed in the <b>7</b>–Nampt cocrystal structure, was also highly detrimental to biological activity (compare <b>15</b> with <b>8</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Heterobiaryl SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0019.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability—% remaining at 30 min.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability—% remaining at 30 min.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Below limit of quantification.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">Not determined. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">Satisfied with the potent biochemical and cellular activity exhibited by the azaindole-containing compounds <b>7</b> and <b>8</b>, we explored incorporation of other fused heterobiaryl systems into the amide-based inhibitor design. We were particularly interested in examining 6,5-fused-heterocycles which lacked the NH present in azaindole-containing molecules such as <b>7</b> and <b>8</b>. Such compounds would test whether loss of the associated H-bond with Asp219 could be tolerated if additional steric bulk was not simultaneously introduced into the inhibitor (as in compound <b>13</b> above). Such toleration might be achieved by the combination of proper steric fit of the nonazaindole heterocycles in the NAM binding region of Nampt and the formation of an appropriate H-bond interaction between the amide NH present in the new designs and Asp219 (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, many compounds bearing furopyridines, thienopyridines, and thiazolopyridines were identified which exhibited potent Nampt inhibition properties in biochemical assays (<b>16</b>–<b>24</b>). These results confirmed that appropriate 6,5-bicyclic heterocycles which were incapable of H-bonding with Asp219 could nevertheless be tolerated in the Nampt active site (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). However, only a subset of these biochemically active molecules displayed submicromolar potency in Nampt-related cell-based assessments (<b>17</b>–<b>20</b>). This discrepancy may partially result from the inability of the less cell-potent compounds to form the corresponding PRPP adducts, although we did not confirm this possibility for all such inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Consistent with this hypothesis, the PRPP–ribose adduct corresponding to <b>20</b>, a potent Nampt inhibitor in cell culture, was indeed detected by mass spectrometry in biochemical Nampt inhibition experiments (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for more details). Many of the disappointing cell culture results might also be related to the relatively weak Nampt biochemical inhibition exhibited by the corresponding molecules (e.g., <b>16</b>, <b>21</b>, <b>23</b>, and <b>24</b>). However, consistent with the PRPP–ribose adduct hypothesis, compound <b>22</b> displayed drastically attenuated cell potency relative to its biochemically equipotent structural isomer <b>19</b>. The latter inhibitor likely positions its thienopyridine nitrogen in a manner similar to that observed crystallographically for the corresponding N-atom of the cell-potent azaindole-containing compound (<b>7</b>) described earlier in this work (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The proposed positioning may reflect an optimal orientation for the formation of the corresponding PRPP adducts in the Nampt active site and, due to the different location of the nitrogen atom in the thienopyridine ring system, is not achievable by the structural isomer <b>22</b>. In addition, the suggested binding of <b>19</b> to Nampt orients the compound’s thienopyridine sulfur atom away from Asp219 and thus avoids an unfavorable electronic interaction between these two moieties. Such binding contrasts with that observed crystallographically for compound <b>7</b>, in which the inhibitor’s azaindole NH faces Asp219 and forms an H-bond with the residue (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>20</b> presumably binds to Nampt in a manner analogous to that described for <b>19</b>, and similar orientations likely also apply to the potent furopyridine-containing inhibitors <b>17</b> and <b>18</b>. These optimal positionings are not possible for the less potent isomeric compounds <b>16</b> and <b>21</b>, as overlap of the respective pyridine nitrogens with the corresponding N-atoms present in <b>17</b>–<b>20</b> unfavorably orients their polar furopyridine oxygen and thienopyridine sulfur moieties toward Asp219.</div><div class="NLM_p">We also explored inhibitors containing other 6,5-bicyclic heterocycles in which the amide group was attached to the 6-membered aromatic ring of the fused system. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, all of these molecules inhibited Nampt to varying degrees in biochemical assays (<b>25</b>–<b>35</b>) but only four, which incorporated two closely related heterocycles, exhibited potent cell-based activity (<b>27</b>, <b>28</b>, <b>32</b>, and <b>33</b>). For compounds <b>25</b>–<b>35</b>, the lack of strong cell potency correlated well with weak biochemical Nampt inhibition (inhibitor <b>25</b> is a possible exception), thus making it difficult to determine whether the ability of the molecules to form PRPP–ribose adducts contributed to their cell culture activity. However, consistent with the ribose adduct hypothesis described above, the PRPP–ribose adducts corresponding to the cell-potent inhibitors <b>28</b> and <b>33</b> were observed in biochemical experiments by mass spectrometry (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for more details). In addition, the exposed imidazopyridine nitrogen atom contained in an optimized compound related to <b>28</b> was crystallographically observed in a location very similar to that noted for the corresponding N-atom of the azaindole-containing molecule <b>7</b> (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Additional details regarding the implications of this common binding mode are provided later in this work.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Co-crystal structure of compound <b>58</b> (green) in complex with Nampt (gray); PBD Code: 4KFO. Water molecules are depicted as red spheres and possible hydrogen bonds are indicated with dashed yellow lines. The resolution of the structure is 1.6 Å. For comparison, the structure of compound <b>7</b> is shown in magenta.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inclusion of 6,6-fused bicyclic heterocycles into the inhibitor design was less successful, with the best compounds showing weak biochemical inhibition and very poor cellular activity (<b>36</b>–<b>38</b>). These results likely reflect the inability of the larger bicyclic heterocycles to fit properly in the NAM binding site of Nampt, in contrast to the good fit observed for many compounds containing 6,5-bicyclic moieties (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In addition, several biaryl-containing molecules exhibited relatively potent biochemical Nampt inhibition properties but were devoid of cell-based activity (<b>39</b> and <b>40</b>). It is unknown at this time whether this discrepancy is related to the PRPP–ribose adduct hypothesis outlined above or is due to some other phenomenon (e.g., relatively weak biochemical Nampt inhibition).</div><div class="NLM_p">Collectively, the above SAR exploration identified the fused heterocycles present in compounds <b>7–8</b>, <b>17–20</b>, <b>27–28</b>, and <b>32–33</b> as those most likely to impart both potent biochemical <i>and</i> cell-based Nampt inhibition properties to compounds which contained them. These five fused heterocycles were therefore employed in the subsequent SAR studies described in the remainder of this work. In addition, in vitro assessments conducted with the Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> compounds in murine and human liver microsomes consistently indicated that biaryl sulfones exhibited improved stability properties relative to the corresponding piperidine-derived phenyl-sulfonamides (e.g., compare <b>17</b> with <b>18</b>). The biaryl sulfone motif was therefore also incorporated into many subsequent inhibitor designs.</div><div class="NLM_p">As a prelude to conducting in vivo efficacy experiments, we next focused our inhibitor optimization efforts on identifying highly potent cell-active compounds which also exhibited attractive in vitro DMPK properties. This work was initially conducted using the azaindole present in <b>8</b> with the expectation that promising modifications so identified could be transferred to compounds containing other fused heterocycles. Previous work with related urea-containing molecules indicated that alterations to the biarylsulfone portion of the inhibitors could greatly impact potency and biopharmaceutical properties.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Similar modifications were expected to be tolerated in the amide-containing Nampt inhibitor series, since the biarylsulfone terminus was anticipated to be highly solvent-exposed (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, derivitization of the terminal phenyl ring contained in <b>8</b> afforded a variety of compounds that all displayed potent biochemical and cell-based anti-Nampt properties (<b>41</b>–<b>51</b>). Among these molecules, those bearing terminal 3-Me-Ph (<b>42</b>), 3-CF<sub>3</sub>-Ph (<b>44</b>), 3,5-di-F-Ph (<b>49</b>), and 4-morpholino-3-pyridyl (<b>51</b>) substituents exhibited A2780 cell IC<sub>50</sub> values of less than 10 nM. The latter three compounds also showed good in vitro stability toward both murine and human liver microsomes. Those three moieties were therefore chosen for inclusion in amide-containing Nampt inhibitors bearing nonazaindole fused heterocycles. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, all such combinations successfully afforded very potent cell-active Nampt inhibitors, and most of these compounds exhibited good microsomal stability properties (exceptions: <b>52</b>, <b>57</b>, <b>59</b>, and <b>62</b>). Crystallographic rationalizations for the structure–activity relationships depicted in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> are provided below.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biarylsulfone Substitution SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0020.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability—% remaining at 30 min.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability—% remaining at 30 min. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Combined SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0021.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Nampt biochemical inhibition.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">A2780 cell proliferation inhibition. This inhibition can be reversed by addition of 0.33 mM of NMN.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Unless otherwise noted, all biochemical and cell-based assay results are reported as the arithmetic mean of at least two separate runs (<i>n</i> = 2).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Mouse liver microsomal stability—% remaining at 30 min.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Human liver microsomal stability—% remaining at 30 min. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div><div></div></div><div class="NLM_p">To enable further optimization of the described amide-containing Nampt inhibitors, a cocrystal structure of compound <b>58</b> in complex with Nampt was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The binding mode of the ligand was very similar to that observed for compound <b>7</b> with a hydrogen bond noted between the amide NH and Asp219. A water-mediated (W1) hydrogen bond was also observed between the amide carbonyl and Ser275. The bicyclic imidazopyridine ring of <b>58</b> was stacked between the side chains of Nampt residues Tyr18′ and Phe193 in the NAM binding region with the imidazole nitrogen pointing toward the PRPP binding site. Interestingly, this nitrogen atom was positioned in a location that was very similar to that observed for the pyridyl N-atom contained in <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This positioning was maintained in spite of the differing connectivities between the bicyclic rings present in <b>7</b> and <b>58</b> and the associated carboxamide moieties of two molecules, and it may reflect an optimal orientation for the formation of the corresponding PRPP adducts in the Nampt active site.<a onclick="showRef(event, 'ref15 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref17">(15, 17)</a> Consistent with this hypothesis, the locations of the exposed heteroaryl N-atoms present in <b>7</b> and <b>58</b> were also very similar to those observed crystallographically for the pyridine nitrogen of the NMN product that results from Nampt-catalyzed condensation of NAM with PRPP (cf., Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Many of the atoms present in the bicyclic heterocycles contained in <b>7</b> and <b>58</b> were observed in close spatial proximity (<3.8 Å) to the side chains of several Nampt residues [e.g., Asp219, Arg311, and Asp16′ (not shown)]. Such proximity likely explains the failure of compounds containing 6,6-bicyclic heterocycles to potently inhibit Nampt (e.g., <b>36</b>–<b>38</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>; may also apply to compounds <b>13</b> and <b>14</b>) but does not illuminate why many close structural isomers of the heterocycles contained in the most active inhibitors lost significant potency (e.g., <b>29</b>–<b>31</b>, <b>34</b>–<b>35</b>).</div><div class="NLM_p">The difluorophenyl moiety of <b>58</b> moved slightly closer to the protein surface relative to the piperidine present in compound <b>7</b> and filled a groove which was defined by His191, Tyr188, Val242, and Tyr240 (not all residues shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). This location oriented one of the <i>meta</i>-substituents (relative to the sulfone moiety) of the terminal phenyl moiety toward the protein surface and the other <i>meta</i>-substituent toward solvent. The vector emerging from the <i>para</i>-position (relative to the sulfone moiety) of the terminal phenyl group also pointed into a solvent-exposed region. The observed binding mode was thus consistent with the structure–activity relationships depicted in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, with analogs bearing 3-substituents being the most potent and a variety of 4-substituents being tolerated. A water-mediated hydrogen bond involving the sulfone moiety of <b>58</b> was also observed, although this was not identical to those noted in the <b>7</b>–Nampt cocrystal structure described at the beginning of this work.</div><div class="NLM_p">The explorations described above identified multiple compounds which exhibited potent anti-Nampt properties in biochemical and cellular assays as well as good microsomal stabilities. In anticipation of conducting in vivo animal experiments with such molecules, we profiled them in various additional in vitro ADME assessments designed to assess their in vivo potential. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, of the molecules profiled in these in vitro ADME assessments, compound <b>58</b> exhibited the most optimal combination of in vitro metabolic stability, MDCK permeability, and protein binding. Collectively, these properties compared favorably with those exhibited by compounds <b>1</b> and <b>2</b> in similar evaluations (<b>58</b> = significantly less protein bound than both <b>1</b> and <b>2</b> and more metabolically stable than <b>2</b>). In addition, compound <b>58</b> displayed potent antiproliferative effects in a variety of cell lines for which mouse xenograft models were available (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The compound was therefore examined in in vivo mouse PK studies and a xenograft efficacy experiment (employing a model derived from one Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> cell line) to evaluate its oral exposure and antitumor effects.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>In Vitro</i> Stability, Permeability, and Plasma Protein Binding of Selected Nampt Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">MH, CL<sub>hep</sub> (mL/min/kg)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HH, CL<sub>hep</sub> (mL/min/kg)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">10<sup>6</sup>MDCK <i>P</i><sub>app,A-B</sub> (cm/s)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse PPB (<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">human PPB (<i>f</i><sub>u</sub>)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.067</td><td class="colsep0 rowsep0" align="char" char=".">0.060</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.133</td><td class="colsep0 rowsep0" align="char" char=".">0.122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.120</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Hepatic clearance predicted from mouse hepatocytes (stable, moderate, labile = <27, 27–63, >63 mL/min/kg, respectively).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Hepatic clearance predicted from human hepatocytes (stable, moderate, labile = <6.2, 6.2–15, >15 mL/min/kg, respectively).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Apparent permeability coefficients (<i>P</i><sub>app,A-B</sub>) across MDCK cell monolayers.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Mouse plasma protein binding; fraction unbound (<i>f</i><sub>u</sub>).</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Human plasma protein binding; fraction unbound (<i>f</i><sub>u</sub>). All the data reported in the table is the average of ≥2 runs. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details associated with each assessment.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Antiproliferation Effects Determined for Compound <b>58</b> in Various Cell Lines<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">U251<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (glioblastoma)</th><th class="colsep0 rowsep0" align="center">HT1080<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (fibrosarcoma)</th><th class="colsep0 rowsep0" align="center">PC3<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (prostate cancer)</th><th class="colsep0 rowsep0" align="center">MiaPaCa2<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (pancreatic cancer)</th><th class="colsep0 rowsep0" align="center">HCT116<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (colon cancer)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">1.8 ± 0.6</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">2.7 ± 1.0</td><td class="colsep0 rowsep0" align="left">7.4 ± 2.7</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">All antiproliferation effects were reversed by addition of 0.3 mM NMN.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">SRB end point.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">CyQuant end point. All the data reported in the table reflect the average of three independent runs. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental details.</p></div></div></div><div class="NLM_p">As summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> and shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, compound <b>58</b> demonstrated reasonable PK properties in mice. After IV dose administration at 5 mg/kg, the plasma clearance was moderate (52.4 mL/min/kg) and the volume of distribution was 6.7 L/kg. Following a single oral dose of 10 mg/kg, absorption of <b>58</b> was rapid (<i>T</i><sub>max</sub> = 0.25 h) and the compound showed good oral exposure (AUC<sub>inf</sub> = 3.06 μM h, <i>C</i><sub>max</sub> = 1.21 μM; %F = 41.1) with a free <i>C</i><sub>max</sub> value ≥18-fold above the cellular IC<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, 0.0018–0.0074 μM).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mean (±standard deviation) plasma concentration–time profiles of compound <b>58</b> in NCR nude mice (<i>n</i> = 3) following intravenous and oral administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mean Pharmacokinetic Parameters of Compound <b>58</b> in NCR Nude Mice (<i>n</i> = 3)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IV</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">52.4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.21</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">41.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Formulations: IV = 35% polyethylene glycol (PEG 400)/10% ethanol/15% PG/40% H<sub>2</sub>O (v/v/v); PO = 60% polyethylene glycol (PEG 400)/10% ethanol/30% H<sub>2</sub>O (v/v/v).</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Maximum plasma concentration.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Time at which maximum plasma concentration was observed.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Volume of distribution (steady-state).</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">Clearance.</p></div><div class="footnote" id="t7fn6"><sup>f</sup><p class="last">Bioavailibility. See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental descriptions.</p></div></div></div><div class="NLM_p">In an efficacy study, compound <b>58</b> exhibited significant antitumor effects against a U251 human glioblastoma tumor xenograft model without significant body weight loss. In mice bearing U251 xenografts, oral administration of the compound for 7 days (25 mg/kg QD) produced rapid tumor regression (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The antitumor effects of compound <b>58</b> were durable, with the mean tumor volume of the treated group failing to return to baseline levels by the end of study (day 13). The described xenograft results confirmed that an amide-containing Nampt inhibitor with appropriate biological and DMPK properties can function as a potent in vivo anticancer agent.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Left panel: compound <b>58</b> in vivo efficacy results in U251 human glioblastoma tumor xenograft model. Right panel: changes in body weight. Data reflect mean values (±standard deviation) of eight animals in each group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p">The amide derivatives were prepared by utilizing the procedures shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch8" aria-label="8">8</a>. As depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, aromatic acids (<b>65</b>) or esters (<b>66</b>) were coupled with appropriate amines (<b>64</b>) to give the amides <b>6–63</b> (details are noted below). To speed up our SAR exploration, a three step parallel synthesis protocol was also developed as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. In this process, sulfinate (<b>67</b>) was coupled with various aryl boronic acids (<b>68a–68g</b>) to provide the corresponding biaryl sulfone intermediates (<b>69</b>). Removal of the Boc protecting group from <b>69</b> led to the benzyl amines (<b>64a–64g</b>). BOP facilitated coupling of the amines (<b>64</b>) with azaindole-2-carboxylic acid (<b>65a</b>) provided the final products <b>41</b>–<b>43</b>, <b>45</b>, <b>46</b>, <b>48</b>, and <b>50</b>. The relatively low yields of the final products reflect the three-step reaction sequence in which the intermediates <b>68</b> and <b>64</b> were not isolated and/or purified.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HATU, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, 25 °C, 5–96%; (ii) EDCI, HOBt, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, 80 °C, 4–76%; (iii) BOP, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, 25 °C, 40–50%; (iv) AlMe<sub>3</sub>, toluene, 0–110 °C, 6–92%.</p></p></figure><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, DMSO, 60 °C; (ii) HCl, 25 °C; (iii) BOP, Et<sub>3</sub>N, DMA, 25 °C, 4–11% over three steps. All steps were performed using a parallel synthesis approach, and intermediates <b>68</b> and <b>64</b> were not isolated and/or purified.</p></p></figure><div class="NLM_p">The syntheses of the aromatic acid methyl esters <b>66a</b> and <b>66b</b> are summarized in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Treatment of the diamine (<b>70</b>) with imidate (<b>71</b>) gave the intermediate <b>72</b>, which was cyclized under basic conditions to yield compound <b>66a</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Cyclization of 5-bromopyrazin-2-amine (<b>73</b>) with 2-bromo-1,1-dimethoxyethane (<b>74</b>) provided the imidazopyrazine intermediate (<b>75</b>). Coupling of <b>75</b> with zinc cyanide afforded the corresponding nitrile compound (<b>76</b>). Partial hydrolysis of <b>76</b> provided the ester compound <b>66b</b>. The methods employed to synthesize <b>66a</b> and <b>66b</b> reflect unoptimized reaction conditions. As the described procedures afforded sufficient quantities of these intermediates for final compound preparation, no attempts were made to further improve these processes.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) CF<sub>3</sub>COOH, 0–25 °C, 98%; (ii) Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O/MeOH, reflux, 3%.</p></p></figure><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) EtOH/48% HBr, 80 °C, 15%; (ii) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 120 °C, 24%; (iii) HCl/MeOH, 80 °C, 12%.</p></p></figure><div class="NLM_p">Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a>–<a class="ref internalNav" href="#sch7" aria-label="7">7</a> highlight the synthesis of various amines (<b>64</b>). In Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, sulfinate (<b>77</b>) was coupled with aryl boronic acids (<b>68h–68j</b>) to provide the corresponding biaryl sulfone intermediates (<b>78</b>). Removal of the acetyl group from <b>78</b> led to the benzyl amines <b>64h–64j</b>. Synthesis of compound <b>64k</b> is summarized in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Nucleophlic reaction of <b>79</b> with <b>80</b> gave the sulfone nitrile (<b>81</b>), which was subsequently reduced to the corresponding benzyl amine <b>64k</b>. In Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, sulfonyl chloride (<b>82</b>) was reacted with piperidine (<b>83</b>) to give the sulfonamide-aldehyde (<b>84</b>), which was then converted to the corresponding sulfinamide (<b>85</b>). Methyllithium addition to <b>85</b> yielded compound <b>86</b>, and subsequent removal of the sulfinyl group gave amine compound <b>64l</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu(OCOCH<sub>3</sub>)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMSO, 25 °C, 16–40%; (ii) 12 M HCl/<i>i</i>-PrOH, 100 °C, 86–100%.</p></p></figure><figure id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DMSO, 120 °C, 30%; (ii) H<sub>2</sub>–Raney Ni, 2 M NH<sub>3</sub>/MeOH, 25 °C, 94%.</p></p></figure><figure id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) EtN(<i>i</i>-Pr)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 100%; (ii) Ti(OEt)<sub>4</sub>, <i>t</i>-BuSONH<sub>2</sub>, THF, 25 °C, 59%; (iii) MeLi, Et<sub>2</sub>O, −78 to 25 °C, 47%; (ii) 4.0 M HCl-1,4-dioxane, MeOH, 25 °C, 68%.</p></p></figure><div class="NLM_p">The synthesis of key intermediate <b>67</b> is shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>. Bromide (<b>87</b>) was coupled with the thiol (<b>88</b>) to give the thioether (<b>89</b>). Oxidation of the thioether (<b>89</b>) with oxone led to compound <b>90</b> and treatment of this intermediate with base provided compound <b>67</b>.</div><figure id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, EtN(<i>i</i>-Pr)<sub>2</sub>, toluene, 100 °C, 94%; (ii) Oxone, H<sub>2</sub>O–CH<sub>3</sub>CN, 25 °C, 94%; (iii) NaOEt, MeOH, 50 °C, 97%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, using structure-guided design and leveraging key information from our previously disclosed (thio)urea cocrystal structures, we discovered a structurally novel amide-containing Nampt inhibitor (<b>7</b>). Guided by the crystal structure of compound <b>7</b> in complex with Nampt, further SAR optimization ultimately yielded compound <b>58</b>, which possessed single digit nanomolar cellular IC<sub>50</sub> against several human tumor cell lines and excellent in vitro and in vivo ADME properties. Our results suggest that (easily synthesized) compound <b>58</b> offers a robust and structurally distinct alternative to the well-known Nampt inhibitors <b>1</b> and <b>2</b> for conducting in vitro and in vivo studies to probe Nampt-related biology. In particular, the binding mode of compound <b>58</b> to Nampt is crystallographically characterized in the present work, thus enabling a good understanding of the molecular interactions which contribute to its potent biochemical inhibition of the protein as well as the SAR associated with close analogs. In contrast, the crystal structure of compound <b>1</b> in complex with Nampt has not been disclosed in the literature. In addition, <b>58</b> exhibits very potent anti-Nampt activity in cell culture against multiple xenograftable lines. It also displays robust and durable efficacy in a mouse xenograft model derived from one such line (U251) at doses that are comparable to those typically employed in related studies with <b>1</b>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a><sup>d</sup> Importantly, these effects are observed after once-daily oral administration of <b>58</b>, in contrast to the intraperitoneal delivery frequently employed in xenograft studies conducted with <b>2</b>.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a><sup>c</sup> As the described experiments are somewhat limited in scope and do not directly compare individual molecules, additional studies will be required to fully define the biological characteristics of <b>58</b> relative to other Nampt inhibitors, including compounds <b>1</b> and <b>2</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General</h3><div class="NLM_p last">Unless otherwise indicated, all reagents and solvents were purchased from commercial sources and were used without further purification (including the following numbered compounds: <b>64n</b>, <b>65a</b>, <b>65d</b>, <b>65e</b>, <b>65f</b>, <b>65g</b>, <b>65h</b>, <b>65i</b>, <b>65k</b>, <b>65l</b>, <b>65m</b>, <b>65n</b>, <b>65p</b>, <b>65r</b>, <b>65s</b>, and <b>66d</b>). Moisture or oxygen sensitive reactions were conducted under an atmosphere of argon or nitrogen gas. Unless otherwise stated, <sup>1</sup>H NMR spectra were recorded at 300 or 400 MHz using Varian or Bruker instruments operating at the indicated frequencies. Chemical shifts are expressed in ppm relative to an internal standard; tetramethylsilane (ppm = 0.00). The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, p = pentet, m = multiplet. Purification by silica gel chromatography was carried out using Biotage systems with prepacked cartridges. Chemical purities were >95% for all final compounds, as assessed by LCMS analysis at UV 220 nm. Details regarding the LCMS conditions can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-[4-(Piperidine-1-sulfonyl)phenyl]-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>6</b>)</h3><div class="NLM_p">To a suspension of 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>, 81 mg, 0.50 mmol) in DMF (8 mL) were added HATU (285 mg, 0.75 mmol) and EtN(<i>i</i>-Pr)<sub>2</sub> (0.131 mL, 0.749 mmol), and the resulting mixture was stirred for 25 min at room temperature. 4-(Piperidin-1-ylsulfonyl)aniline (<b>64m</b>, 120 mg, 0.50 mmol) was then added, and the reaction mixture was stirred at room temperature for 16 h. The mixture was diluted with water (50 mL) and extracted with EtOAc (3 × 20 mL). The organic layers were combined and washed with water (3 × 20 mL) and brine (30 mL), dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by Biotage with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (100:0 to 90:10) to give the title product in 5% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.23 (s, 1H), 10.72 (s, 1H), 9.01 (s, 1H), 8.25 (d, <i>J</i> = 5.7 Hz, 1H), 8.55 (d, <i>J</i> = 8.7 Hz, 2H), 7.73 (d, <i>J</i> = 8.7 Hz, 2H), 7.62 (s, 1H), 7.39 (d, <i>J</i> = 5.1 Hz, 1H), 2.86 (br s, 4H), 1.53 (br s, 4H), 1.34 (br s, 2H). LCMS (method LCMS1, ESI): RT = 1.28 min, <i>m</i>/<i>z</i> = 385.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>7–11</b>,<b> 16</b>,<b> 22–23</b>,<b> 25–26</b>,<b> 28</b>,<b> 31</b>,<b> 33</b>,<b> 35–38</b>,<b> 44</b>,<b> 47</b>,<b> 49</b>,<b> 51</b>,<b> 58</b>,<b> 60–61</b>, and<b> 63</b> were synthesized using conditions (HATU coupling) similar to those employed to make compound <b>6</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>7</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 24% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.07 (s, 1H), 9.32 (t, <i>J</i> = 1.5 Hz, 1H), 8.92 (s, 1H), 8.21 (d, <i>J</i> = 6.0 Hz, 1H), 7.69 (d, <i>J</i> = 8.1 Hz, 2H), 7.56 (d, <i>J</i> = 8.1 Hz, 2H), 7.38–7.31 (m, 2H), 4.61 (d, <i>J</i> = 5.7 Hz, 1H), 2.86–2.81 (m, 4H), 1.51 (br s, 4H), 1.32 (br s, 2H). LCMS (method LCMS1, ESI): RT = 0.99 min, <i>m</i>/<i>z</i> = 399.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>8</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 68% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.0 (s, 1H), 9.25 (s, 1H), 8.92 (s, 1H), 8.20 (s, 1H), 8.00–7.90 (m, 4H), 7.73–7.50 (m, 5H), 7.35 (s, 1H), 7.22 (s, 1H), 4.60 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.50 min, <i>m</i>/<i>z</i> = 392.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> <i>N</i>-{1-[4-(Piperidine-1-sulfonyl)phenyl]ethyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>9</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and 1-(4-(piperidin-1-ylsulfonyl)phenyl)ethanamine hydrochloride (<b>64l</b>), the title product was obtained in 96% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.98 (s, 1H), 8.39 (d, <i>J</i> = 6.0 Hz, 1H), 7.76–7.71 (m, 2H), 7.56–7.52 (m, 2H), 7.35–7.31 (m, 1H), 7.03 (s, 1H), 6.60–6.54 (m, 1H), 5.45–4.36 (m, 1H), 3.01–2.96 (m, 4H), 1.69–1.60 (m, 7 H), 1.45–1.37 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.85 min, <i>m</i>/<i>z</i> = 413.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-{2-[4-(Benzenesulfonyl)phenyl]ethyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>10</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and 2-(4-(phenylsulfonyl)phenyl)ethanamine (<b>64p</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>), the title product was obtained in 57% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.0 (s, 1H), 8.95 (s, 1H), 8.8.85 (s, 1H), 8.20 (s, 1H), 8.00–7.97 (m, 4H), 7.73–7.54 (m, 3H), 7.43 (s, 1H), 7.35 (s, 1H), 7.18 (s, 1H), 3.70–3.30 (m, 2H), 3.00–2.80 (m, 2H). LCMS (method LCMS1, ESI): RT = 0.85 min, <i>m</i>/<i>z</i> = 406.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}-1H-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>11</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid (<b>65b</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 40% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.13 (s, 1H), 9.38 (s, 1H), 8.78 (s, 1H), 8.11 (d, <i>J</i> = 5.1 Hz, 1H), 7.71–7.55 (m, 5H), 7.21 (s, 1H), 4.62 (d, <i>J</i> = 6.0 Hz, 1H), 2.86–2.81 (m, 4H), 1.51 (br s, 4H), 1.32 (br s, 2H). LCMS (method LCMS1, ESI): RT = 1.02 min, <i>m</i>/<i>z</i> = 400.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}furo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with furo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65c</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 15% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.05 (s, 1H), 8.62 (d, <i>J</i> = 6.0 Hz, 1H), 7.73–7.70 (m, 2H), 7.60 (s, 1H), 7.52–7.45 (m, 3H), 7.20–7.13 (m, 1H), 4.76 (d, <i>J</i> = 6.0 Hz, 2H), 3.00–2.93 (m, 4H), 1.68–1.58 (m, 4H), 1.45–1.38 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.89 min, <i>m</i>/<i>z</i> = 400.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}thieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with thieno[2,3-<i>b</i>]pyridine-2-carboxylic acid (<b>65d</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 62% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.52 (t, <i>J</i> = 6.0 Hz, 1H), 8.66–8.63 (m, 1H), 8.37 (d, <i>J</i> = 3.3 Hz, 1H), 8.13 (s, 1H), 7.77–7.64 (m, 2H), 7.61–7.55 (m, 2H), 7.51–7.47 (m, 1H), 4.60 (d, <i>J</i> = 6.0 Hz, 2H), 2.87–2.82 (m, 4H), 1.52–1.47 (m, 4H), 1.35–1.31 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.40 min, <i>m</i>/<i>z</i> = 416.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}thieno[3,2-<i>b</i>]pyridine-2-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with thieno[3,2-<i>b</i>]pyridine-2-carboxylic acid (<b>65e</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained with 22.1% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.72 (d, <i>J</i> = 4.5 Hz, 1H), 8.27–8.19 (m, 1H), 8.04 (s, 1H), 7.98–7.90 (m, 2H), 7.86–7.83 (m, 2H), 7.73–7.43 (m, 5H), 7.34–7.31 (m, 1H), 7.16 (t, J = 5.4 Hz, 1H), 4.70 (d, J = 6.0 Hz, 2H). LCMS (LCMS10, ESI): RT = 1.74 min, <i>m</i>/<i>z</i> = 409.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}-1,3-benzothiazole-6-carboxamide (<b>25</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with benzo[<i>d</i>]thiazole-6-carboxylic acid (<b>65f</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 83% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.12 (s, 1H), 8.56 (s, 1H), 8.16 (d, <i>J</i> = 9.0 Hz, 1H), 7.99–7.94 (m, 1H), 7.65–7.60 (m, 2H), 7.49–7.43 (m, 2H), 7.18–7.10 (m, 1H), 4.76 (d, <i>J</i> = 6.0 Hz, 2H), 2.97–2.91 (m, 4H), 1.66–1.57 (m, 4H), 1.44–1.35 (m, 2H). LCMS (method LCMS1, ESI): RT = 2.18 min, <i>m</i>/<i>z</i> = 416.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}-1H-1,3-benzodiazole-5-carboxamide (<b>26</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-benzo[<i>d</i>]imidazole-6-carboxylic acid (<b>65g</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 77% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.18 (br s, 1H), 8.03 (s, 1H), 7.73–7.66 (m, 2H), 7.62–7.56 (m, 2H), 7.45–7.39 (m, 2H), 4.69 (d, <i>J</i> = 6.0 Hz, 2H), 2.94–2.87 (m, 4H), 1.63–1.53 (m, 4H), 1.42–1.32 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.81 min, <i>m</i>/<i>z</i> = 399.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>28</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyridine-6-carboxylic acid (<b>65h</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 79% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.19 (t, <i>J</i> = 6.0 Hz, 1H), 9.12 (s, 1H), 8.04 (s, 1H), 7.95–7.89 (m, 4H), 7.69–7.52 (m, 8H), 4.53 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.69 min, <i>m</i>/<i>z</i> = 391.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyridine-7-carboxamide (<b>31</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyridine-7-carboxylic acid (<b>65i</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 66% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.23–8.19 (m, 1H), 8.16 (s, 1H), 7.74–7.65 (m, 4H), 7.53–7.49 (m, 2H), 7.39–7.35 (m, 2H), 4.78 (d, <i>J</i> = 6.0 Hz, 2H), 3.00–2.95 (m, 4H), 1.68–1.59 (m, 4H), 1.47–1.38 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.81 min, <i>m</i>/<i>z</i> = 399.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyrimidine-6-carboxamide (<b>33</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyrimidine-6-carboxylic acid (<b>65j</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 3% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.45 (s, 1H), 9.33 (t, <i>J</i> = 5.4 Hz, 1H), 8.91 (d, <i>J</i> = 2.4 Hz, 1H), 8.00 (s, 1H), 7.94–7.90 (m, 4H), 7.79 (s, 1H), 7.68–7.56 (m, 5H), 4.55 (d, <i>J</i> = 5.7 Hz, 1H). LCMS (method LCMS1, ESI): RT = 0.99 min, <i>m</i>/<i>z</i> = 393.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-[1,2,4]triazolo[4,3-<i>a</i>]pyridine-6-carboxamide (<b>35</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with [1,2,4]triazolo[4,3-<i>a</i>]pyridine-6-carboxylic acid (<b>65k</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 20% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.35–9.27 (m, 2H), 9.13–9.09 (m, 1H), 7.96–7.88 (m, 4H), 7.85–7.72 (m, 2H), 7.69–7.53 (m, 5H), 4.54 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.64 min, <i>m</i>/<i>z</i> = 393.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}isoquinoline-6-carboxamide (<b>36</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with isoquinoline-6-carboxylic acid (<b>65l</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 96% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.40 (s, 2H), 8.58 (s, 1H), 8.47 (s, 1H), 8.22–8.18 (m, 1H), 8.05–8.02 (m, 1H), 7.98–7.82 (m, 5H), 7.70–7.50 (m, 5H), 4.60 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.15 min, <i>m</i>/<i>z</i> = 403.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}isoquinoline-7-carboxamide (<b>37</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with isoquinoline-7-carboxylic acid (<b>65m</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 37% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.40 (s, 2H), 8.68 (s, 1H), 8.57 (s, 1H), 8.20 (d, <i>J</i> = 8.6 Hz, 1H), 8.04 (d, <i>J</i> = 8.6 Hz, 1H), 7.98–7.82 (m, 5H), 7.70–7.50 (m, 5H), 4.60 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.16 min, <i>m</i>/<i>z</i> = 403.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}quinazoline-6-carboxamide (<b>38</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with quinazoline-6-carboxylic acid (<b>65n</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 15% yield. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 9.61 (br s, 1H), 9.31 (s, 1H), 8.60 (d, <i>J</i> = 2.1 Hz, 1H), 8.43 (d, <i>J</i> = 2.4 Hz, 1H), 8.40 (d, <i>J</i> = 2.4 Hz, 1H), 8.07 (d, <i>J</i> = 9.3 Hz, 1H), 7.95 (s, 2H), 7.92 (s, 2H), 7.62–7.51 (m, 5H), 4.69 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.77 min, <i>m</i>/<i>z</i> = 404.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-({4-[3-(Trifluoromethyl)benzenesulfonyl]phenyl}methyl)-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>44</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and (4-((3-(trifluoromethyl)phenyl)sulfonyl)phenyl)methanamine (<b>64i</b>), the title product was obtained in 25% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.35 (s, 1H), 9.37 (t, <i>J</i> = 6.0 Hz, 1H), 9.05 (s, 1H), 8.28–8.21 (m, 3H), 8.10–8.01 (m, 3H), 7.85 (t, <i>J</i> = 6.0 Hz, 1H), 7.57 (d, <i>J</i> = 9.0 Hz, 2H), 7.48 (d, <i>J</i> = 6.0 Hz, 1H), 7.39 (s, 1H), 4.58 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.73 min, <i>m</i>/<i>z</i> = 460.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-{[4-(4-Fluorobenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>47</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and (4-((4-fluorophenyl)sulfonyl)phenyl)methanamine (<b>64k</b>), the title product was obtained in 26% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.40 (s, 1H), 9.10 (s, 1H), 8.29 (d, <i>J</i> = 5.9 Hz, 1H), 8.16 (s, 1H), 8.07–7.92 (m, 5H), 7.58–7.40 (m, 6H), 4.57 (s, 2H). LCMS (method LCMS1, ESI): RT = 0.99 min, <i>m</i>/<i>z</i> = 410.17 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-{[4-(3,5-Difluorobenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>49</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and (4-((3,5-difluorophenyl)sulfonyl)phenyl)methanamine (<b>64h</b>), the title product was obtained in 39% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.0 (s, 2H), 9.24 (s, 1H), 8.90 (s, 1H), 8.20 (d, <i>J</i> = 5.8 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 2H), 7.80–7.50 (m, 5H), 7.38–7.23 (m, 2H), 4.60 (s, 2H). LCMS (method LCMS1, ESI) RT = 1.03 min, <i>m</i>/<i>z</i> = 428.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[(4-{[6-(Morpholin-4-yl)pyridin-3-yl]sulfonyl}phenyl)methyl]-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>51</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>) and (4-((6-morpholinopyridin-3-yl)sulfonyl)phenyl)methanamine (<b>64j</b>), the title product was obtained in 57% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.10 (br s, 1H), 9.28 (s, 1H), 8.89 (d, <i>J</i> = 1.0 Hz, 1H), 8.56 (d, <i>J</i> = 2.2 Hz, 1H), 8.17 (d, <i>J</i> = 5.8 Hz, 1H), 7.90–7.84 (m, 3H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.32 (d, <i>J</i> = 5.8 Hz, 1H), 7.25 (s, 1H), 6.88 (d, <i>J</i> = 9.2 Hz, 1H), 4.54 (d, <i>J</i> = 4.7 Hz, 2H), 3.65–3.55 (m, 8H). LCMS (method LCMS3, ESI): RT = 4.78 min, <i>m</i>/<i>z</i> = 478.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-{[4-(3,5-Difluorobenzenesulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>58</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyridine-6-carboxylic acid (<b>65h</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) and (4-((3,5-difluorophenyl)sulfonyl)phenyl)methanamine (<b>64h</b>), the title product was obtained in 57% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.20 (s, 1H), 9.10 (s, 1H), 8.06–7.96 (m, 3H), 7.75 (s, 2H), 7.75–7.50 (m, 5H), 4.60 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.03 min, <i>m</i>/<i>z</i> = 428.04 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[(4-{[6-(Morpholin-4-yl)pyridin-3-yl]sulfonyl}phenyl)methyl]imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>60</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyridine-6-carboxylic acid (<b>65h</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) and (4-((6-morpholinopyridin-3-yl)sulfonyl)phenyl)methanamine (<b>64j</b>), the title product was obtained in 82% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.22–9.16 (m, 1H), 9.13–9.11 (m, 1H), 8.56 (d, <i>J</i> = 2.3 Hz, 1H), 8.12 (s, 1H), 8.04 (s, 1H), 7.90–7.85 (m, 2H), 7.66–7.50 (m, 5H), 6.89 (d, <i>J</i> = 9.2 Hz, 1H), 4.52 (d, <i>J</i> = 5.9 Hz, 2H), 3.65–3.56 (m, 8H). LCMS (method LCMS3, ESI): RT = 4.63 min, <i>m</i>/<i>z</i> = 478.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-{[4-(3,5-Difluorobenzenesulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyrimidine-6-carboxamide (<b>61</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyrimidine-6-carboxylic acid (<b>65j</b>) and (4-((3,5-difluorophenyl)sulfonyl)phenyl)methanamine (<b>64h</b>), the title product was obtained in 66% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.48 (d, <i>J</i> = 2.4 Hz, 1H), 9.38 (t, <i>J</i> = 6.0 Hz, 1H), 8.93 (d, <i>J</i> = 2.4 Hz, 1H), 8.03–7.99 (m, 3H), 7.80 (d, <i>J</i> = 1.5 Hz, 1H), 7.77–7.72 (m, 2H), 7.69–7.60 (m, 3H), 4.58 (d, <i>J</i> = 5.7 Hz, 2H). LCMS (method LCMS3, ESI) RT = 5.64 min, <i>m</i>/<i>z</i> = 429.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-[(4-{[6-(Morpholin-4-yl)pyridin-3-yl]sulfonyl}phenyl)methyl]imidazo[1,2-<i>a</i>]pyrimidine-6-carboxamide (<b>63</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyrimidine-6-carboxylic acid (<b>65j</b>) and (4-((6-morpholinopyridin-3-yl)sulfonyl)phenyl)methanamine (<b>64j</b>), the title product was obtained in 75% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.46 (d, <i>J</i> = 2.5 Hz, 1H), 9.34 (t, <i>J</i> = 5.6 Hz, 1H), 8.92 (d, <i>J</i> = 2.5 Hz, 1H), 8.57 (d, <i>J</i> = 2.6 Hz, 1H), 8.00 (d, <i>J</i> = 1.5 Hz, 1H), 7.91–7.86 (m, 3H), 7.79 (d, <i>J</i> = 1.5 Hz, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 6.88 (d, <i>J</i> = 9.3 Hz, 1H), 4.55 (d, <i>J</i> = 5.7 Hz, 2H), 3.65–3.55 (m, 8H). LCMS (method LCMS3, ESI): RT = 4.94 min, <i>m</i>/<i>z</i> = 478.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-1-methyl-1H-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>14</b>)</h3><div class="NLM_p">A solution of 1-methyl-1H-pyrrolo[2,3-<i>c</i>]pyridine-2-carboxylic acid (<b>65o</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> 200 mg, 1.14 mmol), EDCI (400 mg, 2.09 mmol), HOBt (300 mg, 2.22 mmol), (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>, 500 mg, 2.02 mmol), and EtN(<i>i</i>-Pr)<sub>2</sub> (0.8 g 12.5 mmol) in DMF (50 mL) was stirred at room temperature for 2 days. The resulting mixture was concentrated under vacuum. The residue was first purified on a silica gel column eluted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1). The semipurified product (300 mg) was repurified by Flash-Prep-HPLC using the following conditions (IntelFlash-1): column, silica gel; mobile phase, CH<sub>3</sub>CN/H<sub>2</sub>O = 1 5% increasing to CH<sub>3</sub>CN/H<sub>2</sub>O = 64% within 30 min; detector, UV 254 nm to yield the title product as an off-white solid in 4% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.97 (s, 1H), 8.19 (d, <i>J</i> = 5.7 Hz, 1H), 7.96–7.93 (m, 4H), 7.68–7.56 (m, 6H), 7.15 (s, 1H), 4.55 (d, <i>J</i> = 6.0 Hz, 2H), 4.06 (s, 3H). LCMS (LCMS4, ESI): RT = 1.48 min, <i>m</i>/<i>z</i> = 406.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>15</b>,<b> 27</b>,<b> 30</b>,<b> 39–40</b>,<b> 52</b>,<b> 54</b>,<b> 59</b>, and<b> 62</b> were synthesized using conditions (EDCI/HOBt coupling) similar to those employed to make compound <b>14</b>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-3-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 1H-pyrrolo[3,2-<i>c</i>]pyridine-3-carboxylic acid (<b>65p</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 15% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.96 (s, 1H), 9.31 (s, 1H), 8.74 (t, <i>J</i> = 6.0 Hz, 1H), 8.35–8.22 (m, 1H), 8.14 (s, 1H), 7.94 (d, <i>J</i> = 5.7 Hz, 4H), 7.70–7.56 (m, 5H), 7.43 (d, <i>J</i> = 5.7 Hz, 1H), 4.54 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.55 min, <i>m</i>/<i>z</i> = 391.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>27</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyridine-6-carboxylic acid (<b>65h</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 76% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.23 (s, 1H), 9.16 (s, 1H), 8.07 (s, 1H), 7.71–7.54 (m, 7H), 4.59 (d, <i>J</i> = 6.0 Hz, 1H), 2.86–2.81 (m, 4H), 1.51 (br s, 4H), 1.32 (br s, 2H). LCMS (method LCMS1, ESI): RT = 1.64 min, <i>m</i>/<i>z</i> = 399.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}imidazo[1,5-<i>a</i>]pyridine-7-carboxamide (<b>30</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,5-<i>a</i>]pyridine-7-carboxylic acid (<b>65q</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 11% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.15 (t, <i>J =</i> 5.9 Hz, 1H), 8.46 (d, <i>J =</i> 7.2 Hz, 1H), 8.34 (d, <i>J =</i> 7.5 Hz, 1H), 8.18 (s, 1H), 7.76–7.51 (m, 5H), 7.08–7.05 (m, 1H), 4.53 (d, <i>J =</i> 6.0 Hz, 2H), 2.81 (t, <i>J =</i> 5.2 Hz, 4H), 1.59–1.45 (m, 4H), 1.40–1.19 (m, 2H). LCMS (LCMS4, ESI): RT = 1.43 min, <i>m</i>/<i>z</i> = 399.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-5-(pyridin-3-yl)-1H-pyrazole-3-carboxamide (<b>39</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 3-(pyridin-3-yl)-1H-pyrazole-5-carboxylic acid (<b>65r</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 29% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.8 (s, 1H), 9.00 (s, 1H), 8.95 (s, 1H), 8.18 (s, 1H), 8.00–7.80 (m, 4H), 7.70–7.40 (m, 7H), 7.20 (s, 1H), 4.50 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.13 min, <i>m</i>/<i>z</i> = 419.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> N-{[4-(Benzenesulfonyl)phenyl]methyl}-3-(pyridin-3-yl)-1,2-oxazole-5-carboxamidee (<b>40</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with 3-(pyridin-3-yl)isoxazole-5-carboxylic acid (<b>65s</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 40% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.05 (d, <i>J</i> = 2.1 Hz, 1H), 8.72–8.71 (m, 1H), 8.12–8.06 (m, 1H), 7.93 (dd, <i>J</i> = 7.5, 1.8 Hz, 4H), 7.57–7.47 (m, 6H), 7.37 (d, <i>J</i> = 6.0 Hz, 1H), 7.07 (s, 1H), 4.70 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.93 min, <i>m</i>/<i>z</i> = 420.06 [M + H]<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-({4-[3,5-Difluorobenzenesulfonyl]phenyl}methyl)furo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>52</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with furo[2,3-<i>c</i>]pyridine-2-carboxylic acid (<b>65t</b>) and (4-((3,5-difluorophenyl)sulfonyl)phenyl)methanamine (<b>64h</b>), the title product was obtained in 51% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.65 (t, <i>J =</i> 6.0 Hz, 1H), 9.09 (s, 1H), 8.50 (d, <i>J =</i> 6.0 Hz, 1H), 8.04 (d, <i>J =</i> 9.0 Hz, 2H), 7.62 (m, 7H), 4.59 (d, <i>J =</i> 6.0 Hz, 2H). LCMS (LCMS11, ESI): RT = 1.92 min, <i>m</i>/<i>z</i> = 429.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-[(4-{[6-(Morpholin-4-yl)pyridin-3-yl]sulfonyl}phenyl)methyl]furo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>54</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with furo[2,3-<i>c</i>]pyridine-2-carboxylic acid (<b>65t</b>) and (4-((6-morpholinopyridin-3-yl)sulfonyl)phenyl)methanamine (<b>64j</b>), the title product was obtained in 26% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.60 (m, 1H), 9.01 (s, 1H), 8.48 (m, 1H), 8.44 (m, 1H), 7.90–7.79 (m, 4H), 7.61 (s, 1H), 7.55 (m, 1H), 6.85 (d, <i>J</i> = 8.4 Hz, 1H), 4.51 (d, <i>J</i> = 6.0 Hz, 2H), 3.64–3.48 (m, 8H). LCMS (method LCMS3, ESI): RT = 1.63 min, <i>m</i>/<i>z</i> = 478.98 [M + H]<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-({4-[3-(Trifluoromethyl)benzenesulfonyl]phenyl}methyl)imidazo[1,2-<i>a</i>]pyridine-6-carboxamide (<b>59</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyridine-6-carboxylic acid (<b>65h</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) and (4-((3-(trifluoromethyl)phenyl)sulfonyl)phenyl)methanamine (<b>64i</b>), the title product was obtained in 46% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (t, <i>J</i> = 6.0 Hz, 1H), 9.13–9.12 (m, 1H), 8.28–8.23 (m, 2H), 8.09–8.00 (m, 4H), 7.86 (t, <i>J</i> = 7.8 Hz, 1H), 7.67–7.57 (m, 5H), 4.56 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS3, ESI): RT = 5.72 min, <i>m</i>/<i>z</i> = 460.25 [M + H]<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-({4-[3-(Trifluoromethyl)benzenesulfonyl]phenyl}methyl)imidazo[1,2-<i>a</i>]pyrimidine-6-carboxamide (<b>62</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyrimidine-6-carboxylic acid (<b>65j</b>) and (4-((3-(trifluoromethyl)phenyl)sulfonyl)phenyl)methanamine (<b>64i</b>), the title product was obtained in 23% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.46 (d, <i>J</i> = 2.4 Hz, 1H), 9.35 (t, <i>J</i> = 2.6 Hz, 1H), 8.92 (d, <i>J</i> = 2.4 Hz, 1H), 8.25–8.23 (m, 2H), 8.06–8.00 (m, 4H), 7.86–7.79 (m, 2H), 7.60 (d, <i>J</i> = 8.4 Hz, 2H), 4.57 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI): RT = 5.88 min, <i>m</i>/<i>z</i> = 461.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}furo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>17</b>)</h3><div class="NLM_p last">A solution of (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>, 500 mg, 1.93 mmol), furo[2,3-<i>c</i>]pyridine-3-carboxylic acid (<b>65t</b>, 355 mg, 2.13 mmol), EtN(<i>i</i>-Pr)<sub>2</sub> (762 mg, 5.79 mmol), and BOP (1044 mg, 2.31 mmol) in DMF (5 mL) was stirred overnight at room temperature. The reaction was quenched by the addition of 20 mL of water, and the precipitate was collected by filtration. The solid was purified by recrystallization from ethanol to give the title product as a light brown solid in 40% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.65 (t, <i>J</i> = 6.0 Hz, 1H), 9.06 (s, 1H), 8.49 (d, <i>J</i> = 3.0 Hz, 1H), 7.84 (t, <i>J</i> = 3.0 Hz, 1H), 7.70 (d, <i>J</i> = 4.0 Hz, 3H), 7.58 (d, <i>J</i> = 6.0 Hz, 2H), 4.60 (d, <i>J</i> = 6.0 Hz, 2H), 2.89–2.84 (m, 4H), 1.56–1.51 (m, 4H), 1.35–1.34 (m, 2H). LCMS (LCMS10, ESI): RT = <i>m</i>/<i>z</i> = 400.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyrimidine-6-carboxamide (<b>32</b>)</h3><div class="NLM_p last">This compound was synthesized using conditions (BOP coupling) similar to those employed to make compound <b>17</b>. Substituting the corresponding reagents with imidazo[1,2-<i>a</i>]pyrimidine-6-carboxylic acid (<b>65j</b>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 50% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.52 (d, <i>J</i> = 2.4 Hz, 1H), 9.39 (t, <i>J</i> = 5.6 Hz, 1H), 8.98 (d, <i>J</i> = 2.4 Hz, 1H), 8.05 (d, <i>J</i> = 1.2 Hz, 1H), 7.83 (s, 1H), 7.70 (d, <i>J</i> = 8.4 Hz, 2H), 7.60 (d, <i>J</i> = 8.1 Hz, 2H), 4.63 (d, <i>J</i> = 6.0 Hz, 2H), 2.88–2.85 (m, 4H), 1.53–1.51 (m, 4H), 1.36–1.34 (m, 2H). LCMS (LCMS5, ESI): RT = 1.88 min, <i>m</i>/<i>z</i> = 400.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-3H-imidazo[4,5-<i>c</i>]pyridine-2-carboxamide (<b>12</b>)</h3><div class="NLM_p">To a cooled solution (water bath) of (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>, 154 mg, 0.621 mmol) in toluene (20 mL) was added AlMe<sub>3</sub> (1.13 mL, 2.26 mmol), and the mixture was stirred for 40 min at room temperature. A solution of methyl 3H-imidazo[4,5-<i>c</i>]pyridine-2-carboxylate (<b>66a</b>, 100 mg, 0.564 mmol) in toluene (10 mL) was then added via syringe. The flask was heated to 80 °C for 4 h, during which the solution became dark yellow with heavy precipitate. The mixture was cooled to room temperature, quenched with saturated Na–K tartrate (25 mL), and diluted with EtOAc (25 mL) and water (20 mL). The mixture was stirred vigorously for 1 h and then was filtered. The biphasic filtrate layers were separated, and the organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated to afford a yellow solid. Purification by preparative HPLC [Waters Autopurification MS-directed HPLC prep fraction collection with the following conditions: Column, Xbridge C18 RP 18, 5 μm, 19*50 mm; flow rate 20 mL/min; mobile phase, water with 0.1% ammonium hydroxide (A) and methanol with 0.1% ammonium hydroxide (B) running the following gradient 0 to 2 min (15%B), 2 to 6 min (15–100%B); detector ZQ Mass Detector in electrospray ionization mode] afforded 14 mg (6.3%) of the title compound. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.30 (s, 1H), 8.15 (s, 1H), 7.95–7.85 (m, 5H), 7.65–7.50 (m, 6H), 7.32–7.27 (m, 1H), 4.90 (s, 2H). LCMS (method LCMS1, ESI): RT = 0.92 min, <i>m</i>/<i>z</i> = 393.02 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>13</b>,<b> 18–21</b>,<b> 24</b>,<b> 29</b>,<b> 34</b>,<b> 53</b>, and<b> 55–57</b> were synthesized using conditions (AlMe<sub>3</sub>-mediated amide coupling) similar to those employed to make compound <b>12</b>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-1-methyl-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>13</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl 1-methyl-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (<b>66c</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 92% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.26 (s, 1H), 8.91 (s, 1H), 8.28 (s, 1H), 7.94–7.92 (m, 4H), 7.67–7.53 (m, 6H), 7.27 (s, 1H), 4.52 (s, 2H), 3.32 (s, 3H). LCMS (method LCMS1, ESI): RT = 0.93 min, <i>m</i>/<i>z</i> = 406.01 [M + H]<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}furo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>18</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with ethyl furo[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66d</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 68% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.60 (s, 1H), 9.00 (s, 1H), 8.45–8.40 (m, 1H), 7.96–7.88 (m, 4H), 7.80–7.76 (m, 1H), 7.70–7.50 (m, 6H), 4.52 (d, <i>J</i> = 5.24 Hz, 2H). LCMS (method LCMS1, ESI): RT = 1.11 min, <i>m</i>/<i>z</i> = 392.97 [M + H]<sup>+</sup>.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}thieno[2,3-<i>c</i>]pyridine-2-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thieno[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66e</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 37% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.13 (s, 1H), 8.49 (d, <i>J</i> = 6.0 Hz, 1H), 7.93 (s, 1H), 7.83–7.75 (m, 1H), 7.70–7.65 (m, 1H), 7.51–7.45 (m, 2H), 7.39–7.34 (m, 2H), 4.69 (d, <i>J</i> = 6.0 Hz, 2H), 2.95–2.85 (m, 4H), 1.65–1.55 (m, 4H), 1.42–1.33 (m, 2H). LCMS (method LCMS1, ESI) RT = 2.10 min, <i>m</i>/<i>z</i> = 416.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}thieno[2,3-<i>c</i>]pyridine-2-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thieno[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66e</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 85% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.60–9.55 (m, 1H), 9.29 (s, 1H), 8.50 (d, <i>J</i> = 6.0 Hz, 1H), 8.15 (s, 1H), 7.95–7.89 (m, 5H), 7.68–7.54 (m, 5H), 4.55 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI) RT = 1.65 min, <i>m</i>/<i>z</i> = 409.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>-{[4-(Piperidine-1-sulfonyl)phenyl]methyl}thieno[3,2-<i>c</i>]pyridine-2-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thieno[3,2-<i>c</i>]pyridine-2-carboxylate (<b>66f</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) and (4-(piperidin-1-ylsulfonyl)phenyl)methanamine (<b>64n</b>), the title product was obtained in 39% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1H), 8.48 (d, <i>J</i> = 6.0 Hz, 1H), 8.00 (s, 1H), 7.82–7.74 (m, 2H), 7.54–7.49 (m, 2H), 7.42–7.37 (m, 2H), 4.70 (d, <i>J</i> = 6.0 Hz, 2H), 2.94–2.88 (m, 4H), 1.65–1.55 (m, 4H), 1.43–1.34 (m, 2H). LCMS (method LCMS1, ESI) RT = 2.07 min, <i>m</i>/<i>z</i> = 416.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}-[1,3]thiazolo[5,4-<i>c</i>]pyridine-2-carboxamide (<b>2</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thiazolo[5,4-<i>c</i>]pyridine-2-carboxylate (<b>66g</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 48% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.01 (t, <i>J</i> = 6.0 Hz, 1H), 9.50 (s, 1H), 8.73–8.70 (m, 1 H), 8.11–8.07 (m, 1H), 7.95–7.89 (m, 4H), 7.69–7.54 (m, 5 H), 4.55 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (method LCMS1, ESI) RT = 1.91 min, <i>m</i>/<i>z</i> = 410.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}imidazo[1,5-<i>a</i>]pyridine-6-carboxamide (<b>29</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl imidazo[1,5-<i>a</i>]pyridine-6-carboxylate (<b>66h</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained with 28% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.71 (s, 1H), 8.26 (s, 1H), 7.92–7.84 (m, 4H), 7.60–7.45 (m, 7H), 7.05–6.97 (m, 2H), 4.69 (d, <i>J</i> = 6.3 Hz, 2H). LCMS (LCMS4, ESI): RT = 1.36 min, <i>m</i>/<i>z</i> = 392.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-{[4-(Benzenesulfonyl)phenyl]methyl}imidazo[1,2-<i>a</i>]pyrazine-6-carboxamide (<b>34</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl imidazo[1,2-<i>a</i>]pyrazine-6-carboxylate (<b>66b</b>) and (4-(phenylsulfonyl)phenyl)methanamine (<b>64o</b>), the title product was obtained in 28% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.45 (m, 1H), 9.26 (d, <i>J</i> = 1.2 Hz, 1H), 9.10 (s, 1H), 8.29 (s, 1H), 7.95–7.91 (m, 5H), 7.66 (d, J = 7.2 Hz, 1H), 7.63–7.55 (m, 4H), 4.56, 4.56 (d, <i>J</i> = 6.4 Hz, 2H). LCMS (LCMS4, ESI): RT = 2.08 min, <i>m</i>/<i>z</i> = 393.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-(4-(3-(Trifluoromethyl)phenylsulfonyl)benzyl)furo[2,3-<i>c</i>]pyridine-2-carboxamide (<b>53</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with ethyl furo[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66d</b>) and (4-((3-(trifluoromethyl)phenyl)sulfonyl)phenyl)methanamine (<b>64i</b>), the title product was obtained in 60% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.90 (s, 1H), 8.52–8.47 (m, 1H), 8.20 (s, 1H), 8.16–8.10 (m, 1H), 8.00–7.92 (m, 2H), 7.70–7.60 (m, 2H), 7.58–7.50 (m, 3H), 7.25 (s, 1H), 7.20 (s, 1H), 4.76–4.73 (m, 2H). LCMS (method LCMS1, ESI): RT = 1.35 min, <i>m</i>/<i>z</i> = 460.99 [M + H]<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-{[4-(3,5-Difluorobenzenesulfonyl)phenyl]methyl}thieno[2,3-<i>c</i>]pyridine-2-carboxamide (<b>55</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thieno[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66e</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) and (4-((3,5-difluorophenyl)sulfonyl)phenyl)methanamine (<b>64h</b>), the title product was obtained in 76% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.60 (s, 1H), 9.30 (s, 1H), 8.50 (s, 1H), 8.17 (s, 1H), 8.00–7.82 (m, 2H), 7.90 (s, 1H), 7.75–7.64 (m, 2H), 7.64–7.52 (m, 3H), 4.60 (s, 2H). LCMS (method LCMS1, ESI): RT = 1.31 min, <i>m</i>/<i>z</i> = 445.02 [M + H]<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-({4-[3-(Trifluoromethyl)benzenesulfonyl]phenyl}methyl)thieno[2,3-<i>c</i>]pyridine-2-carboxamide (<b>56</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thieno[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66e</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) and ((4-((3-(trifluoromethyl)phenyl)sulfonyl)phenyl)methanamine (<b>64i</b>), the title product was obtained in 55% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.58 (t, <i>J</i> = 6.0 Hz, 1H), 9.29 (s, 1H), 8.51 (d, <i>J</i> = 5.4 Hz, 1H), 8.27–8.22 (m, 2H), 8.15 (s, 1H), 8.08–8.01 (m, 3H), 7.92–7.83 (m, 2H), 7.59 (d, <i>J</i> = 8.7 Hz, 2H), 4.57 (d, <i>J</i> = 5.7 Hz, 2H). LCMS (method LCMS3, ESI): RT = 6.32 min, <i>m</i>/<i>z</i> = 477.22 [M + H]<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> N-[(4-{[6-(Morpholin-4-yl)pyridin-3-yl]sulfonyl}phenyl)methyl]thieno[2,3-<i>c</i>]pyridine-2-carboxamide (<b>57</b>)</h3><div class="NLM_p last">Substituting the corresponding reagents with methyl thieno[2,3-<i>c</i>]pyridine-2-carboxylate (<b>66e</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>) and (4-((6-morpholinopyridin-3-yl)sulfonyl)phenyl)methanamine (<b>64j</b>), the title product was obtained in 32% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.57 (t, <i>J</i> = 6.0 Hz, 1H), 9.30 (s, 1H), 8.57–8.55 (m, 1H), 8.51 (d, <i>J</i> = 6.0 Hz, 1H), 8.15 (s, 1H), 7.93–7.85 (m, 4 H), 7.53 (d, <i>J</i> = 6.0 Hz, 2H), 6.88 (d, <i>J</i> = 6.0 Hz, 1H), 4.54 (d, <i>J</i> = 6.0 Hz, 2 H), 3.65–3.55 (m, 8H). LCMS (method LCMS3, ESI) RT = 5.15 min, <i>m</i>/<i>z</i> = 495.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-{[4-(2-Methylbenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>41</b>)</h3><div id="sec4_53_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>tert</i>-Butyl 4-(2-Methylbenzenesulfonyl)benzylcarbamate (<b>69a</b>)</h4><div class="NLM_p last">To a glass vial was added sodium 4-(((<i>tert</i>-butoxycarbonyl)amino)methyl)benzenesulfinate (<b>67</b>, 0.2 M in DMSO, 400 μL, 80 μmol), 2-methylbenzeneboronic acid (<b>68a</b>, 0.2 M in 1,4-dioxane, 600 μL, 120 μmol), Et<sub>3</sub>N (50 μL, 360 μmol), and Cu(OAc)<sub>2</sub> (0.2 M in DMSO, 500 μL, 100 μmol). The vial was capped and heated at 65 °C for 16 h on a heater/shaker. The reaction was cooled to RT, and brine (2 mL) was added followed by concentrated NH<sub>4</sub>OH (100 μL) and 3:1 EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (3 mL). The layers were separated, and the organic layer was transferred to a new vial. The aqueous layer was extracted twice with 3:1 EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and the combined organic layers were evaporated to dryness in a Genevac evaporator. The crude title compound was obtained as a dark brown solid, which was used in the next step without further purification.</div></div><div id="sec4_53_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (4-(2-Methylbenzenesulfonyl)phenyl)methanamine Hydrochloride (<b>64a</b>)</h4><div class="NLM_p last">MeOH (500 μL) was added to the vial containing crude <b>69a</b> (80 μmol), and the mixture was heated to 50 °C for 15 min to dissolve the solid. The solution was cooled to RT, HCl (4.0 M in 1,4-dioxane, 400 μL, 1.6 mmol) was added, and the vial was shaken at RT for 30 min and then at 50 °C for 3 h. The solvent was evaporated to dryness in a Genevac evaporator. The light brown solid thus obtained was used in the next step without further purification.</div></div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-{[4-(2-Methylbenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>41</b>)</h3><div class="NLM_p">To the vial containing crude <b>64a</b> was added DMA (250 μL), Et<sub>3</sub>N (67 μL, 480 μmol), 1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (<b>65a</b>, 0.2 M in DMA, 440 μL, 88 μmol), and BOP (0.2 M in DCE, 440 μL, 88 μmol). The mixture was heated at 50 °C for 4 h and then was stirred at room temperature for 16 h. Brine (1.5 mL), NaOH (1 M in water, 100 μL, 100 μmol), and 3:1 EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (2 mL) were added, and the layers were separated. The aqueous layer was extracted twice with 3:1 EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (2 mL), and the combined organic layers were evaporated to dryness in a Genevac evaporator. The residue was purified by preparative HPLC [Waters Autopurification MS-directed HPLC prep fraction collection with the following conditions: column, Xbridge C18 RP 18, 5 μm, 19*50 mm; flow rate 20 mL/min; mobile phase, water with 0.1% ammonium hydroxide (A) and methanol with 0.1% ammonium hydroxide (B) running the following gradient 0 to 2 min (15%B), 2 to 6 min (15–100%B); detector ZQ Mass Detector in electrospray ionization mode] to give the title compound as a white powder with 6.4% yield in 3 steps. LCMS (method LCMS2, ESI): RT = 0.96 min, <i>m</i>/<i>z</i> = 406.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>42–43</b>,<b> 45–46</b>,<b> 48</b>, and<b> 50</b> were synthesized using conditions similar to those employed to make compound <b>41</b>.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-{[4-(3-methylbenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>42</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with 3-methylbenzeneboronic acid (<b>68b</b>), the title product was obtained in 4% yield in 3 steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.99 (s, 1H), 9.24 (t, <i>J</i> = 6.0 Hz, 1H), 8.92 (d, <i>J</i> = 1.0 Hz, 1H), 8.22 (d, <i>J</i> = 5.8 Hz, 1H), 7.96–7.91 (m, 2H), 7.77–7.74 (m, 1H), 7.74–7.70 (m, 1H), 7.59–7.53 (m, 2H), 7.50–7.46 (m, 2H), 7.36 (dt, <i>J</i> = 5.8, 1.1 Hz, 1H), 7.29 (s, 1H), 4.57 (d, <i>J</i> = 5.9 Hz, 2H), 2.37 (s, 3H). LCMS (method LCMS2, ESI): RT = 0.98 min, <i>m</i>/<i>z</i> = 406.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-({4-[2-(Trifluoromethyl)benzenesulfonyl]phenyl}methyl)imidazo[1,2-<i>a</i>]pyrimidine-6-carboxamide (<b>43</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with (2-(trifluoromethyl)phenyl)boronic acid (<b>68c</b>), the title product was obtained in 7% yield in 3 steps. LCMS (method LCMS2, ESI): RT = 0.96 min, <i>m</i>/<i>z</i> = 460.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-({4-[4-(Trifluoromethyl)benzenesulfonyl]phenyl}methyl)-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>45</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with (4-(trifluoromethyl)phenyl)boronic acid (<b>68d</b>), the title product was obtained in 11% yield in 3 steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.61 (br s, 1H), 9.45 (t, <i>J</i> = 6.0 Hz, 1H), 9.16 (s, 1H), 8.31 (d, <i>J</i> = 6.4 Hz, 1H), 8.15 (d, <i>J</i> = 8.4 Hz, 2H), 8.00–7.97 (m, 4H), 7.60–7.57 (m, 3H), 7.47 (s, 1H), 4.59 (d, <i>J</i> = 5.2 Hz, 2H). LCMS (method LCMS2, ESI): RT = 0.96 min, <i>m</i>/<i>z</i> = 460.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-{[4-(3-Fluorobenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>46</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with 3-fluorobenzeneboronic acid (<b>68e</b>), the title product was obtained in 11% yield in 3 steps. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.01 (s, 1H), 9.26 (t, <i>J</i> = 6.0 Hz, 1H), 8.93 (d, <i>J</i> = 1.2 Hz, 1H), 8.22 (d, <i>J</i> = 5.8 Hz, 1H), 8.02–7.95 (m, 2H), 7.83–7.76 (m, 2H), 7.71–7.63 (m, 1H), 7.62–7.52 (m, 3H), 7.36 (dt, <i>J</i> = 5.8, 1.1 Hz, 1H), 7.30 (s, 1H), 4.59 (d, <i>J</i> = 5.9 Hz, 2H). LCMS (method LCMS2, ESI): RT = 0.95 min, <i>m</i>/<i>z</i> = 410.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-{[4-(3,4-Difluorobenzenesulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>48</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with 3,4-difluorobenzeneboronic acid (<b>68f</b>), the title product was obtained in 8% yield in 3 steps. LCMS (method LCMS2, ESI): RT = 1.00 min, <i>m</i>/<i>z</i> = 428.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-{[4-(pyridine-3-sulfonyl)phenyl]methyl}-1H-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxamide (<b>50</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with pyridin-3-ylboronic acid (<b>68g</b>), the title product was obtained in 5% yield in 3 steps. LCMS (method LCMS2, ESI) RT = 0.69 min, <i>m</i>/<i>z</i> = 393.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>N</i>-(3-Aminopyridin-4-yl)-2,2,2-trichloroacetamide (<b>72</b>)</h3><div class="NLM_p last">Pyridine-3.4-diamine (<b>70</b>, 2.5 g, 22.91 mmol) was dissolved in CF<sub>3</sub>COOH (5.3 mL, 68.7 mmol). Methyl 2,2,2-trichloroacetimidate (<b>71</b>, 4.45 g, 25.2 mmol) was added over 30 min at 0 °C. The mixture was then stirred at room temperature for 2 days. The mixture was filtered, and the solid was washed with diethyl ether and dried to afford 5.7 g of desired product as a white solid in 98% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.80 (d, <i>J</i> = 5.4 Hz, 1H), 7.70 (s, 1H), 7.06 (s, 1H), 6.60 (d, <i>J</i> = 5.4 Hz, 1H), 5.33 (s, 2H).</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Methyl 3H-Imidazo[4,5-<i>c</i>]pyridine-2-carboxylate (<b>66a</b>)</h3><div class="NLM_p last">A mixture of H<sub>2</sub>O (1.21 mL, 67.2 mmol), Na<sub>2</sub>CO<sub>3</sub> (7.12 g, 67.2 mmol), and <b>72</b> (5.7 g, 22.40 mmol) in MeOH (80 mL) was heated at reflux overnight. The mixture was cooled to room temperature, diluted with EtOAc, washed with saturated NaHCO<sub>3</sub>, dried, and concentrated. Biotage purification of the residue (10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) afforded 100 mg of the title product in 3% yield. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ: 8.97 (s, 1H), 8.34 (s, 1H), 7.23 (s, 1H), 4.10 (s, 3H).</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 6-Bromoimidazo[1,2-<i>a</i>]pyrazine (<b>75</b>)</h3><div class="NLM_p last">To a solution of 5-bromopyrazin-2-amine (<b>73</b>, 20 g, 114.9 mmol) and 2-bromo-1,1-dimethoxyethane (<b>74</b>, 29 g, 171.6 mmol) in EtOH (500 mL) maintained under argon was added 40% HBr (50 mL). The reaction mixture was stirred at 80 °C for 12 h and then cooled to room temperature. The mixture was concentrated under vacuum to remove the excess EtOH. The pH value of the solution was adjusted to 9 with 1 N NaOH. The solution was extracted with 3 × 100 mL of EtOAc. The organic layers were combined and then washed with 2 × 300 mL of water and 1 × 500 mL of brine. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated under vacuum. The residue was purified on a silica gel column eluted with 45% EtOAc in petroleum ether to give the title product as a light-yellow solid in 15% yield. LCMS (LCMS4, ESI): RT = 0.94 min, <i>m</i>/<i>z</i> = 197.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Imidazo[1,2-<i>a</i>]pyrazine-6-carbonitrile (<b>76</b>)</h3><div class="NLM_p last">A mixture of <b>75</b> (2 g, 10.10 mmol), Zn(CN)<sub>2</sub> (1.4 g, 12.2 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (700 mg, 0.61 mmol) in DMF (30 mL) was stirred under nitrogen at 120 °C for 12 h. The solid was removed by filtration, and the filtrate was diluted with 200 mL of water. The resulting solution was extracted with 3 × 100 mL of CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with 2 × 300 mL of brine, were dried over anhydrous sodium sulfate, and were concentrated under vacuum. The residue was purified on a silica gel column eluted with 70% EtOAc in petroleum ether to give the title product as a white solid in 24% yield. LCMS (LCMS5, ESI): RT = 0.81 min, <i>m</i>/<i>z</i> = 145.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Methyl Imidazo[1,2-<i>a</i>]pyrazine-6-carboxylate (<b>66b</b>)</h3><div class="NLM_p last">Hydrogen chloride gas was bubbled into a solution of <b>76</b> (200 mg, 1.39 mmol) in MeOH (20 mL) for 15 min. The resulting solution was stirred at 80 °C for 2 h. The reaction mixture was concentrated under vacuum. The residue was dissolved in 50 mL of EtOAc and then was washed with 1 × 50 mL of water and 1 × 50 mL of brine. The organic layer was dried over anhydrous sodium sulfate, was filtered, and was concentrated under vacuum. The residue was purified on a silica gel column eluted with EtOAc/petroleum ether (1:4) to give the title product as a white solid in 12% yield. LCMS (LCMS6, ESI): RT = 0.88 min, <i>m</i>/<i>z</i> = 178.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>N</i>-(4-(3,5-Difluorophenylsulfonyl)benzyl)acetamide (<b>78h</b>)</h3><div class="NLM_p">In a 1 L round-bottomed flask was added sodium 4-(acetamidomethyl)benzenesulfinate (<b>77</b>, 7.45 g, 31.7 mmol), 3,5-difluorophenylboronic acid (<b>68h</b>, 5 g, 31.7 mmol), copper(II) acetate (6.33 g, 34.8 mmol), potassium carbonate (9.63 g, 67.9 mmol), and 100 mL of DMSO followed by 10 g of regular 4 Å molecular sieves. The reaction mixture was stirred at room temperature for overnight, and then the solution was filtered through Celite. The filtrate was concentrated under reduced pressure, diluted with EtOAc (300 mL), and washed with water (3 × 50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, was filtered, and was concentrated. Biotage purification of the residue (50% EtOAc/hexanes) afforded 4.07 g of the title product in 40% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.42 (t, <i>J</i> = 5.8 Hz, 1H), 7.99 (d, <i>J</i> = 8.4 Hz, 2H), 7.73–7.61 (m, 5H), 7.48 (d, <i>J</i> = 8.3 Hz, 1H), 4.29 (d, <i>J</i> = 6.0 Hz, 2H), 1.82 (s, 3H). LCMS (method LCMS3, ESI) RT = 5.79 min, <i>m</i>/<i>z</i> = 326.12 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>78i – 78j</b> were synthesized using conditions similar to those employed to make compound <b>78h</b>.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(4-((3-(Trifluoromethyl)phenyl)sulfonyl)benzyl)acetamide (<b>78i</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with 3-(trifluoromethyl)phenylboronic acid (<b>68i</b>), the title product was obtained in 40% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.45–37 (m, 1H), 8.27–8.21 (m, 2H), 8.10–8.05 (m, 1H), 7.99 (d, <i>J</i> = 8.2 Hz, 2H), 7.86 (t, <i>J</i> = 7.8 Hz, 1H), 7.45 (d, <i>J</i> = 8.5 Hz, 2H), 4.29 (d, <i>J</i> = 5.9 Hz, 2H), 1.85 (s, 3H).</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-(4-((6-Morpholinopyridin-3-yl)sulfonyl)benzyl)acetamide (<b>78j</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with 6-morpholinopyridin-3-ylboronic acid (<b>68j</b>), the title product was obtained in 16% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.57–8.54 (m, 1H), 8.43–8.36 (m, 1H), 7.89–7.82 (m, 3H), 7.41 (d, <i>J</i> = 8.2 Hz, 2H), 6.88 (d, <i>J</i> = 9.2 Hz, 1H), 4.26 (d, <i>J</i> = 6.0 Hz, 2H), 3.65–3.55 (m, 8H), 1.84 (s, 3H).</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (4-(3,5-Difluorophenylsulfonyl)phenyl)methanamine (<b>64h</b>)</h3><div class="NLM_p">The mixture of <b>78h</b> (4 g, 12.30 mmol) and 12 M HCl (102 mL, 3 M, 307 mmol) in 2-propanol was heated at 100 °C overnight. The reaction mixture was cooled to room temperature, and the 2-propanol was removed under reduced pressure to afford a white solid. The solid was then suspended in 3 M NaOH, filtered, washed with water (60 mL), and dried to give 3.14 g of the title product in 90% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 7.74–7.62 (m, 4H), 7.57 (d, <i>J</i> = 8.6 Hz, 2H), 3.76 (s, 2H). LCMS (method LCMS1, ESI): RT = 0.91 min, <i>m</i>/<i>z</i> = 284.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>64i–64j</b> were synthesized using conditions similar to those employed to make compound <b>64h</b>.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (4-((3-(Trifluoromethyl)phenyl)sulfonyl)phenyl)methanamine (<b>64i</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with <b>78i</b>, the title product was obtained in 86% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.19 (s, 1H), 8.11 (d, <i>J</i> = 7.9 Hz, 1H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H), 7.80 (d, <i>J</i> = 7.9 Hz, 1H), 7.64 (t, <i>J</i> = 7.9 Hz, 1H), 7.50 (d, <i>J</i> = 8.5 Hz, 2H), 3.94 (s, 2H), 1.48 (s, 2H).</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (4-((6-Morpholinopyridin-3-yl)sulfonyl)phenyl)methanamine (<b>64j</b>)</h3><div class="NLM_p last">Substituting the corresponding reagent with <b>78j</b>, the title product was obtained in 100% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.57–8.55 (m, 1H), 7.90–7.81 (m, 3H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 6.89 (d, <i>J</i> = 9.2 Hz, 1H), 3.73 (s, 2H), 3.65–3.56 (m, 8H), 1.85 (s, 2H).</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 4-(4-Fluorophenylsulfonyl)benzonitrile (<b>81</b>)</h3><div class="NLM_p last">To a solution of 4-fluorobenzonitrile (<b>79</b>, 5.98 g, 49.4 mmol) in 20 mL of DMSO at 120 °C was added dropwise of sodium 4-fluorobenzenesulfinate (<b>80</b>, 3 g, 16.47 mmol) in 20 mL of DMSO. The resulting mixture was stirred at 120 °C overnight and then was cooled to room temperature. 400 mL of ice water was added into the reaction mixture, and the resulting precipitate was filtered, washed with water (2 × 30 mL), and dried. Biotage purification with EtOAc/hexanes afforded 1.30 g of the title product in 30% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.04–8.26 (m, 6H), 7.44–7.52 (m, 2H).</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (4-(4-Fluorophenylsulfonyl)phenyl)methanamine (<b>64k</b>)</h3><div class="NLM_p last">To a solution of <b>81</b> (2.3 g, 8.8 mmol) in 150 mL of 2 N NH<sub>3</sub>/MeOH was added Raney Ni (500 mg), and the mixture was hydrogenated on a Parr apparatus (45 psi) overnight. Nitrogen was bubbled through the crude mixture to purge any residual H<sub>2</sub>, and the mixture was filtered through Celite, rinsing with MeOH (2 × 30 mL). The filtrate was concentrated to dryness and triturated with Et<sub>2</sub>O, and the solid was collected by vacuum filtration to give 2.2 g of the title product in 94% yield which was used for next step without further purification. LCMS (method LCMS2, ESI): RT = 0.87 min, <i>m</i>/<i>z</i> = 266.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 4-(Piperidin-1-ylsulfonyl)benzaldehyde (<b>84</b>)</h3><div class="NLM_p last">In a 100 mL round-bottomed flask was added piperidine (<b>83</b>, 233 mg, 2.74 mmol) and EtN(<i>i</i>-Pr)<sub>2</sub> (0.85 mL, 4.88 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), followed by a solution of 4-formylbenzene-1-sulfonyl chloride (<b>82</b>, 501 mg, 2.448 mmol) in 5 mL of CH<sub>2</sub>Cl<sub>2</sub>. The reaction mixture was stirred at room temperature for 16 h and then was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and was washed successively with water (10 mL) and brine (10 mL). The organic layer was dried over MgSO<sub>4</sub>, was filtered through a short plug of silica gel, and was concentrated to afford the title product as a colorless solid in 100% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 10.11 (s, 1H), 8.06–7.90 (m, 4H), 3.06–3.01 (m, 4H), 1.69–1.61 (m, 4H), 1.48–1.40 (m, 2H).</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (<i>E</i>)-2-Methyl-<i>N</i>-(4-(piperidin-1-ylsulfonyl)benzylidene)propane-2-sulfinamide (<b>85</b>)</h3><div class="NLM_p last">To a 0.5 M solution of 84 (712 mg, 2.81 mmol) in THF (6 mL) under nitrogen was added titanium(IV) ethoxide (1.2 mL, 5.62 mmol). <i>tert</i>-Butanesulfinamide (341 mg, 2.81 mmol) was then added, and the resulting mixture was stirred for 2 h at room temperature. The reaction was poured into an equal volume of sat. NaHCO<sub>3</sub> with rapid stirring and immediately filtered through Celite. The filter cake was washed with EtOAc (2 × 30 mL), and the aqueous layer was separated and washed once with EtOAc (20 mL). The combined organic layers were dried (MgSO<sub>4</sub>), filtered, and concentrated. The title product was obtained as a colorless solid by quick purification using silica gel chromatography (EtOAc/hexanes, 40/60) in 59% yield (the product slowly hydrolyzes on silica gel). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.64 (s, 1H), 8.01–7.84 (m, 4H), 3.05–3.01 (m, 4H), 1.69–1.62 (m, 4H), 1.47–1.43 (m, 2H), 1.29 (s, 9H).</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 2-Methyl-<i>N</i>-(1-(4-(piperidin-1-ylsulfonyl)phenyl)ethyl)propane-2-sulfinamide (<b>86</b>)</h3><div class="NLM_p last">A solution of <b>85</b> (73 mg, 0.21 mmol) was dissolved in 5:1 Et<sub>2</sub>O/THF (6 mL) and cooled to −78 °C. Methyllithium (1.6 M in Et<sub>2</sub>O, 1.5 mL, 2.4 mmol) was added dropwise via syringe and the mixture was stirred 1 h at −78 °C and then was warmed to room temperature for 16 h. The mixture was neutralized with a minimal amount of sat. Na<sub>2</sub>SO<sub>4</sub>, diluted with EtOAc (15 mL). The organic layer was dried (MgSO<sub>4</sub>) and concentrated. The title product was obtained in 47% yield after silica gel chromatography (EtOAc/hexanes, 40/60). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.73 (d, <i>J</i> = 8.4 Hz, 2H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 4.65–4.57 (m, 1H), 3.46 (d, <i>J</i> = 3.4 Hz, 1H), 2.99 (t, <i>J</i> = 5.4 Hz, 4H), 1.68–1.60 (m, 4H), 1.53 (d, <i>J</i> = 5.6 Hz, 3H), 1.47–1.39 (m, 2H), 1.24 (s, 9H).</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 1-(4-(Piperidin-1-ylsulfonyl)phenyl)ethanamine Hydrochloride (<b>64l</b>)</h3><div class="NLM_p last">A solution of <b>86</b> (36 mg, 0.1 mmol) in MeOH (0.5 mL) was treated with 4 M HCl in 1,4-dioxane (0.5 mL), and the mixture was stirred for 30 min before being concentrated to 30% of its original volume. Et<sub>2</sub>O (2 mL) was added, forming a precipitate. The mixture was again concentrated to 30% of the original volume, and Et<sub>2</sub>O (4 mL) was added. The title product was obtained as a colorless solid in 68% yield after vacuum filtration and washing with cold Et<sub>2</sub>O (2 mL). This compound was used directly in the next step (synthesis of compound <b>9</b>) without further purification.</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Methyl 3-(4-((<i>tert</i>-Butoxycarbonylamino)methyl)phenylthio)propanoate (<b>89</b>)</h3><div class="NLM_p last">A 200 mL flask equipped with a magnetic stir bar and containing <i>tert</i>-butyl-4-bromobenzylcarbamate (<b>87</b>, 6.72 g, 23.5 mmol) was charged with toluene (50 mL), EtN(<i>i</i>-Pr)<sub>2</sub> (8.21 mL, 47.0 mmol), Xantphos (0.680 g, 1.175 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.538 g, 0.588 mmol), and methyl 3-mercaptopropanoate (<b>88</b>, 2.60 mL, 23.50 mmol). The mixture was heated to 100 °C under nitrogen for 2.5 h. After cooling, the mixture was loaded directly on a short silica gel column. Elution with 5:1 to 3:1 hexanes–EtOAc afforded the title product as a colorless oil in 94% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.32 (d, <i>J</i> = 8.3 Hz, 2H), 7.21 (d, <i>J</i> = 8.2 Hz, 2H), 4.84 (br s, 1H), 4.28 (d, <i>J</i> = 5.8 Hz, 2H), 3.67 (s, 3H), 3.14 (t, <i>J</i> = 7.4 Hz, 2H), 2.61 (t, <i>J</i> = 7.5 Hz, 2H), 1.45 (s, 9H). LCMS (method LCMS2, ESI) <i>m</i>/<i>z</i> = 348.15 [M + Na]<sup>+</sup>.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Methyl 3-(4-((<i>tert</i>-Butoxycarbonylamino)methyl)phenylsulfonyl)propanoate (<b>90</b>)</h3><div class="NLM_p last">A 500 mL flask equipped with a magnetic stir bar was charged with Oxone (23.61 g, 38.4 mmol) and water (82 mL). The mixture was stirred at RT for 5 min to dissolve the Oxone, and a solution of <b>89</b> (5.0 g, 15.36 mmol) in CH<sub>3</sub>CN (45 mL) was then added at RT with rapid stirring. The mixture was stirred at RT for 3 h. Water (60 mL) and EtOAc (100 mL) were added, and the layers were separated. The aqueous layer was extracted with EtOAc (100 mL). The combined organic layers were washed with half-saturated brine (2 × 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated under reduced pressure to afford the title product as a white solid in 94% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.48 (d, <i>J</i> = 8.6 Hz, 2H), 5.03 (br s, 1H), 4.41 (d, <i>J</i> = 6.2 Hz, 2H), 3.64 (s, 3H), 3.41 (t, <i>J</i> = 7.7 Hz, 2H), 2.74 (t, <i>J</i> = 7.8 Hz, 2H), 1.46 (s, 9H). LCMS (method LCMS2, ESI) <i>m</i>/<i>z</i> = 380.07 [M + Na]<sup>+</sup>.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Sodium 4-(((<i>tert</i>-Butoxycarbonyl)amino)methyl)benzenesulfinate (<b>67</b>)</h3><div class="NLM_p last">To a solution of <b>90</b> (358 mg, 1 mmol) in MeOH (5 mL) was added EtONa (21% in ethanol, 0.38 mL, 1.02 mmol), and the mixture was heated at 50 °C for 1 h. After cooling, the solvent was removed under reduced pressure and the residue was dried under high vacuum to give the title product as a light yellow solid in 97% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.35 (d, <i>J</i> = 8.0 Hz, 2H), 7.13 (d, <i>J</i> = 8.0 Hz, 2H), 4.07 (d, <i>J</i> = 5.6 Hz, 2H), 1.37 (s, 9H).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97"><a href="/doi/suppl/10.1021/jm4008664">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of computational methods; details of analytical LCMS methods; in vitro ADME and experimental procedures; experimental details for PK and efficacy study of compound <b>58</b> in the mouse; protein expression/purification and crystallographic methods and procedures for <b>7</b> and <b>58</b> (in complex with Nampt); details of Nampt biochemical and cell-based assays. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4008664/suppl_file/jm4008664_si_001.pdf">jm4008664_si_001.pdf (442.17 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB nos.: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFN">4KFN</a> for <b>7</b> complexed with Nampt; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFO">4KFO</a> for <b>58</b> complexed with Nampt.</p><div class="testing" data-doi="10.1021/jm4008664" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaozhang Zheng</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#83fbf9ebe6ede4c3e5ecf1eee2f7ebe6f1e2f3e6f6f7eae0f0ade0ecee"><span class="__cf_email__" data-cfemail="8ff7f5e7eae1e8cfe9e0fde2eefbe7eafdeeffeafafbe6ecfca1ece0e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bauer</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timm Baumeister</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre J. Buckmelter</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maureen Caligiuri</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl H. Clodfelter</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bingsong Han</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yen-Ching Ho</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolai Kley</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Lin</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dominic J. Reynolds</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geeta Sharma</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chase C. Smith</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongguo Wang</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter S. Dragovich</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Gunzner-Toste</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bianca M. Liederer</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin Ly</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas O’Brien</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Oh</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie Wang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiru Wang</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Xiao</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Zak</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiling Zhao</span> - <span class="hlFld-Affiliation affiliation">Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Po-wai Yuen</span> - <span class="hlFld-Affiliation affiliation">Pharmaron Beijing,
Co. Ltd., 6 Tai He Road, BDA Beijing, 100176, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth W. Bair</span> - <span class="hlFld-Affiliation affiliation">Forma Therapeutics,
Inc., 500 Arsenal Street, Watertown, Massachusetts 02472,
United States </span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d103e6242-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Forma’s high speed synthesis group and George Luke for their synthetic contributions, ADME group for generating the microsomal and solubility data, Rashida Garcia-Dancey and Shohini Ganguly for helping generate the biochemical and cellular data, and Lakshmanan Manikandan, Saradhi Vijay, and Danilal C. Sharma for generating the in vivo efficacy data. We thank the DMPK group at Genentech for their contribution to the generation of the DMPK data, especially Erlie Marie Delarosa and Jonathan Cheong. We also acknowledge Agilent Technologies (Woburn, MA) for generating the Rapidfire LCMS data, Tandem Laboratories (Woburn, MA) for performing the phosphoribosylated adduct study, Yigong Shi’s group (Tsinghua University, Beijing, China) for providing Nampt DNA construct and Nampt protein, and James Kyranos and Jaime Escobedo for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i100" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i100"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i101" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i101"> Abbreviations Used</h2><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr><tr><td class="NLM_term">CyQuant</td><td class="NLM_def"><p class="first last">cell counting via DNA content to assess proliferative effects</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time to reach the maximum concentration</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">(<i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate)</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">Xantphose</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">SCX</td><td class="NLM_def"><p class="first last">strong cationic exchange</p></td></tr><tr><td class="NLM_term">THPP</td><td class="NLM_def"><p class="first last">tris(hydroxypropyl)phosphine</p></td></tr><tr><td class="NLM_term">D5W</td><td class="NLM_def"><p class="first last">5% dextrose in water</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 24 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Belenky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">NAD+ metabolism in health and disease</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=12-19&author=P.+Belenkyauthor=K.+L.+Boganauthor=C.+Brenner&title=NAD%2B+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelenky%26aufirst%3DP.%26aulast%3DBogan%26aufirst%3DK.%2BL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DNAD%252B%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2007%26volume%3D32%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koppenol, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounds, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Otto Warburg’s contributions to current concepts of cancer metabolism</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fnrc3038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=21508971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=325-337&author=W.+H.+Koppenolauthor=P.+L.+Boundsauthor=C.+V.+Dang&title=Otto+Warburg%E2%80%99s+contributions+to+current+concepts+of+cancer+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Otto Warburg's contributions to current concepts of cancer metabolism</span></div><div class="casAuthors">Koppenol, Willem H.; Bounds, Patricia L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">325-337</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Otto Warburg pioneered quant. investigations of cancer cell metab., as well as photosynthesis and respiration.  Warburg and co-workers showed in the 1920s that, under aerobic conditions, tumor tissues metabolize approx. tenfold more glucose to lactate in a given time than normal tissues, a phenomenon known as the Warburg effect.  However, this increase in aerobic glycolysis in cancer cells is often erroneously thought to occur instead of mitochondrial respiration and has been misinterpreted as evidence for damage to respiration instead of damage to the regulation of glycolysis.  In fact, many cancers exhibit the Warburg effect while retaining mitochondrial respiration.  We re-examine Warburg's observations in relation to the current concepts of cancer metab. as being intimately linked to alterations of mitochondrial DNA, oncogenes and tumor suppressors, and thus readily exploitable for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdteDUarw-PbVg90H21EOLACvtfcHk0liQ4-AYhEL_Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D&md5=72988f428422daecd23b21d242aec18a</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrc3038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3038%26sid%3Dliteratum%253Aachs%26aulast%3DKoppenol%26aufirst%3DW.%2BH.%26aulast%3DBounds%26aufirst%3DP.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DOtto%2520Warburg%25E2%2580%2599s%2520contributions%2520to%2520current%2520concepts%2520of%2520cancer%2520metabolism%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D325%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1016%2Fj.ccr.2012.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=22439925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=297-308&author=P.+S.+Wardauthor=C.+B.+Thompson&title=Metabolic+reprogramming%3A+A+cancer+hallmark+even+Warburg+did+not+anticipate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate</span></div><div class="casAuthors">Ward, Patrick S.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-308</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer metab. has long been equated with aerobic glycolysis, seen by early biochemists as primitive and inefficient.  Despite these early beliefs, the metabolic signatures of cancer cells are not passive responses to damaged mitochondria but result from oncogene-directed metabolic reprogramming required to support anabolic growth.  Recent evidence suggests that metabolites themselves can be oncogenic by altering cell signaling and blocking cellular differentiation.  No longer can cancer-assocd. alterations in metab. be viewed as an indirect response to cell proliferation and survival signals.  We contend that altered metab. has attained the status of a core hallmark of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFCvg4k-_m7Vg90H21EOLACvtfcHk0lj3vSgbQC6gtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D&md5=8e991ba77d1bb0b57c3009b6bc39ee99</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DMetabolic%2520reprogramming%253A%2520A%2520cancer%2520hallmark%2520even%2520Warburg%2520did%2520not%2520anticipate%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D297%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rongvaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span> </span><span class="NLM_article-title">The nicotinamide phosphoribosyltransferase: A molecular link between metabolism, inflammation, and cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8-11&author=M.+Galliauthor=F.+Van+Goolauthor=A.+Rongvauxauthor=F.+Andrisauthor=O.+Leo&title=The+nicotinamide+phosphoribosyltransferase%3A+A+molecular+link+between+metabolism%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DRongvaux%26aufirst%3DA.%26aulast%3DAndris%26aufirst%3DF.%26aulast%3DLeo%26aufirst%3DO.%26atitle%3DThe%2520nicotinamide%2520phosphoribosyltransferase%253A%2520A%2520molecular%2520link%2520between%2520metabolism%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">50754</span><span class="NLM_x">–</span> <span class="NLM_lpage">50763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=50754-50763&author=J.+R.+Revolloauthor=A.+A.+Grimmauthor=S.+Imai&title=The+NAD+biosynthesis+pathway+mediated+by+nicotinamide+phosphoribosyltransferase+regulates+Sir2+activity+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DGrimm%26aufirst%3DA.%2BA.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DThe%2520NAD%2520biosynthesis%2520pathway%2520mediated%2520by%2520nicotinamide%2520phosphoribosyltransferase%2520regulates%2520Sir2%2520activity%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D50754%26epage%3D50763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt: Linking NAD Biology, Metabolism and Cancer</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1016%2Fj.tem.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19109034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=130-138&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Kornerauthor=S.-I.+Imaiauthor=W.+Kiess&title=Nampt%3A+Linking+NAD+Biology%2C+Metabolism+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt: linking NAD biology, metabolism and cancer</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Koerner, Antje; Imai, Shin-ichiro; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to NMN, a key NAD intermediate.  Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biol., metab. and inflammation.  As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt also plays an important part in regulating insulin secretion in pancreatic β-cells.  Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation.  This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMtmRWd15knbVg90H21EOLACvtfcHk0lj3vSgbQC6gtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D&md5=2e6fc10db431e1963b0b827747466c53</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.-I.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%253A%2520Linking%2520NAD%2520Biology%252C%2520Metabolism%2520and%2520Cancer%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">11086</span><span class="NLM_x">–</span> <span class="NLM_lpage">11096</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi801198m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=11086-11096&author=E.+S.+Burgosauthor=V.+L.+Schramm&title=Weak+coupling+of+ATP+hydrolysis+to+the+chemical+equilibrium+of+human+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1021%2Fbi801198m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801198m%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DWeak%2520coupling%2520of%2520ATP%2520hydrolysis%2520to%2520the%2520chemical%2520equilibrium%2520of%2520human%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D11086%26epage%3D11096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zaremba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulthard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fsj.bjc.6605166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19568233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=256-262&author=T.+Zarembaauthor=P.+Ketzerauthor=M.+Coleauthor=S.+Coulthardauthor=E.+R.+Plummerauthor=N.+J.+Curtin&title=Poly%28ADP-ribose%29+polymerase-1+polymorphisms%2C+expression+and+activity+in+selected+human+tumour+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span></div><div class="casAuthors">Zaremba, T.; Ketzer, P.; Cole, M.; Coulthard, S.; Plummer, E. R.; Curtin, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding enzyme activated by DNA breaks and involved in DNA repair and other cellular processes.  Poly(ADP-ribose) polymerase activity can be higher in cancer than in adjacent normal tissue, but cancer predisposition is reported to be greater in individuals with a single-nucleotide polymorphism (SNP) V762A (T2444C) in the catalytic domain that reduces PARP-1 activity.  Methods: To resolve these divergent observations, we detd. PARP-1 polymorphisms, PARP-1 protein expression and activity in a panel of 19 solid and haematol., adult and pediatric human cancer cell lines.  Results: There was a wide variation in PARP activity in the cell line panel (coeff. of variation, CV=103%), with the lowest and the highest activity being 2460 pmol PAR/106 (HS-5 cells) and 85 750 pmol PAR/106 (NGP cells).  Lower variation (CV=32%) was obsd. in PARP-1 protein expression with the lowest expression being 2.0 ng μg-1 (HS-5 cells) and the highest being 7.1 ng μg-1 (ML-1 cells).  The mean activity in the cancer cells was 45-fold higher than the mean activity in normal human lymphocytes and the PARP-1 protein levels were 23-fold higher.  Conclusions: Surprisingly, there was no significant correlation between PARP activity and PARP-1 protein level or the investigated polymorphisms, T2444C and CA.  British Journal of Cancer (2009) 101, 256-262; doi:10.1038/sj.bjc.6605166 www.bjcancer.com Published online 30 June 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiXp9dmBsH7Vg90H21EOLACvtfcHk0lg22IiXi4UoFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D&md5=2e8cbeef3e92351d2afd5bed60ad77d4</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605166%26sid%3Dliteratum%253Aachs%26aulast%3DZaremba%26aufirst%3DT.%26aulast%3DKetzer%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DM.%26aulast%3DCoulthard%26aufirst%3DS.%26aulast%3DPlummer%26aufirst%3DE.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520polymorphisms%252C%2520expression%2520and%2520activity%2520in%2520selected%2520human%2520tumour%2520cell%2520lines%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouhar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1517%2F14728222.11.5.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=17465726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=695-705&author=J.+A.+Khanauthor=F.+Forouharauthor=X.+Taoauthor=L.+Tong&title=Nicotinamide+adenine+dinucleotide+metabolism+as+an+attractive+target+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span></div><div class="casAuthors">Khan, Javed A.; Forouhar, Farhad; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-705</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  NAD (NAD+) has crucial roles in many cellular processes, both as a coenzyme for redox reactions and as a substrate to donate ADP-ribose units.  Enzymes involved in NAD+ metab. are attractive targets for drug discovery against a variety of human diseases, including cancer, multiple sclerosis, neurodegeneration and Huntington's disease.  A small-mol. inhibitor of nicotinamide phosphoribosyltransferase, an enzyme in the salvage pathway of NAD+ biosynthesis, is presently in clin. trials against cancer.  An analog of a kynurenine pathway intermediate is efficacious against multiple sclerosis in an animal model.  Indoleamine 2,3-dioxygenase plays an important role in immune evasion by cancer cells and other disease processes.  Inhibitors against kynurenine 3-hydroxylase can reduce the prodn. of neurotoxic metabolites while increasing the prodn. of neuroprotective compds.  This review summarizes the existing knowledge on NAD+ metabolic enzymes, with emphasis on their relevance for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrpVwpXgPHrVg90H21EOLACvtfcHk0lg2UcagE47f0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D&md5=43a4c12a1a780feddd233e1d8209f3f6</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.5.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.5.695%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DForouhar%26aufirst%3DF.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DNicotinamide%2520adenine%2520dinucleotide%2520metabolism%2520as%2520an%2520attractive%2520target%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D695%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cerna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. S.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by the small molecule GMX1778 regulates ROS-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">22408</span><span class="NLM_x">–</span> <span class="NLM_lpage">22417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=22408-22417&author=D.+Cernaauthor=H.+Liauthor=S.+Flahertyauthor=N.+Takebeauthor=C.+N.+Colemanauthor=S.+S.+Yoo&title=Inhibition+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+activity+by+the+small+molecule+GMX1778+regulates+ROS-mediated+cytotoxicity+in+a+p53-+and+nicotinic+acid+phosphoribosyltransferase1+%28NAPRT1%29-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerna%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DFlaherty%26aufirst%3DS.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DColeman%26aufirst%3DC.%2BN.%26aulast%3DYoo%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520activity%2520by%2520the%2520small%2520molecule%2520GMX1778%2520regulates%2520ROS-mediated%2520cytotoxicity%2520in%2520a%2520p53-%2520and%2520nicotinic%2520acid%2520phosphoribosyltransferase1%2520%2528NAPRT1%2529-dependent%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D22408%26epage%3D22417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0lg2UcagE47f0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Schou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottosen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">Novel cyanoguanidines with potent oral antitumor activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3095-3100&author=C.+Schouauthor=E.+R.+Ottosenauthor=H.+J.+Petersenauthor=F.+Bjorklingauthor=S.+Latiniauthor=P.+V.+Hjarnaaauthor=E.+Brammauthor=L.+Binderup&title=Novel+cyanoguanidines+with+potent+oral+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchou%26aufirst%3DC.%26aulast%3DOttosen%26aufirst%3DE.%2BR.%26aulast%3DPetersen%26aufirst%3DH.%2BJ.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DNovel%2520cyanoguanidines%2520with%2520potent%2520oral%2520antitumor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3095%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Biedermann, E.; Hasmann, M.; Loser, R.; Rattel, B.; Reiter, F.; Schein, B.; Seibel, K.; Vogt, K.</span><span> </span><span class="NLM_article-title">Preparation and formulation of pyridine derivatives as antitumor agents and immunosuppressants</span>. WO 199748397,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=E.+Biedermann&author=M.+Hasmann&author=R.+Loser&author=B.+Rattel&author=F.+Reiter&author=B.+Schein&author=K.+Seibel&author=K.+Vogt&title=Preparation+and+formulation+of+pyridine+derivatives+as+antitumor+agents+and+immunosuppressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiedermann%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520formulation%2520of%2520pyridine%2520derivatives%2520as%2520antitumor%2520agents%2520and%2520immunosuppressants%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ravaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I study and pharmacokinetics of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=702-707&author=A.+Ravaudauthor=T.+Cernyauthor=C.+Terretauthor=J.+Wandersauthor=B.+N.+Buiauthor=D.+Hessauthor=J.-P.+Drozauthor=P.+Fumoleauauthor=C.+Twelves&title=Phase+I+study+and+pharmacokinetics+of+CHS-828%2C+a+guanidino-containing+compound%2C+administered+orally+as+a+single+dose+every+3+weeks+in+solid+tumours%3A+An+ECSG%2FEORTC+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavaud%26aufirst%3DA.%26aulast%3DCerny%26aufirst%3DT.%26aulast%3DTerret%26aufirst%3DC.%26aulast%3DWanders%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DB.%2BN.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DDroz%26aufirst%3DJ.-P.%26aulast%3DFumoleau%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520study%2520and%2520pharmacokinetics%2520of%2520CHS-828%252C%2520a%2520guanidino-containing%2520compound%252C%2520administered%2520orally%2520as%2520a%2520single%2520dose%2520every%25203%2520weeks%2520in%2520solid%2520tumours%253A%2520An%2520ECSG%252FEORTC%2520study%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D702%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hovstadium, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissmeyer, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasilnikoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonnebo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, J.</span><span> </span><span class="NLM_article-title">A phase I study of CHS 828 in patients with solid tumor malignancy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=12231525" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2843-2850&author=P.+Hovstadiumauthor=R.+Larssonauthor=E.+Jonssonauthor=T.+Skovauthor=A.-M.+Kissmeyerauthor=K.+Krasilnikoffauthor=J.+Berghauthor=M.+O.+Karlssonauthor=A.+Lonneboauthor=J.+Ahlgren&title=A+phase+I+study+of+CHS+828+in+patients+with+solid+tumor+malignancy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHovstadium%26aufirst%3DP.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DKissmeyer%26aufirst%3DA.-M.%26aulast%3DKrasilnikoff%26aufirst%3DK.%26aulast%3DBergh%26aufirst%3DJ.%26aulast%3DKarlsson%26aufirst%3DM.%2BO.%26aulast%3DLonnebo%26aufirst%3DA.%26aulast%3DAhlgren%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520CHS%2520828%2520in%2520patients%2520with%2520solid%2520tumor%2520malignancy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D2843%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vig Hjarnaa, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">CHS828, a novel pyridine cyanoguanidine with potent antitumor activity <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5751</span><span class="NLM_x">–</span> <span class="NLM_lpage">5757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5751-5757&author=P.-J.+Vig+Hjarnaaauthor=E.+Jonssonauthor=S.+Latiniauthor=S.+Dharauthor=R.+Larssonauthor=E.+Brammauthor=T.+Skovauthor=L.+Binderup&title=CHS828%2C+a+novel+pyridine+cyanoguanidine+with+potent+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVig%2BHjarnaa%26aufirst%3DP.-J.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DCHS828%252C%2520a%2520novel%2520pyridine%2520cyanoguanidine%2520with%2520potent%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5751%26epage%3D5757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauske, A.-R.</span><span> </span><span class="NLM_article-title">The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=45-51&author=K.+Holenauthor=L.+B.+Saltzauthor=E.+Hollywoodauthor=K.+Burkauthor=A.-R.+Hanauske&title=The+pharmacokinetics%2C+toxicities%2C+and+biologic+effects+of+FK866%2C+a+nicotinamide+adenine+dinucleotide+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DHollywood%26aufirst%3DE.%26aulast%3DBurk%26aufirst%3DK.%26aulast%3DHanauske%26aufirst%3DA.-R.%26atitle%3DThe%2520pharmacokinetics%252C%2520toxicities%252C%2520and%2520biologic%2520effects%2520of%2520FK866%252C%2520a%2520nicotinamide%2520adenine%2520dinucleotide%2520biosynthesis%2520inhibitor%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1158%2F1535-7163.MCT-09-1130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=20515945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1609-1617&author=U.+H.+Olesenauthor=A.+V.+Thougaardauthor=P.+B.+Jensenauthor=M.+Sehested&title=A+preclinical+study+on+the+rescue+of+normal+tissue+by+nicotinic+acid+in+high-dose+treatment+with+APO866%2C+a+specific+nicotinamide+phosphoribosyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase Inhibitor</span></div><div class="casAuthors">Olesen, Uffe Hogh; Thougaard, Annemette V.; Jensen, Peter Buhl; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1609-1617</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of nicotinamide phosphoribosyltransferase APO866 is a promising cancer drug currently in phase II clin. trials in oncol.  Here, we present a strategy for increasing the therapeutic potential of APO866 through the rescue of normal tissues by coadministration of nicotinic acid (Vitamin B3).  We examd. the toxicity profile of APO866 in B6D2F1 mice and the effect of oral administration of nicotinic acid on tissue toxicity.  Nicotinic acid (50 mg/kg) protects mice from death and severe toxicity from an APO866 dose (60 mg/kg) four times the monotherapy max. tolerated dose (15 mg/kg).  In a panel of six cancer cell lines, we find that three (including ML-2 cells) are protected by nicotinic acid in vitro, whereas the cytotoxicity of APO866 remains unaffected in the remaining three (including A2780 cells).  A selective biomarker for the protection by nicotinic acid was subsequently identified by quant. RT-PCR.  The expression of nicotinic acid phosphoribosyltransferase is low in the cell lines not rescued from APO866 by nicotinic acid compared with protected cell lines.  The findings in cell lines translated into xenograft models in which the combination of 50 mg/kg nicotinic acid and 50 mg/kg APO866 in mouse xenografts of A2780 cells increased life span by >3-fold compared with std. treatment of 15 mg/kg, and the effect of APO866 was clearly decreased when using the same treatment paradigm in ML-2 xenografts.  In conclusion, the combination of high doses of APO866 with rescue by nicotinic acid may significantly increase the therapeutic potential in a subset of cancers with low expression of nicotinic acid phosphoribosyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEVf5ZtCvXrVg90H21EOLACvtfcHk0lja58Akq-RRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D&md5=353e954d2fd5308992a0ce8039ef081c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1130%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DA%2520preclinical%2520study%2520on%2520the%2520rescue%2520of%2520normal%2520tissue%2520by%2520nicotinic%2520acid%2520in%2520high-dose%2520treatment%2520with%2520APO866%252C%2520a%2520specific%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1609%26epage%3D1617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckmelter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clodfelter, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span> </span><span class="NLM_article-title">Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4921</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400186h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4921-4937&author=X.+Zhengauthor=P.+Bauerauthor=T.+Baumeisterauthor=A.+J.+Buckmelterauthor=M.+Caligiuriauthor=K.+H.+Clodfelterauthor=B.+Hanauthor=Y.-C.+Hoauthor=N.+Kleyauthor=J.+Linauthor=D.+J.+Reynoldsauthor=G.+Sharmaauthor=C.+C.+Smithauthor=Z.+Wangauthor=P.+S.+Dragovichauthor=A.+Ohauthor=W.+Wangauthor=M.+Zakauthor=J.+Gunzner-Tosteauthor=G.+Zhaoauthor=P.-w.+Yuenauthor=K.+W.+Bair&title=Structure-based+identification+of+ureas+as+novel+nicotinamide+phosphoribosyltransferase+%28Nampt%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm400186h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400186h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBauer%26aufirst%3DP.%26aulast%3DBaumeister%26aufirst%3DT.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DCaligiuri%26aufirst%3DM.%26aulast%3DClodfelter%26aufirst%3DK.%2BH.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DY.-C.%26aulast%3DKley%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DReynolds%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DStructure-based%2520identification%2520of%2520ureas%2520as%2520novel%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4921%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckmelter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiurib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clodfelter, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liederer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3531</span><span class="NLM_x">–</span> <span class="NLM_lpage">3538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3531-3538&author=J.+Gunzner-Tosteauthor=G.+Zhaoauthor=P.+Bauerauthor=T.+Baumeisterauthor=A.+J.+Buckmelterauthor=M.+Caligiuribauthor=K.+H.+Clodfelterauthor=B.+Fuauthor=B.+Hanauthor=Y.-C.+Hoauthor=N.+Kleyauthor=X.+Liangauthor=B.+Liedererauthor=J.+Linauthor=S.+Mukadamauthor=T.+O%E2%80%99Brienauthor=D.+J.+Reynoldsauthor=G.+Sharmaauthor=N.+Skeltonauthor=C.+C.+Smithauthor=W.+Wangauthor=Z.+Wangauthor=Y.+Xiaoauthor=P.-w.+Yuenauthor=M.+Zakauthor=L.+Zhangauthor=X.+Zhengauthor=K.+W.+Bairauthor=P.+S.+Dragovich&title=Discovery+of+potent+and+efficacious+urea-containing+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitors+with+reduced+CYP2C9+inhibition+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DP.%26aulast%3DBaumeister%26aufirst%3DT.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DCaligiurib%26aufirst%3DM.%26aulast%3DClodfelter%26aufirst%3DK.%2BH.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DY.-C.%26aulast%3DKley%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiederer%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DReynolds%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DSkelton%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520efficacious%2520urea-containing%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitors%2520with%2520reduced%2520CYP2C9%2520inhibition%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3531%26epage%3D3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><div class="note"><p class="first last">For a recent and broad review of many different classes of Nampt inhibitors, see:</p></div><span class="NLM_contrib-group">Galli, U.; Travelli, C.; Massarotti, A.; Fakhfouri, G.; Rahimian, R.; Tron, G. C.; Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors</span>. DOI: <span class="refDoi"> DOI: 10.1021/jm4001049</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm4001049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+a+recent+and+broad+review+of+many+different+classes+of+Nampt+inhibitors%2C+see%3AGalli%2C+U.%3B+Travelli%2C+C.%3B+Massarotti%2C+A.%3B+Fakhfouri%2C+G.%3B+Rahimian%2C+R.%3B+Tron%2C+G.+C.%3B+Genazzani%2C+A.+A.+Medicinal+chemistry+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitors.+DOI%3A+10.1021%2Fjm4001049."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm4001049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1021%252Fjm4001049%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26atitle%3DMedicinal%2520chemistry%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitors%26doi%3D10.1021%2Fjm4001049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><div class="note"><p class="first last">Related PRPP adducts have also been described for other Nampt inhibitors. See:</p></div><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">–</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Berger&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0lgwF5KkS5chgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">The antiproliferative effects exhibited in cell culture by <b>7</b> were completely eliminated (“reversed”) when the compound was tested in the presence of 0.33 mM NMN (the product of the Nampt-catalyzed condensation of nicotinamide and PRPP; cf., Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This result strongly suggests that the observed cell-based effects result from Nampt inhibition. Related NMN experiments were conducted in cell-based assessments with all inhibitors reported in this work and all displayed similar reversals of their antiproliferative effects.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">The resolution of the <b>7–</b>Nampt cocrystal structure cannot distinguish the depicted azaindole binding orientation from the rotational isomer which positions the azaindole NH away from Asp219 and toward R311. However, the described orientation optimally locates the azaindole nitrogen atom for condensation with PRPP in the Nampt active site and is thus consistent with the PRPP adduct formation observed for closely related azaindole-containing inhibitors (e.g., <b>8</b>)</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">We currently believe that many cell-potent Nampt inhibitors form PRPP-derived phosphoribosylated adducts in the protein’s active site which block the function of the enzyme. This belief is consistent with the repeated observation of these adducts by mass spectrometry in biochemical experiments (this work and ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>). It is also consistent with the inability to detect similar adduct formation in related experiments with compound <b>10</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and another cell-inactive compound that was nevertheless a potent biochemical Nampt inhibitor (ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>). Once formed, the PRPP adducts may accumulate intracellularly and thereby enhance cell culture antiproliferation effects (see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a> for additional information and discussion). However, there are many other factors that also likely influence Nampt inhibitor cell potency, including the following: biochemical potency, the ability of a given inhibitor and/or its corresponding PRPP-derived ribose adduct to effectively compete with the NAM substrate, cell membreane permeability, and/or protein binding. In addition, performing the PRPP adduct assessments was a relatively resource-intensive task and such determinations were therefore made for only a small number of compounds.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Formation of the <b>11</b>-phosphoribosylated adduct would likely require positioning the inhibitor azaindazole N-atom in the same location occupied by the corresponding atom present in <b>7</b> and <b>8</b>. Such positioning would reorient the azaindazole NH of <b>11</b> relative to the other two molecules and possibly thereby weaken interactions with Nampt.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">As described in this work, compound <b>8</b> (a close structural isomer of compound <b>7</b>) was observed by mass spectrometry to form PRPP-derived adducts in biochemical experiments. Compound <b>58</b> also forms an adduct with PRPP, as evidenced by mass spectrometry analysis of biochemical inhibition reaction mixtures, and we recently solved a crystal structure of phosphoribosylated-<b>58</b> in complex with Nampt. The details associated with the biochemical and crystallography experiments involving the PRPP-derived phosphoribosylated adduct of compound <b>58</b> will be reported in a separate disclosure:</p></div><span class="NLM_contrib-group">Oh, A.; Ho, Y.-C.; Zak, M.; Liu, Y.; Liu, Y.; Yuen, P.-w.; Zheng, X.; Dragovich, P. S.; Wang, W.</span> manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=As+described+in+this+work%2C+compound+8+%28a+close+structural+isomer+of+compound+7%29+was+observed+by+mass+spectrometry+to+form+PRPP-derived+adducts+in+biochemical+experiments.+Compound+58+also+forms+an+adduct+with+PRPP%2C+as+evidenced+by+mass+spectrometry+analysis+of+biochemical+inhibition+reaction+mixtures%2C+and+we+recently+solved+a+crystal+structure+of+phosphoribosylated-58+in+complex+with+Nampt.+The+details+associated+with+the+biochemical+and+crystallography+experiments+involving+the+PRPP-derived+phosphoribosylated+adduct+of+compound+58+will+be+reported+in+a+separate+disclosure%3AOh%2C+A.%3B+Ho%2C+Y.-C.%3B+Zak%2C+M.%3B+Liu%2C+Y.%3B+Liu%2C+Y.%3B+Yuen%2C+P.-w.%3B+Zheng%2C+X.%3B+Dragovich%2C+P.+S.%3B+Wang%2C+W.+manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fnsmb1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=16783377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=582-588&author=J.+A.+Khanauthor=X.+Taoauthor=L.+Tong&title=Molecular+basis+for+the+inhibition+of+human+NMPRTase%2C+a+novel+target+for+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span></div><div class="casAuthors">Khan, Javed A.; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors.  The authors have detd. the crystal structures at up to 2.1-Å resoln. of human and murine NMPRTase, alone and in complex with the reaction product NMN or the inhibitor FK866.  The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies.  FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866.  Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate.  Our structural and biochem. studies provide a starting point for the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s-XY1uB70LVg90H21EOLACvtfcHk0lgSTmm3j-9Fqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D&md5=debef567dbcf629422472ef1b63dc396</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1105%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520inhibition%2520of%2520human%2520NMPRTase%252C%2520a%2520novel%2520target%2520for%2520anticancer%2520agents%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D582%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, S. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span> </span><span class="NLM_article-title">Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2006&pages=66-77&author=M.+K.+Kimauthor=J.+H.+Leeauthor=H.+Kimauthor=S.+J.+Parkauthor=S.+H.+Kimauthor=G.+B.+Kangauthor=Y.+S.+Leeauthor=J.+B.+Kimauthor=K.+K.+Kimauthor=S.+W+Suhauthor=S.+H.+Eom&title=Crystal+structure+of+visfatin%2Fpre-B+cell+colony-enhancing+factor+1%2Fnicotinamide+phosphoribosyltransferase%2C+free+and+in+complex+with+the+anti-cancer+agent+FK-866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKang%26aufirst%3DG.%2BB.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BB.%26aulast%3DKim%26aufirst%3DK.%2BK.%26aulast%3DSuh%26aufirst%3DS.%2BW%26aulast%3DEom%26aufirst%3DS.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520visfatin%252Fpre-B%2520cell%2520colony-enhancing%2520factor%25201%252Fnicotinamide%2520phosphoribosyltransferase%252C%2520free%2520and%2520in%2520complex%2520with%2520the%2520anti-cancer%2520agent%2520FK-866%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D362%26spage%3D66%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bheda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fnsmb1114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=16783373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=661-662&author=T.+Wangauthor=X.+Zhangauthor=P.+Bhedaauthor=J.+R.+Revolloauthor=S.+Imaiauthor=C.+Wolberger&title=Structure+of+Nampt%2FPBEF%2Fvisfatin%2C+a+mammalian+NAD%2B+biosynthetic+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span></div><div class="casAuthors">Wang, Tao; Zhang, Xiangbin; Bheda, Poonam; Revollo, Javier R.; Imai, Shin-ichiro; Wolberger, Cynthia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-662</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt) synthesizes NMN from nicotinamide in a mammalian NAD+ biosynthetic pathway and is required for SirT1 activity in vivo.  Nampt has also been presumed to be a cytokine (PBEF) or a hormone (visfatin).  The crystal structure of Nampt in the presence and absence of NMN shows that Nampt is a dimeric type II phosphoribosyltransferase and provides insights into the enzymic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDB0vef67YbVg90H21EOLACvtfcHk0liD-_LTEtEBwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D&md5=ad2fd7f5cf0085896a157d1f1831f8c6</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1114%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBheda%26aufirst%3DP.%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DStructure%2520of%2520Nampt%252FPBEF%252Fvisfatin%252C%2520a%2520mammalian%2520NAD%252B%2520biosynthetic%2520enzyme%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D661%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">13748</span><span class="NLM_x">–</span> <span class="NLM_lpage">13753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=13748-13753&author=E.+S.+Burgosauthor=M.+C.+Hoauthor=S.+C.+Almoauthor=V.+L.+Schramm&title=A+phosphoenzyme+mimic%2C+overlapping+catalytic+sites+and+reaction+coordinate+motion+for+human+NAMPT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DHo%26aufirst%3DM.%2BC.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DA%2520phosphoenzyme%2520mimic%252C%2520overlapping%2520catalytic%2520sites%2520and%2520reaction%2520coordinate%2520motion%2520for%2520human%2520NAMPT%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D13748%26epage%3D13753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><div class="note"><p class="first last">Compound <b>58</b> also exhibited robust efficacy in xenograft models derived from the other cell lines listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Detailed descriptions of these efficacy assessments and associated PD effects will be presented elsewhere:</p></div><span class="NLM_contrib-group">O’Brien, T.; Xiao, Y.; Oeh, J.; Liang, X.; Vanderbilt, A.; Qin, A.; Yang, L.; Lee, L. B.; Ly, J.; Cosino, E.; LaCap, J. A.; Ogasawara, A.; Nannini, M.; Liederer, B. M.; Jackson, P.; Williams, S.; Dragovich, P. S.; Sampath, D.</span> Submitted to <i>Cancer Res</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+58+also+exhibited+robust+efficacy+in+xenograft+models+derived+from+the+other+cell+lines+listed+in+Table+6.+Detailed+descriptions+of+these+efficacy+assessments+and+associated+PD+effects+will+be+presented+elsewhere%3AO%E2%80%99Brien%2C+T.%3B+Xiao%2C+Y.%3B+Oeh%2C+J.%3B+Liang%2C+X.%3B+Vanderbilt%2C+A.%3B+Qin%2C+A.%3B+Yang%2C+L.%3B+Lee%2C+L.+B.%3B+Ly%2C+J.%3B+Cosino%2C+E.%3B+LaCap%2C+J.+A.%3B+Ogasawara%2C+A.%3B+Nannini%2C+M.%3B+Liederer%2C+B.+M.%3B+Jackson%2C+P.%3B+Williams%2C+S.%3B+Dragovich%2C+P.+S.%3B+Sampath%2C+D.+Submitted+to+Cancer+Res."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sikazwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangisetty, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5217</span><span class="NLM_x">–</span> <span class="NLM_lpage">5225</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060469q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5217-5225&author=D.+Sikazweauthor=M.+L.+Bondarevauthor=M.+Dukatauthor=J.+B.+Rangisettyauthor=B.+L.+Rothauthor=R.+A.+Glennon&title=Binding+of+sulfonyl-containing+arylalkylamines+at+human+5-HT6+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060469q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060469q%26sid%3Dliteratum%253Aachs%26aulast%3DSikazwe%26aufirst%3DD.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DRangisetty%26aufirst%3DJ.%2BB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520of%2520sulfonyl-containing%2520arylalkylamines%2520at%2520human%25205-HT6%2520serotonin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5217%26epage%3D5225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Thurkauf, A.; Chen, D.; Phadke, A.; Li, S.; Deshpande, M.</span><span> </span><span class="NLM_article-title">Preparation of azabenzofuran substituted thioureas as inhibitors of viral replication</span>. WO 2005067900,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Thurkauf&author=D.+Chen&author=A.+Phadke&author=S.+Li&author=M.+Deshpande&title=Preparation+of+azabenzofuran+substituted+thioureas+as+inhibitors+of+viral+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThurkauf%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520azabenzofuran%2520substituted%2520thioureas%2520as%2520inhibitors%2520of%2520viral%2520replication%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehrke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nukkala, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zielinski, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1016%2FS0960-894X%2801%2900759-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=11814821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=465-469&author=Q.+Liauthor=K.+W.+Woodsauthor=A.+Claiborneauthor=S.+L.+Gwaltneyauthor=K.+J.+Barrauthor=G.+Liuauthor=L.+Gehrkeauthor=R.+B.+Credoauthor=Y.+H.+Huiauthor=J.+Leeauthor=R.+B.+Warnerauthor=P.+Kovarauthor=M.+A.+Nukkalaauthor=N.+A.+Zielinskiauthor=S.+K.+Tahirauthor=M.+Fitzgeraldauthor=K.+H.+Kimauthor=K.+Marshauthor=D.+Frostauthor=S.+Ngauthor=S.+Rosenbergauthor=H.+L.+Sham&title=Synthesis+and+biological+evaluation+of+2-indolyloxazolines+as+a+new+class+of+tubulin+polymerization+inhibitors.+Discovery+of+A-289099+as+an+orally+active+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent</span></div><div class="casAuthors">Li, Qun; Woods, Keith W.; Claiborne, Akiyo; Gwaltney, Stephen L., II; Barr, Kenneth J.; Liu, Gang; Gehrke, Laura; Credo, R. Bruce; Hui, Yu Hua; Lee, Jang; Warner, Robert B.; Kovar, Peter; Nukkala, Michael A.; Zielinski, Nicolette A.; Tahir, Stephen K.; Fitzgerald, Michael; Kim, Ki H.; Marsh, Kennan; Frost, David; Ng, Shi-Chung; Rosenberg, Saul; Sham, Hing L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-469</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of indole contg. oxazolines has been discovered as a result of structural modifications of the lead compd. A-105972.  The compds. exert their anticancer activity through inhibition of tubulin polymn. by binding at the colchicine site.  A-289099 (I) was identified as an orally active antimitotic agent active against various cancer cell lines including those that express the MDR phenotype.  The anticancer activity, pharmacokinetics, and an efficient and enantioselective synthesis of I are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2tFNZlJzSbbVg90H21EOLACvtfcHk0lgkND32bjMZfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslKqtQ%253D%253D&md5=01f3a2eb788e454cc65da7ec8b7da409</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900759-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900759-4%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DBarr%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGehrke%26aufirst%3DL.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DHui%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DNukkala%26aufirst%3DM.%2BA.%26aulast%3DZielinski%26aufirst%3DN.%2BA.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DSham%26aufirst%3DH.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25202-indolyloxazolines%2520as%2520a%2520new%2520class%2520of%2520tubulin%2520polymerization%2520inhibitors.%2520Discovery%2520of%2520A-289099%2520as%2520an%2520orally%2520active%2520antitumor%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D465%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fyfe, M. C. T.; Thomas, G. H.; Gardner, L. S.; Bradley, S. E.; Gattrell, W.; Rasamison, C. M.; Shah., V. K.</span><span> </span><span class="NLM_article-title">Preparation of furopyridine and pyrrolopyridine derivatives and analogs thereof as G-protein coupled receptor agonists</span>. WO 2006067532,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+C.+T.+Fyfe&author=G.+H.+Thomas&author=L.+S.+Gardner&author=S.+E.+Bradley&author=W.+Gattrell&author=C.+M.+Rasamison&author=V.+K.+Shah&title=Preparation+of+furopyridine+and+pyrrolopyridine+derivatives+and+analogs+thereof+as+G-protein+coupled+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26atitle%3DPreparation%2520of%2520furopyridine%2520and%2520pyrrolopyridine%2520derivatives%2520and%2520analogs%2520thereof%2520as%2520G-protein%2520coupled%2520receptor%2520agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Walker, D. P.; Piotrowski, D. W.; Jacobsen, E. J.; Acker, B. A.; Wishka, D. G.; Reitz, S. C.; Groppi, V. E.,  Jr.</span><span> </span><span class="NLM_article-title">Preparation of N-(azabicyclyl)arylamides for therapeutic use as nicotinic acetylcholine receptor agonists</span>. WO 2003029252,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=D.+P.+Walker&author=D.+W.+Piotrowski&author=E.+J.+Jacobsen&author=B.+A.+Acker&author=D.+G.+Wishka&author=S.+C.+Reitz&author=V.+E.+Groppi&title=Preparation+of+N-%28azabicyclyl%29arylamides+for+therapeutic+use+as+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BP.%26atitle%3DPreparation%2520of%2520N-%2528azabicyclyl%2529arylamides%2520for%2520therapeutic%2520use%2520as%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':[],'ref14':[],'ref15':[],'ref16':[],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c','cit18d'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 48 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Charles Edwin Raja Gabriel, Trung T. Nguyen, Emanuele Marco Gargano, Jed F. Fisher, Mayland Chang, <span class="NLM_string-name hlFld-ContribAuthor">Shahriar Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism of the Selective Matrix Metalloproteinase-9 Inhibitor (R)-ND-336. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (3)
                                     , 1204-1213. <a href="https://doi.org/10.1021/acsptsci.1c00063" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00063%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DMetabolism%252Bof%252Bthe%252BSelective%252BMatrix%252BMetalloproteinase-9%252BInhibitor%252B%252528R%252529-ND-336%26aulast%3DGabriel%26aufirst%3DCharles%2BEdwin%2BRaja%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25022021%26date%3D06042021%26volume%3D4%26issue%3D3%26spage%3D1204%26epage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhadeep  Ghosh</span>, <span class="hlFld-ContribAuthor ">Sudipto  Debnath</span>, <span class="hlFld-ContribAuthor ">Uttam K.  Das</span>, and <span class="hlFld-ContribAuthor ">Dilip K.  Maiti</span>  . </span><span class="cited-content_cbyCitation_article-title">Fabrication and Diverse Ring-Expansion Nanocatalysis of Functionalized Pt-Nanoparticles to a General Synthesis of Pyrrolines: A 3D-Mid-IR Study. </span><span class="cited-content_cbyCitation_journal-name">Industrial & Engineering Chemistry Research</span><span> <strong>2017,</strong> <em>56 </em>
                                    (42)
                                     , 12056-12069. <a href="https://doi.org/10.1021/acs.iecr.7b02441" title="DOI URL">https://doi.org/10.1021/acs.iecr.7b02441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.iecr.7b02441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.iecr.7b02441%26sid%3Dliteratum%253Aachs%26jtitle%3DIndustrial%2520%2526%2520Engineering%2520Chemistry%2520Research%26atitle%3DFabrication%252Band%252BDiverse%252BRing-Expansion%252BNanocatalysis%252Bof%252BFunctionalized%252BPt-Nanoparticles%252Bto%252Ba%252BGeneral%252BSynthesis%252Bof%252BPyrrolines%25253A%252BA%252B3D-Mid-IR%252BStudy%26aulast%3DGhosh%26aufirst%3DSubhadeep%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14062017%26date%3D04102017%26date%3D23092017%26date%3D16102017%26date%3D25102017%26date%3D04102017%26volume%3D56%26issue%3D42%26spage%3D12056%26epage%3D12069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Travelli</span>, <span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Reza  Rahimian</span>, <span class="hlFld-ContribAuthor ">Ambra A.  Grolla</span>, <span class="hlFld-ContribAuthor ">Federica  Rogati</span>, <span class="hlFld-ContribAuthor ">Mattia  Bertolotti</span>, <span class="hlFld-ContribAuthor ">Floriana  Malagnino</span>, <span class="hlFld-ContribAuthor ">Rosanna  di Paola</span>, <span class="hlFld-ContribAuthor ">Daniela  Impellizzeri</span>, <span class="hlFld-ContribAuthor ">Roberta  Fusco</span>, <span class="hlFld-ContribAuthor ">Valentina  Mercalli</span>, <span class="hlFld-ContribAuthor ">Alberto  Massarotti</span>, <span class="hlFld-ContribAuthor ">Giorgio  Stortini</span>, <span class="hlFld-ContribAuthor ">Salvatore  Terrazzino</span>, <span class="hlFld-ContribAuthor ">Erika  Del Grosso</span>, <span class="hlFld-ContribAuthor ">Gohar  Fakhfouri</span>, <span class="hlFld-ContribAuthor ">Maria Pia  Troiani</span>, <span class="hlFld-ContribAuthor ">Maria Alessandra  Alisi</span>, <span class="hlFld-ContribAuthor ">Giorgio  Grosa</span>, <span class="hlFld-ContribAuthor ">Giovanni  Sorba</span>, <span class="hlFld-ContribAuthor ">Pier Luigi  Canonico</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Orsomando</span>, <span class="hlFld-ContribAuthor ">Salvatore  Cuzzocrea</span>, <span class="hlFld-ContribAuthor ">Armando A.  Genazzani</span>, <span class="hlFld-ContribAuthor ">Ubaldina  Galli</span>, and <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 1768-1792. <a href="https://doi.org/10.1021/acs.jmedchem.6b01392" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01392%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BTriazole-Based%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252BInhibitors%252BEndowed%252Bwith%252BAntiproliferative%252Band%252BAntiinflammatory%252BActivity%26aulast%3DTravelli%26aufirst%3DCristina%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22092016%26date%3D22022017%26date%3D09032017%26date%3D06022017%26volume%3D60%26issue%3D5%26spage%3D1768%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Snahel  Patel</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Jasleen  Sodhi</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, and <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8345-8368. <a href="https://doi.org/10.1021/acs.jmedchem.6b00697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMinimizing%252BCYP2C9%252BInhibition%252Bof%252BExposed-Pyridine%252BNAMPT%252B%252528Nicotinamide%252BPhosphoribosyltransferase%252529%252BInhibitors%26aulast%3DZak%26aufirst%3DMark%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06052016%26date%3D30082016%26date%3D22092016%26date%3D19082016%26volume%3D59%26issue%3D18%26spage%3D8345%26epage%3D8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhong  Bai</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Yanghan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaochu  Qin</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Chen</span>, <span class="hlFld-ContribAuthor ">Yatao  Qiu</span>, <span class="hlFld-ContribAuthor ">Dongguang  Qin</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, and <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Potent Nicotinamide Phosphoribosyltransferase Inhibitors with Promising in Vitro and in Vivo Antitumor Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5766-5779. <a href="https://doi.org/10.1021/acs.jmedchem.6b00324" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00324%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BPotent%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%252Bwith%252BPromising%252Bin%252BVitro%252Band%252Bin%252BVivo%252BAntitumor%252BActivities%26aulast%3DBai%26aufirst%3DJinhong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29022016%26date%3D13062016%26date%3D23062016%26date%3D25052016%26volume%3D59%26issue%3D12%26spage%3D5766%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Brandon J.  Bravo</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Yezhen  Feng</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Youming  Shen</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, and <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Identification of Amides Derived from trans-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 770-792. <a href="https://doi.org/10.1021/jm4015108" title="DOI URL">https://doi.org/10.1021/jm4015108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4015108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4015108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BIdentification%252Bof%252BAmides%252BDerived%252Bfrom%252Btrans-2-%252528Pyridin-3-yl%252529cyclopropanecarboxylic%252BAcid%252Bas%252BPotent%252BInhibitors%252Bof%252BHuman%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DGiannetti%26aufirst%3DAnthony%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27092013%26date%3D22012014%26date%3D13022014%26date%3D09012014%26volume%3D57%26issue%3D3%26spage%3D770%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shruti  Panwar</span>, <span class="hlFld-ContribAuthor ">Anita  Kumari</span>, <span class="hlFld-ContribAuthor ">Hitesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Anoop Kumar  Tiwari</span>, <span class="hlFld-ContribAuthor ">Prabhanshu  Tripathi</span>, <span class="hlFld-ContribAuthor ">Shailendra  Asthana</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based virtual screening, molecular dynamics simulation and
              in vitro
              evaluation to identify inhibitors against NAMPT. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>18 </em>, 1-13. <a href="https://doi.org/10.1080/07391102.2021.1943526" title="DOI URL">https://doi.org/10.1080/07391102.2021.1943526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1943526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1943526%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DStructure-based%252Bvirtual%252Bscreening%25252C%252Bmolecular%252Bdynamics%252Bsimulation%252Band%252Bin%252Bvitro%252Bevaluation%252Bto%252Bidentify%252Binhibitors%252Bagainst%252BNAMPT%26aulast%3DPanwar%26aufirst%3DShruti%26date%3D2021%26date%3D2021%26volume%3D18%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa S.  Ghanem</span>, <span class="hlFld-ContribAuthor ">Fiammetta  Monacelli</span>, <span class="hlFld-ContribAuthor ">Alessio  Nencioni</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in NAD-Lowering Agents for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 1665. <a href="https://doi.org/10.3390/nu13051665" title="DOI URL">https://doi.org/10.3390/nu13051665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu13051665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu13051665%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DAdvances%252Bin%252BNAD-Lowering%252BAgents%252Bfor%252BCancer%252BTreatment%26aulast%3DGhanem%26aufirst%3DMoustafa%2BS.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D1665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>, <span class="hlFld-ContribAuthor ">Kiyotaka  Katsuragi</span>, <span class="hlFld-ContribAuthor ">Takahiro  Oyama</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Yuri  Shibasaki</span>, <span class="hlFld-ContribAuthor ">Yasunobu  Asawa</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Kosho  Makino</span>, <span class="hlFld-ContribAuthor ">Miwa  Okazawa</span>, <span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Miyuki  Nomura</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Hideaki  Abe</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hideyo  Takahashi</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Tanuma</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3633. <a href="https://doi.org/10.3390/molecules25163633" title="DOI URL">https://doi.org/10.3390/molecules25163633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163633%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStructural%252BBasis%252Bof%252BBeneficial%252BDesign%252Bfor%252BEffective%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%26aulast%3DTanuma%26aufirst%3DSei-ichi%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kei  Kudo</span>, <span class="hlFld-ContribAuthor ">Miyuki  Nomura</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Shigemi  Ito</span>, <span class="hlFld-ContribAuthor ">Mami  Morita</span>, <span class="hlFld-ContribAuthor ">Masaaki  Kawai</span>, <span class="hlFld-ContribAuthor ">Yoji  Yamashita</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Ito</span>, <span class="hlFld-ContribAuthor ">Hidekazu  Yamada</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Shima</span>, <span class="hlFld-ContribAuthor ">Nobuo  Yaegashi</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Tanuma</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">FEBS Letters</span><span> <strong>2020,</strong> <em>594 </em>
                                    (9)
                                     , 1379-1388. <a href="https://doi.org/10.1002/1873-3468.13736" title="DOI URL">https://doi.org/10.1002/1873-3468.13736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/1873-3468.13736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F1873-3468.13736%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Letters%26atitle%3DDivergent%252Bmetabolic%252Bresponses%252Bdictate%252Bvulnerability%252Bto%252BNAMPT%252Binhibition%252Bin%252Bovarian%252Bcancer%26aulast%3DKudo%26aufirst%3DKei%26date%3D2020%26date%3D2020%26volume%3D594%26issue%3D9%26spage%3D1379%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fikriye  Ozgencil</span>, <span class="hlFld-ContribAuthor ">Gokcen  Eren</span>, <span class="hlFld-ContribAuthor ">Yesim  Ozkan</span>, <span class="hlFld-ContribAuthor ">Sezen  Guntekin-Ergun</span>, <span class="hlFld-ContribAuthor ">Rengul  Cetin-Atalay</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115217. <a href="https://doi.org/10.1016/j.bmc.2019.115217" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115217%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bsmall-molecule%252Burea%252Bderivatives%252Bas%252Bnovel%252BNAMPT%252Binhibitors%252Bvia%252Bpharmacophore-based%252Bvirtual%252Bscreening%26aulast%3DOzgencil%26aufirst%3DFikriye%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Lin</span>, <span class="hlFld-ContribAuthor ">Dong  Xing</span>, <span class="hlFld-ContribAuthor ">Wen-Biao  Wu</span>, <span class="hlFld-ContribAuthor ">Gao-Ya  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Fang  Yu</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Evaluation of Benzofuro[3,2-c]Quinoline Derivatives as Potential Antileukemia Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 203. <a href="https://doi.org/10.3390/molecules25010203" title="DOI URL">https://doi.org/10.3390/molecules25010203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25010203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25010203%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BEvaluation%252Bof%252BBenzofuro%25255B3%25252C2-c%25255DQuinoline%252BDerivatives%252Bas%252BPotential%252BAntileukemia%252BAgents%26aulast%3DLin%26aufirst%3DYing%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>. </span><span class="cited-content_cbyCitation_article-title">Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Genomics</span><span> <strong>2019,</strong> <em>111 </em>
                                    (6)
                                     , 1889-1895. <a href="https://doi.org/10.1016/j.ygeno.2018.12.012" title="DOI URL">https://doi.org/10.1016/j.ygeno.2018.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ygeno.2018.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ygeno.2018.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DGenomics%26atitle%3DGenomic%252Band%252Btumor%252Bbiological%252Baspects%252Bof%252Bthe%252Banticancer%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitor%252BFK866%252Bin%252Bresistant%252Bhuman%252Bcolorectal%252Bcancer%252Bcells%26aulast%3DOgino%26aufirst%3DYoko%26date%3D2019%26volume%3D111%26issue%3D6%26spage%3D1889%26epage%3D1895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheong</span>, <span class="hlFld-ContribAuthor ">Kang-Jye  Chou</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Hoa  Le</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Sophie  Mukadam</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Susan  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical assessment of the ADME, efficacy and drug-drug interaction potential of a novel NAMPT inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2019,</strong> <em>49 </em>
                                    (9)
                                     , 1063-1077. <a href="https://doi.org/10.1080/00498254.2018.1528407" title="DOI URL">https://doi.org/10.1080/00498254.2018.1528407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00498254.2018.1528407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00498254.2018.1528407%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DPreclinical%252Bassessment%252Bof%252Bthe%252BADME%25252C%252Befficacy%252Band%252Bdrug-drug%252Binteraction%252Bpotential%252Bof%252Ba%252Bnovel%252BNAMPT%252Binhibitor%26aulast%3DLiederer%26aufirst%3DBianca%2BM.%26date%3D2019%26date%3D2019%26volume%3D49%26issue%3D9%26spage%3D1063%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span>, <span class="hlFld-ContribAuthor ">Jolaine  Savoie</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Sieber</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Maurice A.  Marsini</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Daniel  Rivalti</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of Non-Stabilized Carbon-Based Nucleophilic Reagents to Chiral
              N
              -Sulfinyl Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-422. <a href="https://doi.org/10.1002/0471264180.or099.01" title="DOI URL">https://doi.org/10.1002/0471264180.or099.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or099.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or099.01%26sid%3Dliteratum%253Aachs%26atitle%3DAddition%252Bof%252BNon-Stabilized%252BCarbon-Based%252BNucleophilic%252BReagents%252Bto%252BChiral%252BN%252B-Sulfinyl%252BImines%26aulast%3DHerbage%26aufirst%3DMelissa%2BA.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D422%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasunobu  Asawa</span>, <span class="hlFld-ContribAuthor ">Kiyotaka  Katsuragi</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based drug design of novel carborane-containing nicotinamide phosphoribosyltransferase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (13)
                                     , 2832-2844. <a href="https://doi.org/10.1016/j.bmc.2019.05.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdrug%252Bdesign%252Bof%252Bnovel%252Bcarborane-containing%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitors%26aulast%3DAsawa%26aufirst%3DYasunobu%26date%3D2019%26volume%3D27%26issue%3D13%26spage%3D2832%26epage%3D2844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keisuke  Yaku</span>, <span class="hlFld-ContribAuthor ">Keisuke  Okabe</span>, <span class="hlFld-ContribAuthor ">Keisuke  Hikosaka</span>, <span class="hlFld-ContribAuthor ">Takashi  Nakagawa</span>. </span><span class="cited-content_cbyCitation_article-title">NAD Metabolism in Cancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2018,</strong> <em>8 </em><a href="https://doi.org/10.3389/fonc.2018.00622" title="DOI URL">https://doi.org/10.3389/fonc.2018.00622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2018.00622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2018.00622%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DNAD%252BMetabolism%252Bin%252BCancer%252BTherapeutics%26aulast%3DYaku%26aufirst%3DKeisuke%26date%3D2018%26date%3D2018%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher S.  Neumann</span>, <span class="hlFld-ContribAuthor ">Kathleen C.  Olivas</span>, <span class="hlFld-ContribAuthor ">Martha E.  Anderson</span>, <span class="hlFld-ContribAuthor ">Julia H.  Cochran</span>, <span class="hlFld-ContribAuthor ">Steven  Jin</span>, <span class="hlFld-ContribAuthor ">Fu  Li</span>, <span class="hlFld-ContribAuthor ">Luke V.  Loftus</span>, <span class="hlFld-ContribAuthor ">David W.  Meyer</span>, <span class="hlFld-ContribAuthor ">Jason  Neale</span>, <span class="hlFld-ContribAuthor ">Jay C.  Nix</span>, <span class="hlFld-ContribAuthor ">Paul G.  Pittman</span>, <span class="hlFld-ContribAuthor ">Jessica K.  Simmons</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Ulrich</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Waight</span>, <span class="hlFld-ContribAuthor ">Abbie  Wong</span>, <span class="hlFld-ContribAuthor ">Margo C.  Zaval</span>, <span class="hlFld-ContribAuthor ">Weiping  Zeng</span>, <span class="hlFld-ContribAuthor ">Robert P.  Lyon</span>, <span class="hlFld-ContribAuthor ">Peter D.  Senter</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (12)
                                     , 2633-2642. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0643" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0643%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTargeted%252BDelivery%252Bof%252BCytotoxic%252BNAMPT%252BInhibitors%252BUsing%252BAntibody%2525E2%252580%252593Drug%252BConjugates%26aulast%3DNeumann%26aufirst%3DChristopher%2BS.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D12%26spage%3D2633%26epage%3D2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manish  Kesherwani</span>, <span class="hlFld-ContribAuthor ">Sriram  Raghavan</span>, <span class="hlFld-ContribAuthor ">Krishnasamy  Gunasekaran</span>, <span class="hlFld-ContribAuthor ">Devadasan  Velmurugan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel Nicotinamide Phosphoribosyltransferase (NAMPT) inhibitors using computational approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (5)
                                     , 1306-1328. <a href="https://doi.org/10.1080/07391102.2017.1322004" title="DOI URL">https://doi.org/10.1080/07391102.2017.1322004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1322004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1322004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252Bnovel%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Busing%252Bcomputational%252Bapproaches%26aulast%3DKesherwani%26aufirst%3DManish%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D5%26spage%3D1306%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoko  Ogino</span>, <span class="hlFld-ContribAuthor ">Akira  Sato</span>, <span class="hlFld-ContribAuthor ">Fumiaki  Uchiumi</span>, <span class="hlFld-ContribAuthor ">Sei-ichi  Tanuma</span>. </span><span class="cited-content_cbyCitation_article-title">Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (23)
                                     , 16451-16461. <a href="https://doi.org/10.18632/oncotarget.24731" title="DOI URL">https://doi.org/10.18632/oncotarget.24731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24731%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCross%252Bresistance%252Bto%252Bdiverse%252Banticancer%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitors%252Binduced%252Bby%252BFK866%252Btreatment%26aulast%3DOgino%26aufirst%3DYoko%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D23%26spage%3D16451%26epage%3D16461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel S.  Palacios</span>, <span class="hlFld-ContribAuthor ">Erik  Meredith</span>, <span class="hlFld-ContribAuthor ">Toshio  Kawanami</span>, <span class="hlFld-ContribAuthor ">Christopher  Adams</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Veronique  Darsigny</span>, <span class="hlFld-ContribAuthor ">Erin  Geno</span>, <span class="hlFld-ContribAuthor ">Mark  Palermo</span>, <span class="hlFld-ContribAuthor ">Daniel  Baird</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Boynton</span>, <span class="hlFld-ContribAuthor ">Scott A.  Busby</span>, <span class="hlFld-ContribAuthor ">Elizabeth L.  George</span>, <span class="hlFld-ContribAuthor ">Chantale  Guy</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hewett</span>, <span class="hlFld-ContribAuthor ">Laryssa  Tierney</span>, <span class="hlFld-ContribAuthor ">Sachin  Thigale</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Weihofen</span>, <span class="hlFld-ContribAuthor ">Louis  Wang</span>, <span class="hlFld-ContribAuthor ">Nicole  White</span>, <span class="hlFld-ContribAuthor ">Ming  Yin</span>, <span class="hlFld-ContribAuthor ">Upendra A.  Argikar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 365-370. <a href="https://doi.org/10.1016/j.bmcl.2017.12.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bbased%252Bdesign%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bfrom%252Ba%252Bphenotypic%252Bscreen%26aulast%3DPalacios%26aufirst%3DDaniel%2BS.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D365%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Curtin</span>, <span class="hlFld-ContribAuthor ">H. Robin  Heyman</span>, <span class="hlFld-ContribAuthor ">Richard F.  Clark</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Sorensen</span>, <span class="hlFld-ContribAuthor ">George A.  Doherty</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Robin R.  Frey</span>, <span class="hlFld-ContribAuthor ">Kathy A.  Sarris</span>, <span class="hlFld-ContribAuthor ">Ana L.  Aguirre</span>, <span class="hlFld-ContribAuthor ">Anurupa  Shrestha</span>, <span class="hlFld-ContribAuthor ">Noah  Tu</span>, <span class="hlFld-ContribAuthor ">Kevin  Woller</span>, <span class="hlFld-ContribAuthor ">Marina A.  Pliushchev</span>, <span class="hlFld-ContribAuthor ">Ramzi F.  Sweis</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Julie L.  Wilsbacher</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Kenton L.  Longenecker</span>, <span class="hlFld-ContribAuthor ">Diana  Raich</span>, <span class="hlFld-ContribAuthor ">Alla V.  Korepanova</span>, <span class="hlFld-ContribAuthor ">Nirupama B.  Soni</span>, <span class="hlFld-ContribAuthor ">Mikkel A.  Algire</span>, <span class="hlFld-ContribAuthor ">Paul L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Violeta L.  Marin</span>, <span class="hlFld-ContribAuthor ">Ilaria  Badagnani</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>, <span class="hlFld-ContribAuthor ">F. Greg  Buchanan</span>, <span class="hlFld-ContribAuthor ">David  Maag</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chiang</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>, <span class="hlFld-ContribAuthor ">Michael R.  Michaelides</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3317-3325. <a href="https://doi.org/10.1016/j.bmcl.2017.06.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSAR%252Band%252Bcharacterization%252Bof%252Bnon-substrate%252Bisoindoline%252Burea%252Binhibitors%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DCurtin%26aufirst%3DMichael%2BL.%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3317%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. L.  Misner</span>, <span class="hlFld-ContribAuthor ">M. A.  Kauss</span>, <span class="hlFld-ContribAuthor ">J.  Singh</span>, <span class="hlFld-ContribAuthor ">H.  Uppal</span>, <span class="hlFld-ContribAuthor ">A.  Bruening-Wright</span>, <span class="hlFld-ContribAuthor ">B. M.  Liederer</span>, <span class="hlFld-ContribAuthor ">T.  Lin</span>, <span class="hlFld-ContribAuthor ">B.  McCray</span>, <span class="hlFld-ContribAuthor ">N.  La</span>, <span class="hlFld-ContribAuthor ">T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">D.  Sampath</span>, <span class="hlFld-ContribAuthor ">P. S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">T.  O’Brien</span>, <span class="hlFld-ContribAuthor ">T. S.  Zabka</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines. </span><span class="cited-content_cbyCitation_journal-name">Cardiovascular Toxicology</span><span> <strong>2017,</strong> <em>17 </em>
                                    (3)
                                     , 307-318. <a href="https://doi.org/10.1007/s12012-016-9387-6" title="DOI URL">https://doi.org/10.1007/s12012-016-9387-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12012-016-9387-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12012-016-9387-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiovascular%2520Toxicology%26atitle%3DCardiotoxicity%252BAssociated%252Bwith%252BNicotinamide%252BPhosphoribosyltransferase%252BInhibitors%252Bin%252BRodents%252Band%252Bin%252BRat%252Band%252BHuman-Derived%252BCells%252BLines%26aulast%3DMisner%26aufirst%3DD.%2BL.%26date%3D2017%26date%3D2016%26volume%3D17%26issue%3D3%26spage%3D307%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie L.  Wilsbacher</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Samuel A.J.  Trammell</span>, <span class="hlFld-ContribAuthor ">Yan  Shi</span>, <span class="hlFld-ContribAuthor ">Jun  Guo</span>, <span class="hlFld-ContribAuthor ">Stormy L.  Koeniger</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Yupeng  He</span>, <span class="hlFld-ContribAuthor ">Sujatha  Selvaraju</span>, <span class="hlFld-ContribAuthor ">H. Robin  Heyman</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Sorensen</span>, <span class="hlFld-ContribAuthor ">Richard F.  Clark</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Kenton L.  Longenecker</span>, <span class="hlFld-ContribAuthor ">Diana  Raich</span>, <span class="hlFld-ContribAuthor ">Alla V.  Korepanova</span>, <span class="hlFld-ContribAuthor ">Steven  Cepa</span>, <span class="hlFld-ContribAuthor ">Danli L.  Towne</span>, <span class="hlFld-ContribAuthor ">Vivek C.  Abraham</span>, <span class="hlFld-ContribAuthor ">Hua  Tang</span>, <span class="hlFld-ContribAuthor ">Paul L.  Richardson</span>, <span class="hlFld-ContribAuthor ">Shaun M.  McLoughlin</span>, <span class="hlFld-ContribAuthor ">Ilaria  Badagnani</span>, <span class="hlFld-ContribAuthor ">Michael L.  Curtin</span>, <span class="hlFld-ContribAuthor ">Michael R.  Michaelides</span>, <span class="hlFld-ContribAuthor ">David  Maag</span>, <span class="hlFld-ContribAuthor ">F. Gregory  Buchanan</span>, <span class="hlFld-ContribAuthor ">Gary G.  Chiang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Saul H.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Charles  Brenner</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2017,</strong> <em>16 </em>
                                    (7)
                                     , 1236-1245. <a href="https://doi.org/10.1158/1535-7163.MCT-16-0819" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-16-0819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-16-0819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-16-0819%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BNovel%252BNonsubstrate%252Band%252BSubstrate%252BNAMPT%252BInhibitors%26aulast%3DWilsbacher%26aufirst%3DJulie%2BL.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D7%26spage%3D1236%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanad  Alonezi</span>, <span class="hlFld-ContribAuthor ">Jonans  Tusiimire</span>, <span class="hlFld-ContribAuthor ">Jennifer  Wallace</span>, <span class="hlFld-ContribAuthor ">Mark  Dufton</span>, <span class="hlFld-ContribAuthor ">John  Parkinson</span>, <span class="hlFld-ContribAuthor ">Louise  Young</span>, <span class="hlFld-ContribAuthor ">Carol  Clements</span>, <span class="hlFld-ContribAuthor ">Jin-Kyu  Park</span>, <span class="hlFld-ContribAuthor ">Jong-Woon  Jeon</span>, <span class="hlFld-ContribAuthor ">Valerie  Ferro</span>, <span class="hlFld-ContribAuthor ">David  Watson</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolomic Profiling of the Synergistic Effects of Melittin in Combination with Cisplatin on Ovarian Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Metabolites</span><span> <strong>2017,</strong> <em>7 </em>
                                    (2)
                                     , 14. <a href="https://doi.org/10.3390/metabo7020014" title="DOI URL">https://doi.org/10.3390/metabo7020014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/metabo7020014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmetabo7020014%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolites%26atitle%3DMetabolomic%252BProfiling%252Bof%252Bthe%252BSynergistic%252BEffects%252Bof%252BMelittin%252Bin%252BCombination%252Bwith%252BCisplatin%252Bon%252BOvarian%252BCancer%252BCells%26aulast%3DAlonezi%26aufirst%3DSanad%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D2%26spage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Mandy  Kwong</span>, <span class="hlFld-ContribAuthor ">Anneleen  Daemen</span>, <span class="hlFld-ContribAuthor ">Marcia  Belvin</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Georgia  Hatzivassiliou</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, . </span><span class="cited-content_cbyCitation_article-title">Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (10)
                                     , e0164166. <a href="https://doi.org/10.1371/journal.pone.0164166" title="DOI URL">https://doi.org/10.1371/journal.pone.0164166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0164166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0164166%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DMetabolic%252BResponse%252Bto%252BNAD%252BDepletion%252Bacross%252BCell%252BLines%252BIs%252BHighly%252BVariable%26aulast%3DXiao%26aufirst%3DYang%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D10%26spage%3De0164166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Chen</span>, <span class="hlFld-ContribAuthor ">Shiyu  Wang</span>, <span class="hlFld-ContribAuthor ">Haiyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Edouard C.  Nice</span>, <span class="hlFld-ContribAuthor ">Canhua  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anticancer Therapy</span><span> <strong>2016,</strong> <em>16 </em>
                                    (8)
                                     , 827-838. <a href="https://doi.org/10.1080/14737140.2016.1190649" title="DOI URL">https://doi.org/10.1080/14737140.2016.1190649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737140.2016.1190649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737140.2016.1190649%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anticancer%2520Therapy%26atitle%3DNicotinamide%252Bphosphoribosyltransferase%252B%252528Nampt%252529%252Bin%252Bcarcinogenesis%25253A%252Bnew%252Bclinical%252Bopportunities%26aulast%3DChen%26aufirst%3DHang%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D8%26spage%3D827%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David E.  Clark</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Melanie  Wong</span>, <span class="hlFld-ContribAuthor ">Peter M.  Lockey</span>, <span class="hlFld-ContribAuthor ">Robert  Adalbert</span>, <span class="hlFld-ContribAuthor ">Jonathan  Gilley</span>, <span class="hlFld-ContribAuthor ">Jonathan  Clark</span>, <span class="hlFld-ContribAuthor ">Michael P.  Coleman</span>. </span><span class="cited-content_cbyCitation_article-title">Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2920-2926. <a href="https://doi.org/10.1016/j.bmcl.2016.04.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplication%252Bof%252Bvirtual%252Bscreening%252Bto%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bwith%252Bpotential%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%252Band%252Baxonopathies%26aulast%3DClark%26aufirst%3DDavid%2BE.%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2920%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Tianying  Xu</span>, <span class="hlFld-ContribAuthor ">Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chaoyu  Miao</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 765-768. <a href="https://doi.org/10.1016/j.bmcl.2015.12.101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bbenzothiophene%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%26aulast%3DChen%26aufirst%3DWei%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D765%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  Roulston</span>, <span class="hlFld-ContribAuthor ">Gordon C.  Shore</span>. </span><span class="cited-content_cbyCitation_article-title">New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Oncology</span><span> <strong>2016,</strong> <em>3 </em>
                                    (1)
                                     , e1052180. <a href="https://doi.org/10.1080/23723556.2015.1052180" title="DOI URL">https://doi.org/10.1080/23723556.2015.1052180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/23723556.2015.1052180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F23723556.2015.1052180%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Oncology%26atitle%3DNew%252Bstrategies%252Bto%252Bmaximize%252Btherapeutic%252Bopportunities%252Bfor%252BNAMPT%252Binhibitors%252Bin%252Boncology%26aulast%3DRoulston%26aufirst%3DAnne%26date%3D2016%26date%3D2015%26volume%3D3%26issue%3D1%26spage%3De1052180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kayvan R.  Keshari</span>, <span class="hlFld-ContribAuthor ">David M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Mark  Van Criekinge</span>, <span class="hlFld-ContribAuthor ">Renuka  Sriram</span>, <span class="hlFld-ContribAuthor ">Bertram L.  Koelsch</span>, <span class="hlFld-ContribAuthor ">Zhen J.  Wang</span>, <span class="hlFld-ContribAuthor ">Henry F.  VanBrocklin</span>, <span class="hlFld-ContribAuthor ">Donna M.  Peehl</span>, <span class="hlFld-ContribAuthor ">Tom  O'Brien</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Richard A. D.  Carano</span>, <span class="hlFld-ContribAuthor ">John  Kurhanewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. </span><span class="cited-content_cbyCitation_journal-name">The Prostate</span><span> <strong>2015,</strong> <em>75 </em>
                                    (14)
                                     , 1601-1609. <a href="https://doi.org/10.1002/pros.23036" title="DOI URL">https://doi.org/10.1002/pros.23036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pros.23036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpros.23036%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Prostate%26atitle%3DMetabolic%252Bresponse%252Bof%252Bprostate%252Bcancer%252Bto%252Bnicotinamide%252Bphophoribosyltransferase%252Binhibition%252Bin%252Ba%252Bhyperpolarized%252BMR%25252FPET%252Bcompatible%252Bbioreactor%26aulast%3DKeshari%26aufirst%3DKayvan%2BR.%26date%3D2015%26date%3D2015%26volume%3D75%26issue%3D14%26spage%3D1601%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Feisong  Zhang</span>, <span class="hlFld-ContribAuthor ">Huanhuan  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Xinyu  Duan</span>, <span class="hlFld-ContribAuthor ">Qingfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Tongxin  Liu</span>, <span class="hlFld-ContribAuthor ">Guisheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-Free Domino Reaction of 1-Acryloyl-1-
              N
              -arylcarbamylcyclopropanes with Amines: One-Pot Approach to 2,3,6,7-Tetrahydro-1
              H
              -pyrrolo[3,2-
              c
              ]pyridin-4(5
              H
              )-ones. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2015,</strong> <em>357 </em>
                                    (12)
                                     , 2681-2686. <a href="https://doi.org/10.1002/adsc.201500251" title="DOI URL">https://doi.org/10.1002/adsc.201500251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201500251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201500251%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalyst-Free%252BDomino%252BReaction%252Bof%252B1-Acryloyl-1-%252BN%252B-arylcarbamylcyclopropanes%252Bwith%252BAmines%25253A%252BOne-Pot%252BApproach%252Bto%252B2%25252C3%25252C6%25252C7-Tetrahydro-1%252BH%252B-pyrrolo%25255B3%25252C2-%252Bc%252B%25255Dpyridin-4%2525285%252BH%252B%252529-ones%26aulast%3DZhang%26aufirst%3DZhiguo%26date%3D2015%26date%3D2015%26volume%3D357%26issue%3D12%26spage%3D2681%26epage%3D2686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Tanja S.  Zabka</span>, <span class="hlFld-ContribAuthor ">Dinah L.  Misner</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>151 </em>, 16-31. <a href="https://doi.org/10.1016/j.pharmthera.2015.02.004" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DInhibition%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bin%252Bcancer%26aulast%3DSampath%26aufirst%3DDeepak%26date%3D2015%26volume%3D151%26spage%3D16%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Tan</span>, <span class="hlFld-ContribAuthor ">Sucai  Dong</span>, <span class="hlFld-ContribAuthor ">Robert L.  Shepard</span>, <span class="hlFld-ContribAuthor ">Lisa  Kays</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Roth</span>, <span class="hlFld-ContribAuthor ">Sandaruwan  Geeganage</span>, <span class="hlFld-ContribAuthor ">Ming-Shang  Kuo</span>, <span class="hlFld-ContribAuthor ">Genshi  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2015,</strong> <em>290 </em>
                                    (25)
                                     , 15812-15824. <a href="https://doi.org/10.1074/jbc.M114.632141" title="DOI URL">https://doi.org/10.1074/jbc.M114.632141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.632141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.632141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DInhibition%252Bof%252BNicotinamide%252BPhosphoribosyltransferase%252B%252528NAMPT%252529%25252C%252Ban%252BEnzyme%252BEssential%252Bfor%252BNAD%25252B%252BBiosynthesis%25252C%252BLeads%252Bto%252BAltered%252BCarbohydrate%252BMetabolism%252Bin%252BCancer%252BCells%26aulast%3DTan%26aufirst%3DBo%26date%3D2015%26volume%3D290%26issue%3D25%26spage%3D15812%26epage%3D15824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline M.  Tarrant</span>, <span class="hlFld-ContribAuthor ">Preeti  Dhawan</span>, <span class="hlFld-ContribAuthor ">Jatinder  Singh</span>, <span class="hlFld-ContribAuthor ">Tanja S.  Zabka</span>, <span class="hlFld-ContribAuthor ">Emer  Clarke</span>, <span class="hlFld-ContribAuthor ">Garry  DosSantos</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Tori  Lin</span>, <span class="hlFld-ContribAuthor ">Bobbi  McCray</span>, <span class="hlFld-ContribAuthor ">Nghi  La</span>, <span class="hlFld-ContribAuthor ">Trung  Nguyen</span>, <span class="hlFld-ContribAuthor ">Ariel  Kauss</span>, <span class="hlFld-ContribAuthor ">Donna  Dambach</span>, <span class="hlFld-ContribAuthor ">Dinah L.  Misner</span>, <span class="hlFld-ContribAuthor ">Dolores  Diaz</span>, <span class="hlFld-ContribAuthor ">Hirdesh  Uppal</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid. </span><span class="cited-content_cbyCitation_journal-name">Toxicology Mechanisms and Methods</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 201-211. <a href="https://doi.org/10.3109/15376516.2015.1014080" title="DOI URL">https://doi.org/10.3109/15376516.2015.1014080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/15376516.2015.1014080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F15376516.2015.1014080%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520Mechanisms%2520and%2520Methods%26atitle%3DPreclinical%252Bmodels%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252Binhibitor-mediated%252Bhematotoxicity%252Band%252Bmitigation%252Bby%252Bco-treatment%252Bwith%252Bnicotinic%252Bacid%26aulast%3DTarrant%26aufirst%3DJacqueline%2BM.%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanja S.  Zabka</span>, <span class="hlFld-ContribAuthor ">Jatinder  Singh</span>, <span class="hlFld-ContribAuthor ">Preeti  Dhawan</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Mara A.  Kauss</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Tori  Lin</span>, <span class="hlFld-ContribAuthor ">Bobbi  McCray</span>, <span class="hlFld-ContribAuthor ">Nghi  La</span>, <span class="hlFld-ContribAuthor ">Trung  Nguyen</span>, <span class="hlFld-ContribAuthor ">Joseph  Beyer</span>, <span class="hlFld-ContribAuthor ">Cynthia  Farman</span>, <span class="hlFld-ContribAuthor ">Hirdesh  Uppal</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Dinah L.  Misner</span>. </span><span class="cited-content_cbyCitation_article-title">Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Sciences</span><span> <strong>2015,</strong> <em>144 </em>
                                    (1)
                                     , 163-172. <a href="https://doi.org/10.1093/toxsci/kfu268" title="DOI URL">https://doi.org/10.1093/toxsci/kfu268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/toxsci/kfu268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ftoxsci%2Fkfu268%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Sciences%26atitle%3DRetinal%252BToxicity%25252C%252Bin%252Bvivo%252Band%252Bin%252Bvitro%25252C%252BAssociated%252Bwith%252BInhibition%252Bof%252BNicotinamide%252BPhosphoribosyltransferase%26aulast%3DZabka%26aufirst%3DTanja%2BS.%26date%3D2015%26date%3D2014%26volume%3D144%26issue%3D1%26spage%3D163%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Bang  Fu</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Guangkun  Li</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Suzanne  Tay</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 529-541. <a href="https://doi.org/10.1016/j.bmcl.2014.12.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%252Binhibitors%252Bwith%252Bno%252Bevidence%252Bof%252BCYP3A4%252Btime-dependent%252Binhibition%252Band%252Bimproved%252Baqueous%252Bsolubility%26aulast%3DZak%26aufirst%3DMark%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D529%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Del Nagro</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Linda  Rangell</span>, <span class="hlFld-ContribAuthor ">Mike  Reichelt</span>, <span class="hlFld-ContribAuthor ">Thomas  O'Brien</span>. </span><span class="cited-content_cbyCitation_article-title">Depletion of the Central Metabolite NAD Leads to Oncosis-mediated Cell Death. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2014,</strong> <em>289 </em>
                                    (51)
                                     , 35182-35192. <a href="https://doi.org/10.1074/jbc.M114.580159" title="DOI URL">https://doi.org/10.1074/jbc.M114.580159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.580159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.580159%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDepletion%252Bof%252Bthe%252BCentral%252BMetabolite%252BNAD%252BLeads%252Bto%252BOncosis-mediated%252BCell%252BDeath%26aulast%3DDel%2BNagro%26aufirst%3DChristopher%26date%3D2014%26volume%3D289%26issue%3D51%26spage%3D35182%26epage%3D35192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Kristi  Elkins</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Mandy  Kwong</span>, <span class="hlFld-ContribAuthor ">Mary  Coons</span>, <span class="hlFld-ContribAuthor ">Bobby  Brillantes</span>, <span class="hlFld-ContribAuthor ">Eric  Cheng</span>, <span class="hlFld-ContribAuthor ">Lisa  Crocker</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Thomas  O'Brien</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Belmont</span>, . </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (10)
                                     , e109366. <a href="https://doi.org/10.1371/journal.pone.0109366" title="DOI URL">https://doi.org/10.1371/journal.pone.0109366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0109366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0109366%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DStructural%252BBasis%252Bfor%252BResistance%252Bto%252BDiverse%252BClasses%252Bof%252BNAMPT%252BInhibitors%26aulast%3DWang%26aufirst%3DWeiru%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D10%26spage%3De109366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kanchan  Mal</span>, <span class="hlFld-ContribAuthor ">Abhinandan  Sharma</span>, <span class="hlFld-ContribAuthor ">Indrajit  Das</span>. </span><span class="cited-content_cbyCitation_article-title">Gold(III) Chloride Catalyzed Synthesis of Chiral Substituted 3-Formyl Furans from Carbohydrates: Application in the Synthesis of 1,5-Dicarbonyl Derivatives and Furo[3,2-
              c
              ]pyridine. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2014,</strong> <em>20 </em>
                                    (37)
                                     , 11932-11945. <a href="https://doi.org/10.1002/chem.201402286" title="DOI URL">https://doi.org/10.1002/chem.201402286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201402286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201402286%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DGold%252528III%252529%252BChloride%252BCatalyzed%252BSynthesis%252Bof%252BChiral%252BSubstituted%252B3-Formyl%252BFurans%252Bfrom%252BCarbohydrates%25253A%252BApplication%252Bin%252Bthe%252BSynthesis%252Bof%252B1%25252C5-Dicarbonyl%252BDerivatives%252Band%252BFuro%25255B3%25252C2-%252Bc%252B%25255Dpyridine%26aulast%3DMal%26aufirst%3DKanchan%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D37%26spage%3D11932%26epage%3D11945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Xukun  Chen</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2014,</strong> <em>15 </em>
                                    (8)
                                     , 1121-1130. <a href="https://doi.org/10.1002/cbic.201402023" title="DOI URL">https://doi.org/10.1002/cbic.201402023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201402023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201402023%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DStructural%252Band%252BBiochemical%252BAnalyses%252Bof%252Bthe%252BCatalysis%252Band%252BPotency%252BImpact%252Bof%252BInhibitor%252BPhosphoribosylation%252Bby%252BHuman%252BNicotinamide%252BPhosphoribosyltransferase%26aulast%3DOh%26aufirst%3DAngela%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D8%26spage%3D1121%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Brandon  Bravo</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Giannetti</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Rongbao  Hua</span>, <span class="hlFld-ContribAuthor ">Guangkun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Ma</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 954-962. <a href="https://doi.org/10.1016/j.bmcl.2013.12.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-based%252Bdesign%252Bof%252B3-aminopyridine-derived%252Bamides%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D954%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Yunli  Wang</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 337-343. <a href="https://doi.org/10.1016/j.bmcl.2013.11.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Befficacious%252Bcyanoguanidine-containing%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528Nampt%252529%252Binhibitors%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D337%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Shames</span>, <span class="hlFld-ContribAuthor ">Kristi  Elkins</span>, <span class="hlFld-ContribAuthor ">Kimberly  Walter</span>, <span class="hlFld-ContribAuthor ">Thomas  Holcomb</span>, <span class="hlFld-ContribAuthor ">Pan  Du</span>, <span class="hlFld-ContribAuthor ">Dane  Mohl</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Thinh  Pham</span>, <span class="hlFld-ContribAuthor ">Peter M.  Haverty</span>, <span class="hlFld-ContribAuthor ">Bianca  Liederer</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Robert L.  Yauch</span>, <span class="hlFld-ContribAuthor ">Thomas  O'Brien</span>, <span class="hlFld-ContribAuthor ">Richard  Bourgon</span>, <span class="hlFld-ContribAuthor ">Hartmut  Koeppen</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Belmont</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2013,</strong> <em>19 </em>
                                    (24)
                                     , 6912-6923. <a href="https://doi.org/10.1158/1078-0432.CCR-13-1186" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-13-1186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-13-1186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-13-1186%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DLoss%252Bof%252BNAPRT1%252BExpression%252Bby%252BTumor-Specific%252BPromoter%252BMethylation%252BProvides%252Ba%252BNovel%252BPredictive%252BBiomarker%252Bfor%252BNAMPT%252BInhibitors%26aulast%3DShames%26aufirst%3DDavid%2BS.%26date%3D2013%26date%3D2013%26volume%3D19%26issue%3D24%26spage%3D6912%26epage%3D6923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven  Stirdivant</span>, <span class="hlFld-ContribAuthor ">Michael  Milburn</span>, <span class="hlFld-ContribAuthor ">Andrea  Eckhart</span>, <span class="hlFld-ContribAuthor ">Kirk  Beebe</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding Tumour Metabolic Reprogramming with Metabolomics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,<a href="https://doi.org/10.1002/9780470015902.a0025297" title="DOI URL">https://doi.org/10.1002/9780470015902.a0025297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470015902.a0025297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470015902.a0025297%26sid%3Dliteratum%253Aachs%26atitle%3DUnderstanding%252BTumour%252BMetabolic%252BReprogramming%252Bwith%252BMetabolomics%26aulast%3DStirdivant%26aufirst%3DSteven%26date%3D2013%26date%3D2013%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DeLS%26aulast%3DJohn%2BWiley%2B%2526%2BSons%2BLtd%26date%3D2001%26date%3D2001%26volume%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  O'Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Alexander  Vanderbilt</span>, <span class="hlFld-ContribAuthor ">Ann  Qin</span>, <span class="hlFld-ContribAuthor ">Lulu  Yang</span>, <span class="hlFld-ContribAuthor ">Leslie B.  Lee</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Ely  Cosino</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  LaCap</span>, <span class="hlFld-ContribAuthor ">Annie  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Simon  Williams</span>, <span class="hlFld-ContribAuthor ">Michelle  Nannini</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Peter  Jackson</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>. </span><span class="cited-content_cbyCitation_article-title">Supplementation of Nicotinic Acid with NAMPT Inhibitors Results in Loss of In Vivo Efficacy in NAPRT1-Deficient Tumor Models. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2013,</strong> <em>15 </em>
                                    (12)
                                     , 1314-IN3. <a href="https://doi.org/10.1593/neo.131718" title="DOI URL">https://doi.org/10.1593/neo.131718</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1593/neo.131718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1593%2Fneo.131718%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DSupplementation%252Bof%252BNicotinic%252BAcid%252Bwith%252BNAMPT%252BInhibitors%252BResults%252Bin%252BLoss%252Bof%252BIn%252BVivo%252BEfficacy%252Bin%252BNAPRT1-Deficient%252BTumor%252BModels%26aulast%3DO%2527Brien%26aufirst%3DThomas%26date%3D2013%26volume%3D15%26issue%3D12%26spage%3D1314%26epage%3DIN3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Paul  Bauer</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Alexandre J.  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Maureen  Caligiuri</span>, <span class="hlFld-ContribAuthor ">Karl H.  Clodfelter</span>, <span class="hlFld-ContribAuthor ">Yezhen  Feng</span>, <span class="hlFld-ContribAuthor ">Bingsong  Han</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Nikolai  Kley</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">Dominic J.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Geeta  Sharma</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Chase C.  Smith</span>, <span class="hlFld-ContribAuthor ">Jarrod  Tremayne</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Guangxing  Yang</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (20)
                                     , 5488-5497. <a href="https://doi.org/10.1016/j.bmcl.2013.08.074" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bamides%252Bderived%252Bfrom%252B1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine-5-carboxylic%252Bacid%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DZheng%26aufirst%3DXiaozhang%26date%3D2013%26volume%3D23%26issue%3D20%26spage%3D5488%26epage%3D5497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Bair</span>, <span class="hlFld-ContribAuthor ">Timm  Baumeister</span>, <span class="hlFld-ContribAuthor ">Yen-Ching  Ho</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Liederer</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Yongbo  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  O’Brien</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Nicholas  Skelton</span>, <span class="hlFld-ContribAuthor ">Leslie  Wang</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Hongxing  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Xiao</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaozhang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (17)
                                     , 4875-4885. <a href="https://doi.org/10.1016/j.bmcl.2013.06.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.06.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.06.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.06.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B2%25252C3-dihydro-1H-pyrrolo%25255B3%25252C4-c%25255Dpyridine-derived%252Bureas%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Bnicotinamide%252Bphosphoribosyltransferase%252B%252528NAMPT%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D4875%26epage%3D4885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of NAD biosynthetic pathways found in mammalian cells. Nampt catalyzes the conversion of NAM to NMN.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of Nampt inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Discovery of a novel amide-containing Nampt inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Cocrystal structure of <b>7</b> (green) in complex with Nampt (determined in this work; PBD code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFN">4KFN</a>; monomers in gray and cyan).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Water molecules are depicted as red spheres and possible hydrogen bonds are indicated with dashed yellow lines. The resolution of the structure is 1.87 Å. For comparison, the previously published crystal structure of a related thiourea-containing inhibitor (<b>5</b>) is shown in magenta.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Co-crystal structure of compound <b>58</b> (green) in complex with Nampt (gray); PBD Code: 4KFO. Water molecules are depicted as red spheres and possible hydrogen bonds are indicated with dashed yellow lines. The resolution of the structure is 1.6 Å. For comparison, the structure of compound <b>7</b> is shown in magenta.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mean (±standard deviation) plasma concentration–time profiles of compound <b>58</b> in NCR nude mice (<i>n</i> = 3) following intravenous and oral administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Left panel: compound <b>58</b> in vivo efficacy results in U251 human glioblastoma tumor xenograft model. Right panel: changes in body weight. Data reflect mean values (±standard deviation) of eight animals in each group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HATU, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, 25 °C, 5–96%; (ii) EDCI, HOBt, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, 80 °C, 4–76%; (iii) BOP, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, 25 °C, 40–50%; (iv) AlMe<sub>3</sub>, toluene, 0–110 °C, 6–92%.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu(OAc)<sub>2</sub>, Et<sub>3</sub>N, DMSO, 60 °C; (ii) HCl, 25 °C; (iii) BOP, Et<sub>3</sub>N, DMA, 25 °C, 4–11% over three steps. All steps were performed using a parallel synthesis approach, and intermediates <b>68</b> and <b>64</b> were not isolated and/or purified.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) CF<sub>3</sub>COOH, 0–25 °C, 98%; (ii) Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O/MeOH, reflux, 3%.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) EtOH/48% HBr, 80 °C, 15%; (ii) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 120 °C, 24%; (iii) HCl/MeOH, 80 °C, 12%.</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Cu(OCOCH<sub>3</sub>)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMSO, 25 °C, 16–40%; (ii) 12 M HCl/<i>i</i>-PrOH, 100 °C, 86–100%.</p></p></figure><figure data-id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DMSO, 120 °C, 30%; (ii) H<sub>2</sub>–Raney Ni, 2 M NH<sub>3</sub>/MeOH, 25 °C, 94%.</p></p></figure><figure data-id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) EtN(<i>i</i>-Pr)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 25 °C, 100%; (ii) Ti(OEt)<sub>4</sub>, <i>t</i>-BuSONH<sub>2</sub>, THF, 25 °C, 59%; (iii) MeLi, Et<sub>2</sub>O, −78 to 25 °C, 47%; (ii) 4.0 M HCl-1,4-dioxane, MeOH, 25 °C, 68%.</p></p></figure><figure data-id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/medium/jm-2013-008664_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-16/jm4008664/production/images/large/jm-2013-008664_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4008664&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, EtN(<i>i</i>-Pr)<sub>2</sub>, toluene, 100 °C, 94%; (ii) Oxone, H<sub>2</sub>O–CH<sub>3</sub>CN, 25 °C, 94%; (iii) NaOEt, MeOH, 50 °C, 97%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i102">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 24 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Belenky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, C.</span><span> </span><span class="NLM_article-title">NAD+ metabolism in health and disease</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=12-19&author=P.+Belenkyauthor=K.+L.+Boganauthor=C.+Brenner&title=NAD%2B+metabolism+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelenky%26aufirst%3DP.%26aulast%3DBogan%26aufirst%3DK.%2BL.%26aulast%3DBrenner%26aufirst%3DC.%26atitle%3DNAD%252B%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2007%26volume%3D32%26spage%3D12%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koppenol, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounds, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, C. V.</span><span> </span><span class="NLM_article-title">Otto Warburg’s contributions to current concepts of cancer metabolism</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fnrc3038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=21508971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=325-337&author=W.+H.+Koppenolauthor=P.+L.+Boundsauthor=C.+V.+Dang&title=Otto+Warburg%E2%80%99s+contributions+to+current+concepts+of+cancer+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Otto Warburg's contributions to current concepts of cancer metabolism</span></div><div class="casAuthors">Koppenol, Willem H.; Bounds, Patricia L.; Dang, Chi V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">325-337</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Otto Warburg pioneered quant. investigations of cancer cell metab., as well as photosynthesis and respiration.  Warburg and co-workers showed in the 1920s that, under aerobic conditions, tumor tissues metabolize approx. tenfold more glucose to lactate in a given time than normal tissues, a phenomenon known as the Warburg effect.  However, this increase in aerobic glycolysis in cancer cells is often erroneously thought to occur instead of mitochondrial respiration and has been misinterpreted as evidence for damage to respiration instead of damage to the regulation of glycolysis.  In fact, many cancers exhibit the Warburg effect while retaining mitochondrial respiration.  We re-examine Warburg's observations in relation to the current concepts of cancer metab. as being intimately linked to alterations of mitochondrial DNA, oncogenes and tumor suppressors, and thus readily exploitable for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdteDUarw-PbVg90H21EOLACvtfcHk0lianDmXe8u0Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1ags70%253D&md5=72988f428422daecd23b21d242aec18a</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnrc3038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3038%26sid%3Dliteratum%253Aachs%26aulast%3DKoppenol%26aufirst%3DW.%2BH.%26aulast%3DBounds%26aufirst%3DP.%2BL.%26aulast%3DDang%26aufirst%3DC.%2BV.%26atitle%3DOtto%2520Warburg%25E2%2580%2599s%2520contributions%2520to%2520current%2520concepts%2520of%2520cancer%2520metabolism%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D325%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1016%2Fj.ccr.2012.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=22439925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=297-308&author=P.+S.+Wardauthor=C.+B.+Thompson&title=Metabolic+reprogramming%3A+A+cancer+hallmark+even+Warburg+did+not+anticipate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate</span></div><div class="casAuthors">Ward, Patrick S.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-308</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer metab. has long been equated with aerobic glycolysis, seen by early biochemists as primitive and inefficient.  Despite these early beliefs, the metabolic signatures of cancer cells are not passive responses to damaged mitochondria but result from oncogene-directed metabolic reprogramming required to support anabolic growth.  Recent evidence suggests that metabolites themselves can be oncogenic by altering cell signaling and blocking cellular differentiation.  No longer can cancer-assocd. alterations in metab. be viewed as an indirect response to cell proliferation and survival signals.  We contend that altered metab. has attained the status of a core hallmark of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFCvg4k-_m7Vg90H21EOLACvtfcHk0li2lzGq93PMLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1ylsbc%253D&md5=8e991ba77d1bb0b57c3009b6bc39ee99</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DMetabolic%2520reprogramming%253A%2520A%2520cancer%2520hallmark%2520even%2520Warburg%2520did%2520not%2520anticipate%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D21%26spage%3D297%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Galli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rongvaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, O.</span><span> </span><span class="NLM_article-title">The nicotinamide phosphoribosyltransferase: A molecular link between metabolism, inflammation, and cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8-11&author=M.+Galliauthor=F.+Van+Goolauthor=A.+Rongvauxauthor=F.+Andrisauthor=O.+Leo&title=The+nicotinamide+phosphoribosyltransferase%3A+A+molecular+link+between+metabolism%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DM.%26aulast%3DVan%2BGool%26aufirst%3DF.%26aulast%3DRongvaux%26aufirst%3DA.%26aulast%3DAndris%26aufirst%3DF.%26aulast%3DLeo%26aufirst%3DO.%26atitle%3DThe%2520nicotinamide%2520phosphoribosyltransferase%253A%2520A%2520molecular%2520link%2520between%2520metabolism%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span> </span><span class="NLM_article-title">The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">50754</span><span class="NLM_x">–</span> <span class="NLM_lpage">50763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=50754-50763&author=J.+R.+Revolloauthor=A.+A.+Grimmauthor=S.+Imai&title=The+NAD+biosynthesis+pathway+mediated+by+nicotinamide+phosphoribosyltransferase+regulates+Sir2+activity+in+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DGrimm%26aufirst%3DA.%2BA.%26aulast%3DImai%26aufirst%3DS.%26atitle%3DThe%2520NAD%2520biosynthesis%2520pathway%2520mediated%2520by%2520nicotinamide%2520phosphoribosyltransferase%2520regulates%2520Sir2%2520activity%2520in%2520mammalian%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D50754%26epage%3D50763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Garten, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiess, W.</span><span> </span><span class="NLM_article-title">Nampt: Linking NAD Biology, Metabolism and Cancer</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1016%2Fj.tem.2008.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19109034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=130-138&author=A.+Gartenauthor=S.+Petzoldauthor=A.+Kornerauthor=S.-I.+Imaiauthor=W.+Kiess&title=Nampt%3A+Linking+NAD+Biology%2C+Metabolism+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Nampt: linking NAD biology, metabolism and cancer</span></div><div class="casAuthors">Garten, Antje; Petzold, Stefanie; Koerner, Antje; Imai, Shin-ichiro; Kiess, Wieland</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Nicotinamide phosphoribosyltransferase (Nampt) converts nicotinamide to NMN, a key NAD intermediate.  Previously identified as a cytokine pre-B-cell colony-enhancing factor and controversially claimed as an insulin-mimetic hormone visfatin, Nampt has recently drawn much attention in several fields, including NAD biol., metab. and inflammation.  As a NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses.  Nampt also plays an important part in regulating insulin secretion in pancreatic β-cells.  Nampt seems to have another function as an immunomodulatory cytokine and, therefore, has a role in inflammation.  This review summarizes these various functional aspects of Nampt and discusses its potential roles in diseases, including type 2 diabetes and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMtmRWd15knbVg90H21EOLACvtfcHk0li2lzGq93PMLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFanu7o%253D&md5=2e6fc10db431e1963b0b827747466c53</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2008.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2008.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DGarten%26aufirst%3DA.%26aulast%3DPetzold%26aufirst%3DS.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DImai%26aufirst%3DS.-I.%26aulast%3DKiess%26aufirst%3DW.%26atitle%3DNampt%253A%2520Linking%2520NAD%2520Biology%252C%2520Metabolism%2520and%2520Cancer%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D20%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">11086</span><span class="NLM_x">–</span> <span class="NLM_lpage">11096</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi801198m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=11086-11096&author=E.+S.+Burgosauthor=V.+L.+Schramm&title=Weak+coupling+of+ATP+hydrolysis+to+the+chemical+equilibrium+of+human+nicotinamide+phosphoribosyltransferase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1021%2Fbi801198m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi801198m%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DWeak%2520coupling%2520of%2520ATP%2520hydrolysis%2520to%2520the%2520chemical%2520equilibrium%2520of%2520human%2520nicotinamide%2520phosphoribosyltransferase%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D11086%26epage%3D11096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zaremba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketzer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulthard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plummer, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span> </span><span class="NLM_article-title">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fsj.bjc.6605166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19568233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=256-262&author=T.+Zarembaauthor=P.+Ketzerauthor=M.+Coleauthor=S.+Coulthardauthor=E.+R.+Plummerauthor=N.+J.+Curtin&title=Poly%28ADP-ribose%29+polymerase-1+polymorphisms%2C+expression+and+activity+in+selected+human+tumour+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines</span></div><div class="casAuthors">Zaremba, T.; Ketzer, P.; Cole, M.; Coulthard, S.; Plummer, E. R.; Curtin, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-262</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Poly(ADP-ribose) polymerase-1 (PARP-1) is a DNA-binding enzyme activated by DNA breaks and involved in DNA repair and other cellular processes.  Poly(ADP-ribose) polymerase activity can be higher in cancer than in adjacent normal tissue, but cancer predisposition is reported to be greater in individuals with a single-nucleotide polymorphism (SNP) V762A (T2444C) in the catalytic domain that reduces PARP-1 activity.  Methods: To resolve these divergent observations, we detd. PARP-1 polymorphisms, PARP-1 protein expression and activity in a panel of 19 solid and haematol., adult and pediatric human cancer cell lines.  Results: There was a wide variation in PARP activity in the cell line panel (coeff. of variation, CV=103%), with the lowest and the highest activity being 2460 pmol PAR/106 (HS-5 cells) and 85 750 pmol PAR/106 (NGP cells).  Lower variation (CV=32%) was obsd. in PARP-1 protein expression with the lowest expression being 2.0 ng μg-1 (HS-5 cells) and the highest being 7.1 ng μg-1 (ML-1 cells).  The mean activity in the cancer cells was 45-fold higher than the mean activity in normal human lymphocytes and the PARP-1 protein levels were 23-fold higher.  Conclusions: Surprisingly, there was no significant correlation between PARP activity and PARP-1 protein level or the investigated polymorphisms, T2444C and CA.  British Journal of Cancer (2009) 101, 256-262; doi:10.1038/sj.bjc.6605166 www.bjcancer.com Published online 30 June 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGiXp9dmBsH7Vg90H21EOLACvtfcHk0lh0iXi3fhCtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXoslOmurg%253D&md5=2e8cbeef3e92351d2afd5bed60ad77d4</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605166%26sid%3Dliteratum%253Aachs%26aulast%3DZaremba%26aufirst%3DT.%26aulast%3DKetzer%26aufirst%3DP.%26aulast%3DCole%26aufirst%3DM.%26aulast%3DCoulthard%26aufirst%3DS.%26aulast%3DPlummer%26aufirst%3DE.%2BR.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26atitle%3DPoly%2528ADP-ribose%2529%2520polymerase-1%2520polymorphisms%252C%2520expression%2520and%2520activity%2520in%2520selected%2520human%2520tumour%2520cell%2520lines%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D256%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouhar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1517%2F14728222.11.5.695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=17465726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=695-705&author=J.+A.+Khanauthor=F.+Forouharauthor=X.+Taoauthor=L.+Tong&title=Nicotinamide+adenine+dinucleotide+metabolism+as+an+attractive+target+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery</span></div><div class="casAuthors">Khan, Javed A.; Forouhar, Farhad; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-705</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  NAD (NAD+) has crucial roles in many cellular processes, both as a coenzyme for redox reactions and as a substrate to donate ADP-ribose units.  Enzymes involved in NAD+ metab. are attractive targets for drug discovery against a variety of human diseases, including cancer, multiple sclerosis, neurodegeneration and Huntington's disease.  A small-mol. inhibitor of nicotinamide phosphoribosyltransferase, an enzyme in the salvage pathway of NAD+ biosynthesis, is presently in clin. trials against cancer.  An analog of a kynurenine pathway intermediate is efficacious against multiple sclerosis in an animal model.  Indoleamine 2,3-dioxygenase plays an important role in immune evasion by cancer cells and other disease processes.  Inhibitors against kynurenine 3-hydroxylase can reduce the prodn. of neurotoxic metabolites while increasing the prodn. of neuroprotective compds.  This review summarizes the existing knowledge on NAD+ metabolic enzymes, with emphasis on their relevance for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCrpVwpXgPHrVg90H21EOLACvtfcHk0lh0iXi3fhCtEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslCltbg%253D&md5=43a4c12a1a780feddd233e1d8209f3f6</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.5.695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.5.695%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DForouhar%26aufirst%3DF.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DNicotinamide%2520adenine%2520dinucleotide%2520metabolism%2520as%2520an%2520attractive%2520target%2520for%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D695%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cerna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaherty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, S. S.</span><span> </span><span class="NLM_article-title">Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by the small molecule GMX1778 regulates ROS-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">22408</span><span class="NLM_x">–</span> <span class="NLM_lpage">22417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=22408-22417&author=D.+Cernaauthor=H.+Liauthor=S.+Flahertyauthor=N.+Takebeauthor=C.+N.+Colemanauthor=S.+S.+Yoo&title=Inhibition+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+activity+by+the+small+molecule+GMX1778+regulates+ROS-mediated+cytotoxicity+in+a+p53-+and+nicotinic+acid+phosphoribosyltransferase1+%28NAPRT1%29-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerna%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DFlaherty%26aufirst%3DS.%26aulast%3DTakebe%26aufirst%3DN.%26aulast%3DColeman%26aufirst%3DC.%2BN.%26aulast%3DYoo%26aufirst%3DS.%2BS.%26atitle%3DInhibition%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520activity%2520by%2520the%2520small%2520molecule%2520GMX1778%2520regulates%2520ROS-mediated%2520cytotoxicity%2520in%2520a%2520p53-%2520and%2520nicotinic%2520acid%2520phosphoribosyltransferase1%2520%2528NAPRT1%2529-dependent%2520manner%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D22408%26epage%3D22417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vander Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1033</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1126%2Fscience.1160809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19460998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2009&pages=1029-1033&author=M.+G.+Vander+Heidenauthor=L.+C.+Cantleyauthor=C.+B.+Thompson&title=Understanding+the+Warburg+effect%3A+the+metabolic+requirements+of+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation</span></div><div class="casAuthors">Vander Heiden, Matthew G.; Cantley, Lewis C.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">5930</span>),
    <span class="NLM_cas:pages">1029-1033</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed "the Warburg effect".  Aerobic glycolysis is an inefficient way to generate ATP, however, and the advantage it confers to cancer cells has been unclear.  Here we propose that the metab. of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell.  Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-assocd. mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP prodn.  A better understanding of the mechanistic links between cellular metab. and growth control may ultimately lead to better treatments for human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGvLHGQ9TX77Vg90H21EOLACvtfcHk0lh8KfaqrxPf8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKlsbg%253D&md5=f927402a43cdca471c3f4874dcbeb943</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1160809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1160809%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DUnderstanding%2520the%2520Warburg%2520effect%253A%2520the%2520metabolic%2520requirements%2520of%2520cell%2520proliferation%26jtitle%3DScience%26date%3D2009%26volume%3D324%26spage%3D1029%26epage%3D1033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Schou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottosen, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorkling, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjarnaa, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">Novel cyanoguanidines with potent oral antitumor activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3095</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3095-3100&author=C.+Schouauthor=E.+R.+Ottosenauthor=H.+J.+Petersenauthor=F.+Bjorklingauthor=S.+Latiniauthor=P.+V.+Hjarnaaauthor=E.+Brammauthor=L.+Binderup&title=Novel+cyanoguanidines+with+potent+oral+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchou%26aufirst%3DC.%26aulast%3DOttosen%26aufirst%3DE.%2BR.%26aulast%3DPetersen%26aufirst%3DH.%2BJ.%26aulast%3DBjorkling%26aufirst%3DF.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DHjarnaa%26aufirst%3DP.%2BV.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DNovel%2520cyanoguanidines%2520with%2520potent%2520oral%2520antitumor%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3095%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Biedermann, E.; Hasmann, M.; Loser, R.; Rattel, B.; Reiter, F.; Schein, B.; Seibel, K.; Vogt, K.</span><span> </span><span class="NLM_article-title">Preparation and formulation of pyridine derivatives as antitumor agents and immunosuppressants</span>. WO 199748397,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=E.+Biedermann&author=M.+Hasmann&author=R.+Loser&author=B.+Rattel&author=F.+Reiter&author=B.+Schein&author=K.+Seibel&author=K.+Vogt&title=Preparation+and+formulation+of+pyridine+derivatives+as+antitumor+agents+and+immunosuppressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiedermann%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520formulation%2520of%2520pyridine%2520derivatives%2520as%2520antitumor%2520agents%2520and%2520immunosuppressants%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ravaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Droz, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twelves, C.</span><span> </span><span class="NLM_article-title">Phase I study and pharmacokinetics of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=702-707&author=A.+Ravaudauthor=T.+Cernyauthor=C.+Terretauthor=J.+Wandersauthor=B.+N.+Buiauthor=D.+Hessauthor=J.-P.+Drozauthor=P.+Fumoleauauthor=C.+Twelves&title=Phase+I+study+and+pharmacokinetics+of+CHS-828%2C+a+guanidino-containing+compound%2C+administered+orally+as+a+single+dose+every+3+weeks+in+solid+tumours%3A+An+ECSG%2FEORTC+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavaud%26aufirst%3DA.%26aulast%3DCerny%26aufirst%3DT.%26aulast%3DTerret%26aufirst%3DC.%26aulast%3DWanders%26aufirst%3DJ.%26aulast%3DBui%26aufirst%3DB.%2BN.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DDroz%26aufirst%3DJ.-P.%26aulast%3DFumoleau%26aufirst%3DP.%26aulast%3DTwelves%26aufirst%3DC.%26atitle%3DPhase%2520I%2520study%2520and%2520pharmacokinetics%2520of%2520CHS-828%252C%2520a%2520guanidino-containing%2520compound%252C%2520administered%2520orally%2520as%2520a%2520single%2520dose%2520every%25203%2520weeks%2520in%2520solid%2520tumours%253A%2520An%2520ECSG%252FEORTC%2520study%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D702%26epage%3D707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hovstadium, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissmeyer, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasilnikoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonnebo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, J.</span><span> </span><span class="NLM_article-title">A phase I study of CHS 828 in patients with solid tumor malignancy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=12231525" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2843-2850&author=P.+Hovstadiumauthor=R.+Larssonauthor=E.+Jonssonauthor=T.+Skovauthor=A.-M.+Kissmeyerauthor=K.+Krasilnikoffauthor=J.+Berghauthor=M.+O.+Karlssonauthor=A.+Lonneboauthor=J.+Ahlgren&title=A+phase+I+study+of+CHS+828+in+patients+with+solid+tumor+malignancy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHovstadium%26aufirst%3DP.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DKissmeyer%26aufirst%3DA.-M.%26aulast%3DKrasilnikoff%26aufirst%3DK.%26aulast%3DBergh%26aufirst%3DJ.%26aulast%3DKarlsson%26aufirst%3DM.%2BO.%26aulast%3DLonnebo%26aufirst%3DA.%26aulast%3DAhlgren%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520CHS%2520828%2520in%2520patients%2520with%2520solid%2520tumor%2520malignancy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D2843%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vig Hjarnaa, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binderup, L.</span><span> </span><span class="NLM_article-title">CHS828, a novel pyridine cyanoguanidine with potent antitumor activity <i>in vitro</i> and <i>in vivo</i></span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5751</span><span class="NLM_x">–</span> <span class="NLM_lpage">5757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=5751-5757&author=P.-J.+Vig+Hjarnaaauthor=E.+Jonssonauthor=S.+Latiniauthor=S.+Dharauthor=R.+Larssonauthor=E.+Brammauthor=T.+Skovauthor=L.+Binderup&title=CHS828%2C+a+novel+pyridine+cyanoguanidine+with+potent+antitumor+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVig%2BHjarnaa%26aufirst%3DP.-J.%26aulast%3DJonsson%26aufirst%3DE.%26aulast%3DLatini%26aufirst%3DS.%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DBramm%26aufirst%3DE.%26aulast%3DSkov%26aufirst%3DT.%26aulast%3DBinderup%26aufirst%3DL.%26atitle%3DCHS828%252C%2520a%2520novel%2520pyridine%2520cyanoguanidine%2520with%2520potent%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D5751%26epage%3D5757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Holen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollywood, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauske, A.-R.</span><span> </span><span class="NLM_article-title">The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=45-51&author=K.+Holenauthor=L.+B.+Saltzauthor=E.+Hollywoodauthor=K.+Burkauthor=A.-R.+Hanauske&title=The+pharmacokinetics%2C+toxicities%2C+and+biologic+effects+of+FK866%2C+a+nicotinamide+adenine+dinucleotide+biosynthesis+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolen%26aufirst%3DK.%26aulast%3DSaltz%26aufirst%3DL.%2BB.%26aulast%3DHollywood%26aufirst%3DE.%26aulast%3DBurk%26aufirst%3DK.%26aulast%3DHanauske%26aufirst%3DA.-R.%26atitle%3DThe%2520pharmacokinetics%252C%2520toxicities%252C%2520and%2520biologic%2520effects%2520of%2520FK866%252C%2520a%2520nicotinamide%2520adenine%2520dinucleotide%2520biosynthesis%2520inhibitor%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2008%26volume%3D26%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Olesen, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thougaard, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehested, M.</span><span> </span><span class="NLM_article-title">A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1158%2F1535-7163.MCT-09-1130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=20515945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1609-1617&author=U.+H.+Olesenauthor=A.+V.+Thougaardauthor=P.+B.+Jensenauthor=M.+Sehested&title=A+preclinical+study+on+the+rescue+of+normal+tissue+by+nicotinic+acid+in+high-dose+treatment+with+APO866%2C+a+specific+nicotinamide+phosphoribosyltransferase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase Inhibitor</span></div><div class="casAuthors">Olesen, Uffe Hogh; Thougaard, Annemette V.; Jensen, Peter Buhl; Sehested, Maxwell</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1609-1617</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibitor of nicotinamide phosphoribosyltransferase APO866 is a promising cancer drug currently in phase II clin. trials in oncol.  Here, we present a strategy for increasing the therapeutic potential of APO866 through the rescue of normal tissues by coadministration of nicotinic acid (Vitamin B3).  We examd. the toxicity profile of APO866 in B6D2F1 mice and the effect of oral administration of nicotinic acid on tissue toxicity.  Nicotinic acid (50 mg/kg) protects mice from death and severe toxicity from an APO866 dose (60 mg/kg) four times the monotherapy max. tolerated dose (15 mg/kg).  In a panel of six cancer cell lines, we find that three (including ML-2 cells) are protected by nicotinic acid in vitro, whereas the cytotoxicity of APO866 remains unaffected in the remaining three (including A2780 cells).  A selective biomarker for the protection by nicotinic acid was subsequently identified by quant. RT-PCR.  The expression of nicotinic acid phosphoribosyltransferase is low in the cell lines not rescued from APO866 by nicotinic acid compared with protected cell lines.  The findings in cell lines translated into xenograft models in which the combination of 50 mg/kg nicotinic acid and 50 mg/kg APO866 in mouse xenografts of A2780 cells increased life span by >3-fold compared with std. treatment of 15 mg/kg, and the effect of APO866 was clearly decreased when using the same treatment paradigm in ML-2 xenografts.  In conclusion, the combination of high doses of APO866 with rescue by nicotinic acid may significantly increase the therapeutic potential in a subset of cancers with low expression of nicotinic acid phosphoribosyltransferase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEVf5ZtCvXrVg90H21EOLACvtfcHk0lhVmxrbcZg7ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFGgsbg%253D&md5=353e954d2fd5308992a0ce8039ef081c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1130%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DU.%2BH.%26aulast%3DThougaard%26aufirst%3DA.%2BV.%26aulast%3DJensen%26aufirst%3DP.%2BB.%26aulast%3DSehested%26aufirst%3DM.%26atitle%3DA%2520preclinical%2520study%2520on%2520the%2520rescue%2520of%2520normal%2520tissue%2520by%2520nicotinic%2520acid%2520in%2520high-dose%2520treatment%2520with%2520APO866%252C%2520a%2520specific%2520nicotinamide%2520phosphoribosyltransferase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D1609%26epage%3D1617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckmelter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clodfelter, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span> </span><span class="NLM_article-title">Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4921</span><span class="NLM_x">–</span> <span class="NLM_lpage">4937</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400186h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4921-4937&author=X.+Zhengauthor=P.+Bauerauthor=T.+Baumeisterauthor=A.+J.+Buckmelterauthor=M.+Caligiuriauthor=K.+H.+Clodfelterauthor=B.+Hanauthor=Y.-C.+Hoauthor=N.+Kleyauthor=J.+Linauthor=D.+J.+Reynoldsauthor=G.+Sharmaauthor=C.+C.+Smithauthor=Z.+Wangauthor=P.+S.+Dragovichauthor=A.+Ohauthor=W.+Wangauthor=M.+Zakauthor=J.+Gunzner-Tosteauthor=G.+Zhaoauthor=P.-w.+Yuenauthor=K.+W.+Bair&title=Structure-based+identification+of+ureas+as+novel+nicotinamide+phosphoribosyltransferase+%28Nampt%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm400186h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400186h%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBauer%26aufirst%3DP.%26aulast%3DBaumeister%26aufirst%3DT.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DCaligiuri%26aufirst%3DM.%26aulast%3DClodfelter%26aufirst%3DK.%2BH.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DY.-C.%26aulast%3DKley%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DReynolds%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DStructure-based%2520identification%2520of%2520ureas%2520as%2520novel%2520nicotinamide%2520phosphoribosyltransferase%2520%2528Nampt%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4921%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckmelter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiurib, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clodfelter, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kley, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liederer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukadam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, P.-w.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3531</span><span class="NLM_x">–</span> <span class="NLM_lpage">3538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=3531-3538&author=J.+Gunzner-Tosteauthor=G.+Zhaoauthor=P.+Bauerauthor=T.+Baumeisterauthor=A.+J.+Buckmelterauthor=M.+Caligiuribauthor=K.+H.+Clodfelterauthor=B.+Fuauthor=B.+Hanauthor=Y.-C.+Hoauthor=N.+Kleyauthor=X.+Liangauthor=B.+Liedererauthor=J.+Linauthor=S.+Mukadamauthor=T.+O%E2%80%99Brienauthor=D.+J.+Reynoldsauthor=G.+Sharmaauthor=N.+Skeltonauthor=C.+C.+Smithauthor=W.+Wangauthor=Z.+Wangauthor=Y.+Xiaoauthor=P.-w.+Yuenauthor=M.+Zakauthor=L.+Zhangauthor=X.+Zhengauthor=K.+W.+Bairauthor=P.+S.+Dragovich&title=Discovery+of+potent+and+efficacious+urea-containing+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitors+with+reduced+CYP2C9+inhibition+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DP.%26aulast%3DBaumeister%26aufirst%3DT.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DCaligiurib%26aufirst%3DM.%26aulast%3DClodfelter%26aufirst%3DK.%2BH.%26aulast%3DFu%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DB.%26aulast%3DHo%26aufirst%3DY.-C.%26aulast%3DKley%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DLiederer%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DReynolds%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DG.%26aulast%3DSkelton%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520efficacious%2520urea-containing%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitors%2520with%2520reduced%2520CYP2C9%2520inhibition%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D3531%26epage%3D3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><div class="note"><p class="first last">For a recent and broad review of many different classes of Nampt inhibitors, see:</p></div><span class="NLM_contrib-group">Galli, U.; Travelli, C.; Massarotti, A.; Fakhfouri, G.; Rahimian, R.; Tron, G. C.; Genazzani, A. A.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors</span>. DOI: <span class="refDoi"> DOI: 10.1021/jm4001049</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm4001049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+a+recent+and+broad+review+of+many+different+classes+of+Nampt+inhibitors%2C+see%3AGalli%2C+U.%3B+Travelli%2C+C.%3B+Massarotti%2C+A.%3B+Fakhfouri%2C+G.%3B+Rahimian%2C+R.%3B+Tron%2C+G.+C.%3B+Genazzani%2C+A.+A.+Medicinal+chemistry+of+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+inhibitors.+DOI%3A+10.1021%2Fjm4001049."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm4001049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1021%252Fjm4001049%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DU.%26atitle%3DMedicinal%2520chemistry%2520of%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520inhibitors%26doi%3D10.1021%2Fjm4001049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><div class="note"><p class="first last">Related PRPP adducts have also been described for other Nampt inhibitors. See:</p></div><span class="NLM_contrib-group">Watson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roulston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belec, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billot, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratton, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khadir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawless, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcotte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">–</span> <span class="NLM_lpage">5888</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1128%2FMCB.00112-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=19703994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=5872-5888&author=M.+Watsonauthor=A.+Roulstonauthor=L.+Belecauthor=X.+Billotauthor=R.+Marcellusauthor=D.+Bedardauthor=C.+Bernierauthor=S.+Branchaudauthor=H.+Chanauthor=K.+Dairiauthor=K.+Gilbertauthor=D.+Gouletauthor=M.+O.+Grattonauthor=H.+Isakauauthor=A.+Jangauthor=A.+Khadirauthor=E.+Kochauthor=M.+Lavoieauthor=M.+Lawlessauthor=M.+Nguyenauthor=D.+Paquetteauthor=E.+Turcotteauthor=A.+Berger&title=The+small+molecule+GMX1778+is+a+potent+inhibitor+of+NAD%2B+biosynthesis%3A+strategy+for+enhanced+therapy+in+nicotinic+acid+phosphoribosyltransferase+1-deficient+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors</span></div><div class="casAuthors">Watson, Mark; Roulston, Anne; Belec, Laurent; Billot, Xavier; Marcellus, Richard; Bedard, Dominique; Bernier, Cynthia; Branchaud, Stephane; Chan, Helen; Dairi, Kenza; Gilbert, Karine; Goulet, Daniel; Gratton, Michel-Olivier; Isakau, Henady; Jang, Anne; Khadir, Abdelkrim; Koch, Elizabeth; Lavoie, Manon; Lawless, Michael; Nguyen, Mai; Paquette, Denis; Turcotte, Emilie; Berger, Alvin; Mitchell, Matthew; Shore, Gordon C.; Beauparlant, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5872-5888</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GMX1777 is a prodrug of the small mol. GMX1778, currently in phase I clin. trials for the treatment of cancer.  We describe findings indicating that GMX1778 is a potent and specific inhibitor of the NAD+ biosynthesis enzyme nicotinamide phosphoribosyltransferase (NAMPT).  Cancer cells have a very high rate of NAD+ turnover, which makes NAD+ modulation an attractive target for anticancer therapy.  Selective inhibition by GMX1778 of NAMPT blocks the prodn. of NAD+ and results in tumor cell death.  Furthermore, GMX1778 is phosphoribosylated by NAMPT, which increases its cellular retention.  The cytotoxicity of GMX1778 can be bypassed with exogenous nicotinic acid (NA), which permits NAD+ repletion via NA phosphoribosyltransferase 1 (NAPRT1).  The cytotoxicity of GMX1778 in cells with NAPRT1 deficiency, however, cannot be rescued by NA.  Analyses of NAPRT1 mRNA and protein levels in cell lines and primary tumor tissue indicate that high frequencies of glioblastomas, neuroblastomas, and sarcomas are deficient in NAPRT1 and not susceptible to rescue with NA.  As a result, the therapeutic index of GMX1777 can be widended in the treatment animals bearing NAPRT1-deficient tumors by coadministration with NA.  This provides the rationale for a novel therapeutic approach for the use of GMX1777 in the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT7TUeIRTTIrVg90H21EOLACvtfcHk0liieMiuTHUJcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKntbvE&md5=a6157117d7e67368954ff5ae11986879</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.00112-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00112-09%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DM.%26aulast%3DRoulston%26aufirst%3DA.%26aulast%3DBelec%26aufirst%3DL.%26aulast%3DBillot%26aufirst%3DX.%26aulast%3DMarcellus%26aufirst%3DR.%26aulast%3DBedard%26aufirst%3DD.%26aulast%3DBernier%26aufirst%3DC.%26aulast%3DBranchaud%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DDairi%26aufirst%3DK.%26aulast%3DGilbert%26aufirst%3DK.%26aulast%3DGoulet%26aufirst%3DD.%26aulast%3DGratton%26aufirst%3DM.%2BO.%26aulast%3DIsakau%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DA.%26aulast%3DKhadir%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DE.%26aulast%3DLavoie%26aufirst%3DM.%26aulast%3DLawless%26aufirst%3DM.%26aulast%3DNguyen%26aufirst%3DM.%26aulast%3DPaquette%26aufirst%3DD.%26aulast%3DTurcotte%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DThe%2520small%2520molecule%2520GMX1778%2520is%2520a%2520potent%2520inhibitor%2520of%2520NAD%252B%2520biosynthesis%253A%2520strategy%2520for%2520enhanced%2520therapy%2520in%2520nicotinic%2520acid%2520phosphoribosyltransferase%25201-deficient%2520tumors%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26spage%3D5872%26epage%3D5888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">The antiproliferative effects exhibited in cell culture by <b>7</b> were completely eliminated (“reversed”) when the compound was tested in the presence of 0.33 mM NMN (the product of the Nampt-catalyzed condensation of nicotinamide and PRPP; cf., Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This result strongly suggests that the observed cell-based effects result from Nampt inhibition. Related NMN experiments were conducted in cell-based assessments with all inhibitors reported in this work and all displayed similar reversals of their antiproliferative effects.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">The resolution of the <b>7–</b>Nampt cocrystal structure cannot distinguish the depicted azaindole binding orientation from the rotational isomer which positions the azaindole NH away from Asp219 and toward R311. However, the described orientation optimally locates the azaindole nitrogen atom for condensation with PRPP in the Nampt active site and is thus consistent with the PRPP adduct formation observed for closely related azaindole-containing inhibitors (e.g., <b>8</b>)</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">We currently believe that many cell-potent Nampt inhibitors form PRPP-derived phosphoribosylated adducts in the protein’s active site which block the function of the enzyme. This belief is consistent with the repeated observation of these adducts by mass spectrometry in biochemical experiments (this work and ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>). It is also consistent with the inability to detect similar adduct formation in related experiments with compound <b>10</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and another cell-inactive compound that was nevertheless a potent biochemical Nampt inhibitor (ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>). Once formed, the PRPP adducts may accumulate intracellularly and thereby enhance cell culture antiproliferation effects (see ref <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a> for additional information and discussion). However, there are many other factors that also likely influence Nampt inhibitor cell potency, including the following: biochemical potency, the ability of a given inhibitor and/or its corresponding PRPP-derived ribose adduct to effectively compete with the NAM substrate, cell membreane permeability, and/or protein binding. In addition, performing the PRPP adduct assessments was a relatively resource-intensive task and such determinations were therefore made for only a small number of compounds.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Formation of the <b>11</b>-phosphoribosylated adduct would likely require positioning the inhibitor azaindazole N-atom in the same location occupied by the corresponding atom present in <b>7</b> and <b>8</b>. Such positioning would reorient the azaindazole NH of <b>11</b> relative to the other two molecules and possibly thereby weaken interactions with Nampt.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">As described in this work, compound <b>8</b> (a close structural isomer of compound <b>7</b>) was observed by mass spectrometry to form PRPP-derived adducts in biochemical experiments. Compound <b>58</b> also forms an adduct with PRPP, as evidenced by mass spectrometry analysis of biochemical inhibition reaction mixtures, and we recently solved a crystal structure of phosphoribosylated-<b>58</b> in complex with Nampt. The details associated with the biochemical and crystallography experiments involving the PRPP-derived phosphoribosylated adduct of compound <b>58</b> will be reported in a separate disclosure:</p></div><span class="NLM_contrib-group">Oh, A.; Ho, Y.-C.; Zak, M.; Liu, Y.; Liu, Y.; Yuen, P.-w.; Zheng, X.; Dragovich, P. S.; Wang, W.</span> manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=As+described+in+this+work%2C+compound+8+%28a+close+structural+isomer+of+compound+7%29+was+observed+by+mass+spectrometry+to+form+PRPP-derived+adducts+in+biochemical+experiments.+Compound+58+also+forms+an+adduct+with+PRPP%2C+as+evidenced+by+mass+spectrometry+analysis+of+biochemical+inhibition+reaction+mixtures%2C+and+we+recently+solved+a+crystal+structure+of+phosphoribosylated-58+in+complex+with+Nampt.+The+details+associated+with+the+biochemical+and+crystallography+experiments+involving+the+PRPP-derived+phosphoribosylated+adduct+of+compound+58+will+be+reported+in+a+separate+disclosure%3AOh%2C+A.%3B+Ho%2C+Y.-C.%3B+Zak%2C+M.%3B+Liu%2C+Y.%3B+Liu%2C+Y.%3B+Yuen%2C+P.-w.%3B+Zheng%2C+X.%3B+Dragovich%2C+P.+S.%3B+Wang%2C+W.+manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DA." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Khan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">582</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fnsmb1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=16783377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=582-588&author=J.+A.+Khanauthor=X.+Taoauthor=L.+Tong&title=Molecular+basis+for+the+inhibition+of+human+NMPRTase%2C+a+novel+target+for+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents</span></div><div class="casAuthors">Khan, Javed A.; Tao, Xiao; Tong, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">582-588</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors.  The authors have detd. the crystal structures at up to 2.1-Å resoln. of human and murine NMPRTase, alone and in complex with the reaction product NMN or the inhibitor FK866.  The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies.  FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866.  Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate.  Our structural and biochem. studies provide a starting point for the development of new anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1s-XY1uB70LVg90H21EOLACvtfcHk0lgRqENUd4UQ3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1elt7k%253D&md5=debef567dbcf629422472ef1b63dc396</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1105%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DJ.%2BA.%26aulast%3DTao%26aufirst%3DX.%26aulast%3DTong%26aufirst%3DL.%26atitle%3DMolecular%2520basis%2520for%2520the%2520inhibition%2520of%2520human%2520NMPRTase%252C%2520a%2520novel%2520target%2520for%2520anticancer%2520agents%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D582%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, S. W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eom, S. H.</span><span> </span><span class="NLM_article-title">Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2006&pages=66-77&author=M.+K.+Kimauthor=J.+H.+Leeauthor=H.+Kimauthor=S.+J.+Parkauthor=S.+H.+Kimauthor=G.+B.+Kangauthor=Y.+S.+Leeauthor=J.+B.+Kimauthor=K.+K.+Kimauthor=S.+W+Suhauthor=S.+H.+Eom&title=Crystal+structure+of+visfatin%2Fpre-B+cell+colony-enhancing+factor+1%2Fnicotinamide+phosphoribosyltransferase%2C+free+and+in+complex+with+the+anti-cancer+agent+FK-866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKang%26aufirst%3DG.%2BB.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DJ.%2BB.%26aulast%3DKim%26aufirst%3DK.%2BK.%26aulast%3DSuh%26aufirst%3DS.%2BW%26aulast%3DEom%26aufirst%3DS.%2BH.%26atitle%3DCrystal%2520structure%2520of%2520visfatin%252Fpre-B%2520cell%2520colony-enhancing%2520factor%25201%252Fnicotinamide%2520phosphoribosyltransferase%252C%2520free%2520and%2520in%2520complex%2520with%2520the%2520anti-cancer%2520agent%2520FK-866%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D362%26spage%3D66%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bheda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revollo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolberger, C.</span><span> </span><span class="NLM_article-title">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1038%2Fnsmb1114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=16783373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=661-662&author=T.+Wangauthor=X.+Zhangauthor=P.+Bhedaauthor=J.+R.+Revolloauthor=S.+Imaiauthor=C.+Wolberger&title=Structure+of+Nampt%2FPBEF%2Fvisfatin%2C+a+mammalian+NAD%2B+biosynthetic+enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme</span></div><div class="casAuthors">Wang, Tao; Zhang, Xiangbin; Bheda, Poonam; Revollo, Javier R.; Imai, Shin-ichiro; Wolberger, Cynthia</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">661-662</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (Nampt) synthesizes NMN from nicotinamide in a mammalian NAD+ biosynthetic pathway and is required for SirT1 activity in vivo.  Nampt has also been presumed to be a cytokine (PBEF) or a hormone (visfatin).  The crystal structure of Nampt in the presence and absence of NMN shows that Nampt is a dimeric type II phosphoribosyltransferase and provides insights into the enzymic mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDB0vef67YbVg90H21EOLACvtfcHk0lgtH-pnUav1WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eltLg%253D&md5=ad2fd7f5cf0085896a157d1f1831f8c6</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1038%2Fnsmb1114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb1114%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBheda%26aufirst%3DP.%26aulast%3DRevollo%26aufirst%3DJ.%2BR.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DWolberger%26aufirst%3DC.%26atitle%3DStructure%2520of%2520Nampt%252FPBEF%252Fvisfatin%252C%2520a%2520mammalian%2520NAD%252B%2520biosynthetic%2520enzyme%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D661%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Burgos, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schramm, V. L.</span><span> </span><span class="NLM_article-title">A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">13748</span><span class="NLM_x">–</span> <span class="NLM_lpage">13753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=13748-13753&author=E.+S.+Burgosauthor=M.+C.+Hoauthor=S.+C.+Almoauthor=V.+L.+Schramm&title=A+phosphoenzyme+mimic%2C+overlapping+catalytic+sites+and+reaction+coordinate+motion+for+human+NAMPT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurgos%26aufirst%3DE.%2BS.%26aulast%3DHo%26aufirst%3DM.%2BC.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DSchramm%26aufirst%3DV.%2BL.%26atitle%3DA%2520phosphoenzyme%2520mimic%252C%2520overlapping%2520catalytic%2520sites%2520and%2520reaction%2520coordinate%2520motion%2520for%2520human%2520NAMPT%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D13748%26epage%3D13753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><div class="note"><p class="first last">Compound <b>58</b> also exhibited robust efficacy in xenograft models derived from the other cell lines listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Detailed descriptions of these efficacy assessments and associated PD effects will be presented elsewhere:</p></div><span class="NLM_contrib-group">O’Brien, T.; Xiao, Y.; Oeh, J.; Liang, X.; Vanderbilt, A.; Qin, A.; Yang, L.; Lee, L. B.; Ly, J.; Cosino, E.; LaCap, J. A.; Ogasawara, A.; Nannini, M.; Liederer, B. M.; Jackson, P.; Williams, S.; Dragovich, P. S.; Sampath, D.</span> Submitted to <i>Cancer Res</i>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+58+also+exhibited+robust+efficacy+in+xenograft+models+derived+from+the+other+cell+lines+listed+in+Table+6.+Detailed+descriptions+of+these+efficacy+assessments+and+associated+PD+effects+will+be+presented+elsewhere%3AO%E2%80%99Brien%2C+T.%3B+Xiao%2C+Y.%3B+Oeh%2C+J.%3B+Liang%2C+X.%3B+Vanderbilt%2C+A.%3B+Qin%2C+A.%3B+Yang%2C+L.%3B+Lee%2C+L.+B.%3B+Ly%2C+J.%3B+Cosino%2C+E.%3B+LaCap%2C+J.+A.%3B+Ogasawara%2C+A.%3B+Nannini%2C+M.%3B+Liederer%2C+B.+M.%3B+Jackson%2C+P.%3B+Williams%2C+S.%3B+Dragovich%2C+P.+S.%3B+Sampath%2C+D.+Submitted+to+Cancer+Res."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sikazwe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondarev, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dukat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangisetty, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennon, R. A.</span><span> </span><span class="NLM_article-title">Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5217</span><span class="NLM_x">–</span> <span class="NLM_lpage">5225</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060469q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5217-5225&author=D.+Sikazweauthor=M.+L.+Bondarevauthor=M.+Dukatauthor=J.+B.+Rangisettyauthor=B.+L.+Rothauthor=R.+A.+Glennon&title=Binding+of+sulfonyl-containing+arylalkylamines+at+human+5-HT6+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060469q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060469q%26sid%3Dliteratum%253Aachs%26aulast%3DSikazwe%26aufirst%3DD.%26aulast%3DBondarev%26aufirst%3DM.%2BL.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DRangisetty%26aufirst%3DJ.%2BB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520of%2520sulfonyl-containing%2520arylalkylamines%2520at%2520human%25205-HT6%2520serotonin%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5217%26epage%3D5225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Thurkauf, A.; Chen, D.; Phadke, A.; Li, S.; Deshpande, M.</span><span> </span><span class="NLM_article-title">Preparation of azabenzofuran substituted thioureas as inhibitors of viral replication</span>. WO 2005067900,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Thurkauf&author=D.+Chen&author=A.+Phadke&author=S.+Li&author=M.+Deshpande&title=Preparation+of+azabenzofuran+substituted+thioureas+as+inhibitors+of+viral+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThurkauf%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520azabenzofuran%2520substituted%2520thioureas%2520as%2520inhibitors%2520of%2520viral%2520replication%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehrke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nukkala, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zielinski, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm4008664&amp;key=10.1016%2FS0960-894X%2801%2900759-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm4008664&amp;key=11814821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm4008664&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=465-469&author=Q.+Liauthor=K.+W.+Woodsauthor=A.+Claiborneauthor=S.+L.+Gwaltneyauthor=K.+J.+Barrauthor=G.+Liuauthor=L.+Gehrkeauthor=R.+B.+Credoauthor=Y.+H.+Huiauthor=J.+Leeauthor=R.+B.+Warnerauthor=P.+Kovarauthor=M.+A.+Nukkalaauthor=N.+A.+Zielinskiauthor=S.+K.+Tahirauthor=M.+Fitzgeraldauthor=K.+H.+Kimauthor=K.+Marshauthor=D.+Frostauthor=S.+Ngauthor=S.+Rosenbergauthor=H.+L.+Sham&title=Synthesis+and+biological+evaluation+of+2-indolyloxazolines+as+a+new+class+of+tubulin+polymerization+inhibitors.+Discovery+of+A-289099+as+an+orally+active+antitumor+agent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 2-Indolyloxazolines as a New Class of Tubulin Polymerization Inhibitors. Discovery of A-289099 as an Orally Active Antitumor Agent</span></div><div class="casAuthors">Li, Qun; Woods, Keith W.; Claiborne, Akiyo; Gwaltney, Stephen L., II; Barr, Kenneth J.; Liu, Gang; Gehrke, Laura; Credo, R. Bruce; Hui, Yu Hua; Lee, Jang; Warner, Robert B.; Kovar, Peter; Nukkala, Michael A.; Zielinski, Nicolette A.; Tahir, Stephen K.; Fitzgerald, Michael; Kim, Ki H.; Marsh, Kennan; Frost, David; Ng, Shi-Chung; Rosenberg, Saul; Sham, Hing L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">465-469</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of indole contg. oxazolines has been discovered as a result of structural modifications of the lead compd. A-105972.  The compds. exert their anticancer activity through inhibition of tubulin polymn. by binding at the colchicine site.  A-289099 (I) was identified as an orally active antimitotic agent active against various cancer cell lines including those that express the MDR phenotype.  The anticancer activity, pharmacokinetics, and an efficient and enantioselective synthesis of I are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2tFNZlJzSbbVg90H21EOLACvtfcHk0lgtH-pnUav1WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslKqtQ%253D%253D&md5=01f3a2eb788e454cc65da7ec8b7da409</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900759-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900759-4%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWoods%26aufirst%3DK.%2BW.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DBarr%26aufirst%3DK.%2BJ.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGehrke%26aufirst%3DL.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DHui%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DNukkala%26aufirst%3DM.%2BA.%26aulast%3DZielinski%26aufirst%3DN.%2BA.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DSham%26aufirst%3DH.%2BL.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25202-indolyloxazolines%2520as%2520a%2520new%2520class%2520of%2520tubulin%2520polymerization%2520inhibitors.%2520Discovery%2520of%2520A-289099%2520as%2520an%2520orally%2520active%2520antitumor%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D465%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fyfe, M. C. T.; Thomas, G. H.; Gardner, L. S.; Bradley, S. E.; Gattrell, W.; Rasamison, C. M.; Shah., V. K.</span><span> </span><span class="NLM_article-title">Preparation of furopyridine and pyrrolopyridine derivatives and analogs thereof as G-protein coupled receptor agonists</span>. WO 2006067532,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+C.+T.+Fyfe&author=G.+H.+Thomas&author=L.+S.+Gardner&author=S.+E.+Bradley&author=W.+Gattrell&author=C.+M.+Rasamison&author=V.+K.+Shah&title=Preparation+of+furopyridine+and+pyrrolopyridine+derivatives+and+analogs+thereof+as+G-protein+coupled+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26atitle%3DPreparation%2520of%2520furopyridine%2520and%2520pyrrolopyridine%2520derivatives%2520and%2520analogs%2520thereof%2520as%2520G-protein%2520coupled%2520receptor%2520agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Walker, D. P.; Piotrowski, D. W.; Jacobsen, E. J.; Acker, B. A.; Wishka, D. G.; Reitz, S. C.; Groppi, V. E.,  Jr.</span><span> </span><span class="NLM_article-title">Preparation of N-(azabicyclyl)arylamides for therapeutic use as nicotinic acetylcholine receptor agonists</span>. WO 2003029252,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=D.+P.+Walker&author=D.+W.+Piotrowski&author=E.+J.+Jacobsen&author=B.+A.+Acker&author=D.+G.+Wishka&author=S.+C.+Reitz&author=V.+E.+Groppi&title=Preparation+of+N-%28azabicyclyl%29arylamides+for+therapeutic+use+as+nicotinic+acetylcholine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BP.%26atitle%3DPreparation%2520of%2520N-%2528azabicyclyl%2529arylamides%2520for%2520therapeutic%2520use%2520as%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFN','PDB','4KFN'); return false;">PDB: 4KFN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFO','PDB','4KFO'); return false;">PDB: 4KFO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i97"><a href="/doi/suppl/10.1021/jm4008664">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11410"></div></div></div></div></div><hr /></hr><p class="last">Details of computational methods; details of analytical LCMS methods; in vitro ADME and experimental procedures; experimental details for PK and efficacy study of compound <b>58</b> in the mouse; protein expression/purification and crystallographic methods and procedures for <b>7</b> and <b>58</b> (in complex with Nampt); details of Nampt biochemical and cell-based assays. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4008664/suppl_file/jm4008664_si_001.pdf">jm4008664_si_001.pdf (442.17 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB nos.: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFN">4KFN</a> for <b>7</b> complexed with Nampt; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KFO">4KFO</a> for <b>58</b> complexed with Nampt.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4008664&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm4008664%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4008664" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993b53089f3cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
